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Preterm birth is a significant public health concern as a leading cause of infant mortality; it also 
contributes substantially to childhood and adult morbidity. Other adverse birth outcomes including 
low birthweight are associated with later comorbidities. There is growing evidence that the 
underlying contributors to adverse birth outcomes may include environmental contaminants (like 
metals), but these factors are understudied. Puerto Rico has one of the highest preterm birth rates 
of all U.S. states and territories. Moreover, the population in Puerto Rico is exposed to higher 
levels of many environmental chemicals because of heavily contaminated hazardous industrial 
sites. Even though prenatal exposure to heavy metals has been well investigated, our knowledge 
of the threats to the fetus at low levels of exposure remains rather limited. From animal studies, 
few data are available on the effects of excessive exposure from essential trace elements on adverse 
pregnancy outcomes. As humans are continuously exposed to a mixture of environmental 
toxicants, and typically not to single agents in isolation, there is a pressing need to study the 
relationship of exposures both individually and as mixtures. This dissertation investigates the 
predictors of environmental metal exposures among pregnant women, and the potential of metal 
exposures measured in different media to increase the risk of adverse birth outcomes. The 
interactions between psychosocial stress and the exposure biomarkers on adverse birth outcomes 
are also explored.  
  
The four aims of this dissertation examine a subset of participants from the “Puerto Rico Testsite 
for Exploring Contamination Threats (PROTECT)” cohort. Aim 1 of this dissertation identifies 
levels, trend, and predictors of prenatal exposure for 14 metals. Aim 2 investigates the individual 
and collective effects of metals on adverse birth outcomes. Of all the metals assessed, blood lead 
at low levels, and potentially below current reference levels, was the most strongly associated with 
increased risk of preterm birth and decreased gestational length. Findings in Aim 2 also showed 
that lead, zinc, and manganese may contribute to adverse birth outcomes. Aim 3 explores the 
modifying effect of maternal psychosocial stress on the association between the metal exposure 
 xii 
biomarkers and adverse birth outcomes. Presence of “poor” psychosocial status strengthened the 
adverse associations between Mn and preterm birth, indicating that prenatal psychosocial stress 
may modify vulnerability to metal exposure. Finally, Aim 4 examines the mixture predictive 
performance of urine and blood metal biomarkers, and integrated multimedia biomarkers 
incorporating both matrices, in association with preterm birth. Metal mixtures measured in urine 
(specific gravity corrected), blood, and integrated biomarkers had comparable performance in 
associations with preterm birth, indicating that using urine or blood may be an equally good 
approach to evaluate the metals as a mixture, but only when urine measurements of metal account 
for urinary dilution. 
  
Overall, these results broaden our understanding of the effects of metal mixtures on birth 
outcomes. We identify dietary and behavioral predictors of metal exposures which could inform 
exposure reduction strategies, and potentially result in an eventual reduction in preterm birth rates. 
Furthermore, our novel study design underscores the importance of considering the performance 
of exposure biomarkers measured in different media, and modifying effects of non-chemical 
exposures, when evaluating the relationship between chemical exposures and birth outcomes. 
Further studies are needed to substantiate these findings to advance our knowledge on the impact 





Chapter I  
Introduction 
 
Adverse birth outcomes and environmental exposures in Puerto Rico 
Preterm birth (prematurity) is defined as delivery <37 completed weeks of gestation and is the 
leading cause of newborn death [1, 2]. Survivors are at risk for many adverse health consequences, 
including neuro-developmental delays, disability, chronic respiratory, vision impairment, and 
hearing impairment [1, 3, 4]. In addition to the health consequences of preterm birth, the emotional 
and economic impact of preterm birth on families are high. Therefore, preterm birth and its 
consequences constitute a major public health problem in the United States and worldwide [5]. 
The Institute of Medicine estimates the annual societal economic burden (medical, educational, 
and lost productivity) associated with preterm birth in the United States to be at least $26.2 billion 
in 2005 [5]. Other important adverse birth outcomes including low birthweight (<2500g) and being 
small for gestational age (SGA) may result directly from preterm labor and/or growth restriction 
and also contribute substantially to childhood and adult morbidity [6-8]. 
 
Thus, there is a need to identify risk factors to adverse birth outcomes and find ways to prevent 
preterm birth and low birthweight. This is especially important in a region like Puerto Rico, which 
has one of the highest incidences of preterm births among all US jurisdictions. In addition, Puerto 
Rico has higher rates of childhood obesity and asthma [9-11] as well as adult obesity, metabolic 
syndrome, and diabetes [12, 13] compared to the rest of the U.S., all of which have been associated 
with adverse birth outcomes. Moreover, the traditional risk factors, such as mother’s age and use 
of tobacco and alcohol, do little to explain this high rate of preterm birth and associated 
consequences [14]. Even though there is growing evidence that environmental factors may play a 
key role, these factors remain understudied and underappreciated.  
 
Puerto Rico, a self-governing dependent territory of the United States, has a long-standing history 
of contamination with environmental chemicals, as there are sixteen active Superfund sites and 
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200+ hazardous waste sites [15]. Many of these sites lie on unlined landfills that overlie Karst 
aquifers, which creates pathways for toxic substances to contaminate groundwater. Therefore, the 
risk of human exposure to contamination is high. For example, previous research within this area 
suggests that pregnant women in Puerto Rico may have higher exposure to certain phenols [16, 
17] and phthalates [18], compared to women of reproductive age in the U.S. general population. 
Our preliminary analysis on metals also showed a higher level of exposure among Puerto Rican 
pregnant women compared to the general U.S female population.  
 
The Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) study was launched 
in 2010 with funding from the NIEHS Superfund Research Program and is conducted in Puerto 
Rico because of its high preterm birth rate and the extent of hazardous waste contamination [16, 
17]. A prospective cohort of more than 2000 pregnant women has been recruited since 2010 and 
followed until delivery. PROTECT aims to explore environmental, clinical, demographic, 
behavioral factors contributing to preterm birth risk in Puerto Rico. The project also provides 
information on the predictors and sources of exposure among pregnant women as well as the 
potential mechanistic pathways involved in preterm birth. Particular attention is paid to chemicals 
commonly found at Superfund sites, including phthalates, phenols, and metals, suspected to be 
associated with high preterm birth rates [19-21]. 
 
Exposures to metals 
Metals occur naturally in the environment and enter the human body through ingestion of food, 
supplements, and water, and through inhalation and skin contact of metal-containing products [22, 
23]. In the United States, reports from the National Health and Nutrition Examination Survey 
(NHANES) showed that children and adults have detectable concentrations of a range of metals 
in their bodies [24], including pregnant women and their fetuses because of the trans-placental 
metal transfer [25-27]. 
 
Some of these metals are essential for human health and required for fetal growth, such as cobalt 
(Co), copper (Cu), iron (Fe), magnesium (Mg), manganese (Mn), molybdenum (Mo), selenium 
(Se) and zinc (Zn). At the same time, excess or insufficient exposure poses risks to pregnancy. 
Others can be toxic even at low concentrations [22]; some are reproductive toxicants and 
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neurotoxicants, such as lead (Pb) and mercury (Hg), while others are known as human carcinogens, 
including cadmium (Cd) and arsenic (As). The toxic metals have been shown to induce oxidative 
stress, which plays an important role in the development of many adverse health outcomes, 
including cardiovascular, metabolic, and renal disease [28, 29]. Several metals are also suspected 
endocrine disruptors [30-33].  
 
Prenatal metal exposure and adverse birth outcomes 
Adverse birth outcomes, including pregnancy and fetal growth outcomes, encompass overall and 
spontaneous preterm birth, low birth weight, and small and large for gestational age, etc. [34].  
Pregnant women and developing fetuses have increased vulnerability to the toxicological 
consequences of environmental exposures to metals. Prenatal exposures to metals have been 
suspected risk factors for adverse pregnancy outcomes, including the following: 
 
(1) Pregnancy outcomes (gestational length, preterm and spontaneous preterm birth): Although 
exposure to several metals is highly prevalent [35], with the exception of some heavy metals (Pb, 
Cd, Hg, and As) human studies of exposure and pregnancy outcomes are quite limited: 
 
Pb: Pb is generally present in water, food, air, soil, and dust. Pb is a neurotoxicant [36] and is 
harmful to reproductive health [37]. Pb readily crosses the placenta by passive diffusion, and 
therefore easily enters the fetus from the mother. From studies conducted in the US, Mexico, 
Japan, Indian, China, there is strong evidence for an association between high-level lead 
exposure during pregnancy and significant decreases in gestational length and increased risk 
of preterm birth [38-41]. In addition, limited studies have found evidence of the effect of low 
Pb exposure on pregnancy outcome [42, 43], and one study conducted in upstate New York 
with more than 43,288 mother-infant pairs, with an average blood Pb concentration of 2.1 
μg/dL, found no association of maternal blood Pb with preterm birth but did find a relationship 
between Pb exposure and decreased birth weight [44]. As for the mechanism, Pb may induce 
oxidative stress by producing reactive oxygen species (ROS) that alters the placental functions 
possibly leading to preterm birth [45, 46]. Numerous experimental studies have also indicated 
that Pb increases the parameters of oxidative stress in the placenta [47, 48]. 
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Cd: Cd is a well-known environmental toxic pollutant, and it is accumulated in food, air, and 
water. Once absorbed into the body, Cd can diffuse through the blood to the placenta and pose 
reproductive and fetal toxicity. In early studies, the reports on associations of Cd and preterm 
birth were mixed. Fagher et al. reported associations with higher blood Cd levels and preterm 
delivery among a small cohort of Polish and Swedish women (n=30) [49], while another small 
cohort of women in China (n=44) and an ecologic study conducted among women (n=38,718) 
in southern Sweden both found no association [50, 51]. However, caution must be taken since 
those studies either were ecologic studies or had a small sample size. Recently, large cohort 
studies from China [52, 53] and Japan [54] have reported that maternal serum/urine levels 
of Cd during pregnancy are positively associated with higher risk of preterm births. Studies 
have indicated that Cd can disturb normal fetus growth and pregnancy outcomes by altering 
placental functions, such as the transfer of essential metals (calcium and zinc), and by reducing 
blood flow in the placental tissue [52, 53, 55-57]. 
 
Hg: Hg is a non-essential and toxic metal in the human body. Inorganic Hg does not readily 
cross the placental barrier to enter the fetus; however, elemental and organic Hg are lipid 
soluble and therefore can cross the placenta and cause developmental toxicity to the fetus. 
Among two studies that evaluated the effects of Hg exposure measured in maternal blood on 
birth outcomes, one showed that higher maternal blood Hg was associated with higher risk of 
preterm birth and low birth weight [25], while the other observed a null association [58]. One 
study conducted in Michigan found a positive association between maternal Hg levels in hair 
and risk of very preterm (between 28 to 32 weeks) delivery [59]. 
 
As: As is identified as a human carcinogen by the International Agency for Research on Cancer 
[60]. Among the various routes of As exposure, drinking water and food, especially 
contaminated rice, are the largest sources of As. Both inorganic and methylated organic forms 
of As (the inorganic form is more toxic but also rarer) can easily cross the placenta [55]. A 
number of epidemiological studies have reported that As exposure from drinking water is 
associated with spontaneous abortion, stillbirth, and preterm birth [61-63]. In contrast, a study 
conducted in Taiwan suggested a null association between As levels in well-water in the 
residence and preterm delivery [64]. Animal studies and in vitro studies have proposed that the 
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mechanism of action for As and Hg is similar to Pb. Those metals may activate the oxidative 
perceptive signaling pathways by either forming free radicals or inhibiting anti-oxidative 
enzyme processes, which in turn damage the placental cell and eventually cause preterm 
delivery [65-67] 
 
To date, existing research has focused primarily on the reproductive effects of heavy metals, with 
most reports involving high doses not commonly encountered by pregnant women and fetuses 
[68]. More recently, a growing body of evidence is suggesting that certain essential trace metals, 
including Cu [69, 70] and Ni [71], are associated with an increased risk of preterm delivery.  
However, most of the studies investigating the association between metals and preterm birth were 
cross-sectional. Given the recent evidence, it is imperative to study how both essential and non-
essential metals are affecting pregnancy, at low doses found in everyday environments.   
 
(2) Fetal growth outcomes (birthweight, small or large for gestational age): Low birth weight may 
result directly from preterm labor or growth restriction due to detrimental factors occurring during 
pregnancy, such as lack of nutrition, maternal infection, and exposure to environmental toxicants 
[72]. Small for gestational age (SGA), a manifestation of intrauterine growth restriction (IUGR), 
results when fetuses fail to reach their full genetic growth potential relative to their gestational age 
[73]. Low birth weight and small for gestational age (SGA) correlates with infant mortality, but 
also increased risk of chronic disease and cancer later in life [6-8]. Newborn babies that weigh 
more than usual relative to their gestational age are termed large for gestational age (LGA) and are 
at higher risk of long-term health consequences [74]. Accumulation of toxic metals in the placenta 
may result in altered growth patterns and adverse fetal growth outcomes [57, 75, 76].  As stated 
previously, many human and animal studies have elucidated the effects associated with heavy 
metals (Pb, Cd, Hg, and As) on fetal growth outcomes, mainly on low birth weight and SGA. The 
reports are inconsistent, as described below: 
 
Pb: Pb in maternal blood [44, 77, 78], cord blood [79, 80], and the placenta [55, 81] has 
been significantly negatively correlated with birth weight. While additional evidence of the 
effects of Pb on SGA births were reported [82-84], a few other studies showed lack of 
association between maternal exposure to Pb and SGA [85-88]. 
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Cd: Reports on associations of Cd and fetal growth outcomes have been mixed. One study 
from an e-waste recycling town in China reported no significant correlations between 
placental Cd and birth weight [89]. Urinary Cd was negatively associated with birthweight 
among pregnant women in Tokyo [87] and Toyama [90], Japan, while a similar inverse 
association was found with cord blood Cd in Mexico [91] and Italy [92], and placenta Cd 
in Chile [55]. A different study from Bangladesh found significant inverse associations 
between maternal Cd exposure and birth weight only in girls but not in boys [93]. 
 
Hg: A few studies have suggested a negative correlation between maternal blood Hg levels 
and newborn birth weight [58, 59, 94, 95] while several other studies reported a null 
association between elevated Hg levels and birth weight [96-98].  A Canadian birth cohort 
with 1835 pregnant women reported a small increase in risk for SGA in infants born to 
women with higher exposure to Hg and As. [85] 
 
As: There is considerable evidence for associations between maternal As exposure and low 
birth weight [55, 64, 99, 100] and increased risk of SGA. A causal pathway analysis in a  
Bangladesh population suggested that the toxicological effect of As on fetal growth was 
the result of As exposure decreasing gestational length and maternal weight gain during 
pregnancy [101]. 
 
Recent studies on metals and fetal growth outcomes have also paid more attention to essential trace 
metals; a few studies reported inverted U-shaped dose-response curves for the associations 
between birth weight and maternal metal exposures, including cobalt (Co) [81] and manganese 
(Mn) [102, 103]. These results indicate that both too low and too high metal concentrations may 
affect mechanisms underlying fetal growth. However, other studies found no evidence of 
nonlinearity between trace metals and birth weight [104, 105]. Reports of other metal 
concentrations in relation to birth weight are none to very limited. In addition, most previous 
reports on the effects of metals on pregnancy are from studies usually involving high doses (e.g., 
studies on Pd before the elimination of Pb in paint and gasoline), that are not commonly 
encountered by pregnant women today [38, 68]. However, due to the widespread exposure of 
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humans and known toxicity of these metals, concern is growing that low-level exposure may also 
adversely affect birth outcomes, and several birth cohorts have evaluated the health effects of low-
level exposure to metals during pregnancy [103, 106-110]. Therefore, there is a pressing need to 
study the effects of excessive exposure to essential trace elements on adverse pregnancy outcomes. 
 
In summary, caution must be taken while comparing studies evaluating metals in relation with 
adverse birth outcomes as there were potentially important differences between the studies: 1) 
Study populations and study designs vary across those studies; and 2) Metal concentrations were 
measured in various media (blood, urine, cord blood etc.). In addition, most studies were cross-
sectional and included biological samples from a single time point during pregnancy.  
 
Interaction between metals and psychosocial status during pregnancy 
There is a growing interest in the combined effect of chemical and non-chemical exposures in the 
environment on human health, among which evaluating the interactions and cumulative effects of 
chemicals and stress has been identified as a key research need [111, 112]. Prenatal maternal 
psychosocial status has been found to be associated with an increased risk of adverse pregnancy 
outcomes—psychological distress, perceived stress, anxiety, depression symptoms, and low social 
support among pregnant women were associated with an increased risk of pre-eclampsia [113], 
preterm birth [114-119], and low birth weight [114, 118]. The majority of epidemiologic studies 
in this area to date have evaluated the impact of individual chemical and non-chemical exposures. 
However, pregnant women are exposed to both environmental chemical and psychosocial 
stressors, and psychosocial factors may influence how a particular environmental chemical is 
experienced or what the physical response to it may be. Recently, there has been a general 
acknowledgment that there is likely to be joint effects of environmental chemicals (e.g. phthalates, 
black carbon, lead [Pb]) and psychosocial stress exposure on pregnancy and child development 
outcomes [112, 120-127]. Similarly, when looking at the effect of metals on maternal and children 
health, psychosocial factors are important to consider in deepening our understanding on how the 
environment impacts humans. Ultimately, the identification of modifiable psychosocial factors 
may lead to interventions during pregnancy to reduce the harmful effects of metals on birth 
outcomes.   
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Studying metals as mixtures 
We have summarized inconsistent results from studies assessing the deleterious effect of 
individual metals on adverse birth outcomes. This discrepancy in the literature may be due, in part, 
to the fact that humans are exposed to hundreds of metals and other chemicals simultaneously. 
Moreover, human biomonitoring data have shown the presence of a mixture of metals in the 
prenatal environment [24-26]. Given that variety, we need to characterize associations between 
metals and adverse birth outcomes, not only individually, but also collectively. A few studies 
published recently have specifically focused on the general impact of collective metal exposure 
effects in health outcomes [69, 128-136], and a few have explored metal mixtures in relation to 
adverse birth outcomes [69, 133-136]. PROTECT has one of the largest numbers of toxic and 
essential trace metal analytes measured to date, which enables us to investigate the effects of 
metal(loid)s on adverse birth outcomes both individually and as mixtures. 
 
Challenges in metal mixture exposure assessment 
Epidemiologic studies aiming to determine the effects of environmental chemical mixtures on 
human health are growing rapidly. Due to limiting factors such as the financial cost and 
methodologic challenges, mixture studies based on biomarkers typically use a unified human 
specimen, such as blood or urine to determine exposure to various chemicals [23, 47, 137-139]. 
Although this approach applies well to chemicals with similar structure and pharmacokinetics, it 
is challenging to accurately describe metal mixtures using one unified medium. Each metal 
exhibits unique physiochemical properties and toxicokinetics, such as half-life, storage, or 
elimination rate from the body. As such, the preference for either blood or urine concentration as 
a better indicator is different across metals. For example, urinary concentration of As has often 
been used as an indicator of recent exposure because urine is the main route of excretion of most 
arsenic species [140, 141]. In contrast, blood is the preferred specimen for Pb as blood Pb has a 
longer half-life and subsequently lower variability in the body compared to urine [142]. As for 
other metals such as Mn, Cu, and Cr, there is a lack of consensus in the literature as to which 
biomarker is the most consistent and valid. Previous mixture studies on prenatal metal exposures 
and birth outcomes measured metals in different media including urine [143-146], whole blood 
[135, 147], cord blood [148], toenails [133], and teeth [149]. As mentioned above, each medium 
biomarker depicts levels in a particular body compartment that may have differential biological 
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relevance and may not fully represent the best measure of internal dose for all the metals. 
Therefore, it is imperative that we understand how the choice of different media can impact the 
performance of analyzing chemical mixtures in relation to a certain health outcome. 
 
In conclusion, pregnancy and birth are time periods when the health of women and children is 
most vulnerable to the exposure to chemicals, including metals. While many human and animal 
studies have elucidated the effects associated with non-essential metals and have reported mixed 
effects, less attention has been given to other metals. Moreover, as humans are continuously 
exposed to a mixture of environmental toxicants, which are often correlated, there is a pressing 
need to study the relationship of exposures both individually and as mixtures. We also have a 
limited understanding of how metals interact with psychosocial stress during pregnancy. 
Investigating the sources, predictors, and effects of metal mixtures, their interaction with stress, 
and identifying the specific metal(s) that is/are most critical to adverse pregnancy outcomes are 
paramount for understanding how environmental chemicals impact preterm birth. Characterizing 
modifiable factors, including sources and psychosocial modifiers of metal exposure, could have 
huge public health impact as it potentially leads to contaminant remediation strategies and 
eventually a reduction in preterm birth rates.  
 
Specific Aims 
This dissertation advances our understanding of the effects of metal mixtures on birth outcomes 
by exploring the potential of metal exposures measured in different media to increase the risk of 
adverse birth outcomes. A conceptual diagram outlining the specific aims of this dissertation is 
illustrated in Figure I.1. This dissertation draws upon a prospective birth cohort, The Puerto Rico 
Testsite for Exploring Contamination Threats (PROTECT) study. PROTECT launched in 2010 
with funding from the Superfund Research Program and conducted in Puerto Rico because of its 
high preterm birth rate and the extent of hazardous waste contamination. PROTECT aims to 
explore environmental, clinical, demographic, behavioral factors contributing to preterm birth risk 
in Puerto Rico. The center also aims to provide information on the predictors and sources of 
exposure among pregnant women as well as the potential mechanistic pathways involved in 
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preterm birth. Particular attention is paid to chemicals commonly found at Superfund sites, 
including phthalates and metals, suspected to be associated with high preterm birth rates. 
 
Specific Aim 1: I characterized metal exposures among pregnant women and to identify predictors 
of prenatal metal exposure. Specifically, I analyzed the repeated measurements from up to three 
study visits of urine and blood levels of metals for their distributions, trends, and correlations 
within and between urine and blood biomarkers. I then explored the associations between metal 
concentrations and potential predictors (demographic variables, personal care products, food, and 
water usage) using linear mixed models (LLM) with random intercepts.  
Hypothesis 1: The blood and urine concentrations of metals will be correlated to the different 
degrees for different metals, and the levels of urine, blood metals, and urine/blood ratio are 
comparable to similar cohorts (NHANES) and reports from recent literature. 
 Hypothesis #2: Reported demographics/household characteristics and use of certain personal care 
products will be predictive of concentrations of urinary and blood metals. 
Specific Aim 2: I investigated the associations between blood concentrations of metals and birth 
outcomes (preterm and spontaneous preterm birth, gestational age, birthweight, small for 
gestational age, and large for gestational age). First, I applied multivariate linear and logistic 
regression analyses to assess single pollutant associations between average exposure and each birth 
outcome. Differences in associations between study visits and infant sex were also tested. Upon 
evaluating the results, I utilized two distinct mixtures analysis methods, environmental risk score 
and Bayesian Kernel Machine Regressions (BKMR), to determine the cumulative effect of 
multiple metals and identify the most predictive metals. 
Hypothesis #3:  Increased metal concentrations in blood will be associated with birth outcomes 
and the collective effect of metal mixtures will have greater association with the adverse birth 
outcomes compared to individual metals.  
Specific Aim 3: I examined the extent to which maternal psychosocial status modifies the 
associations between the metal biomarkers and adverse birth outcomes. Using K-means clustering, 
I categorized pregnant women into one of two groups: “good” and “poor” psychosocial status, 
based on overall psychosocial well-being characterized by depression, perceived stress, social 
support, and life events. I then evaluated whether the effect of blood metals (geometric average) 
on adverse birth outcomes varies between two clusters of women. 
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Hypothesis #4:  The associations between metal exposure biomarkers and adverse birth outcomes 
will be stronger in the presence of “poor” psychosocial status. 
Specific Aim 4: I assessed the mixture predictive performance of urine and blood metal 
biomarkers, and integrated multi-media biomarkers, in association with preterm birth. For each 
metal, I integrated exposure estimates from paired urine and blood biomarkers into multi-media 
biomarker (MMB). I then built Environmental risk scores (ERSs) of the metal mixtures to evaluate 
the performance of urine, blood, and multi-media biomarkers by examining the association 
between ERSs and preterm birth, using logistic regressions. 
Hypothesis #5: The use of urine, blood, and the integrated metal mixtures will demonstrate 
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Chapter II  
Predictors of Urinary and Blood Metal(loid) Concentrations Among Pregnant 
Women in Northern Puerto Rico 
 
Abstract 
Background: Given the potential adverse health effects related to toxic trace metal exposure and 
insufficient or excessive levels of essential trace metals in pregnant women and their fetuses, the 
present study characterizes biomarkers of metal and metalloid exposure at repeated time points 
during pregnancy among women in Puerto Rico. Methods: We recruited 1,040 pregnant women 
from prenatal clinics and collected urine, blood, and questionnaire data on demographics, product 
use, food consumption, and water usage at up to three visits. All samples were analyzed for 16 
metal(loid)s: arsenic (As), barium (Ba), beryllium (Be), cadmium (Cd), cobalt (Co), chromium 
(Cr), cesium (Cs), copper (Cu), mercury (Hg), manganese (Mn), nickel (Ni), lead (Pb), titanium 
(Ti), uranium (U), vanadium (V), and zinc (Zn). Urine samples were additionally analyzed for 
molybdenum (Mo), platinum (Pt), antimony (Sb), tin (Sn), and tungsten (W). Results: Mean 
concentrations of most metal(loid)s were higher among participants compared to the general US 
female population. We found weak to moderate correlations for inter-matrix comparisons, and 
moderate to strong correlations between several metal(loid)s measured within each biological 
matrix. Blood concentrations of Cu, Zn, Mn, Hg, and Pb, and urinary concentrations of As, Ni, 
and Co, were shown to reflect reliable biomarkers of exposure. For other metals, repeated samples 
are recommended for exposure assessment in epidemiology studies. Predictors of metal(loid) 
biomarkers included fish and rice consumption (urinary As), fish and canned food (blood Hg), 
drinking public water (blood Pb), smoking (blood Cd), and iron/folic acid supplement use (urinary 
Cs, Mo, and Sb). Conclusions: Characterization of metal(loid) biomarker variation over time and 
between matrices, and identification of important exposure sources, may inform future 




Metals and metalloids occur naturally in the environment and enter the human body through 
ingestion of food, water, and supplements, and the use of metal-containing products via inhalation, 
dermal absorption, and incidental ingestion [1-5]. In the United States, reports from the National 
Health and Nutrition Examination Survey (NHANES) show that children and adults have 
detectable concentrations of a range of metal(loid)s in their bodies [6], including pregnant women 
and their fetuses because of trans-placental metal(loid) transfer [7-9]. Some of these metals are 
essential for human health and required for fetal growth [10, 11], such as cobalt (Co), copper (Cu), 
iron (Fe), magnesium (Mg), manganese (Mn), molybdenum (Mo), nickel (Ni), selenium (Se) and 
zinc (Zn). Excess or insufficient levels of these metals may pose risks to pregnancy [11, 12]. Other 
metal(loid)s do not play an essential physiologic role and can be toxic if present even at low 
concentrations [1, 13, 14]; some, including lead (Pb) and mercury (Hg), are reproductive toxicants 
and neurotoxicants, while others, such as cadmium (Cd) and arsenic (As), are known human 
carcinogens. Several metal(loid)s (Pb, Hg, Cd, As, Mn, Zn) are also suspected endocrine disruptors 
[15-18].  
 
Puerto Rico has a long-standing history of contamination with environmental chemicals, with 
200+ hazardous waste sites and 16 active Superfund sites (the hazardous waste lands identified by 
the EPA as a site for cleanup because it poses a risk to human health and/or the environment) [19]. 
Many contaminated sites are above unlined landfills that overlie Karst aquifers, creating pathways 
for contamination of groundwater and potential drinking water sources. Therefore, the risk of 
human exposure to metal(loid) contamination is high. However, little is known regarding the 
extent and specific sources of human metal(loid) exposure on the island. This is the first study to 
examine distributions, time trends, and predictors of urinary and blood metal(loid) biomarkers 
measured at multiple times during pregnancy among women living in Northern Puerto Rico. 
Characterizing relationships of metal(loid) biomarkers over time and between matrices, and 
identifying important exposure sources to metal(loid)s, may inform risk evaluations in 
epidemiology and targeted approaches to reduce metal(loid) exposure.  
 
2. Methods 
2.1 Study population  
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This study was conducted among pregnant women participating in the Puerto Rico Testsite for 
Exploring Contamination Threats (PROTECT) project [20-23], an ongoing prospective birth 
cohort in the Northern Karst Region of Puerto Rico that began in 2010. PROTECT aims to explore 
environmental toxicants and other factors contributing to preterm birth risk and other adverse birth 
outcomes in Puerto Rico.   
 
Study participants were recruited at approximately 14 ± 2 weeks of gestation at seven prenatal 
clinics and hospitals throughout Northern Puerto Rico and followed until delivery. The present 
analysis reflects 1,040 women recruited into the study thus far at 18 to 40 years of age. Details on 
the recruitment and inclusion criteria have been described previously [20, 21]. Spot urine samples 
were collected from women at three separate study visits (18 ± 2 weeks, 22 ± 2 weeks, and 26 ± 2 
weeks of gestation) and blood samples were collected during the first and third visits. During the 
initial visit, questionnaires collecting demographic information were administered to participants. 
Information on housing characteristics, employment status, and family situation were collected 
during a second, in-home visit using a nurse-administered questionnaire. Household product, 
personal care product use, and water source and usage information were collected at each visit.  
 
The research protocol was approved by the Ethics and Research Committees of the University of 
Puerto Rico and participating clinics, the University of Michigan, and Northeastern University. 
The study was described in detail to all participants, and informed consent was obtained prior to 
study enrollment. 
 
2.2 Measurement of metal(loid)s 
Spot urine was collected in sterile polypropylene cups and aliquoted within one hour after 
collection, while blood samples were collected in metal-free whole blood tubes. All samples were 
frozen and stored at -80°C and shipped on dry ice to NSF International (Ann Arbor, MI, USA) for 
analysis. Concentrations of 16 metals and metalloids (As) were measured in both urine and blood: 
As, barium (Ba), beryllium (Be), Cd, Co, chromium (Cr), cesium (Cs), Cu, Hg, Mn, Ni, Pb, 
titanium (Ti), uranium (U), vanadium (V), and Zn; an additional 5 metals and metalloids 
(antimony) were measured in urine only: Mo, platinum (Pt), antimony (Sb), tin (Sn), and tungsten 
(W). Metal(loid) concentrations were measured using inductively coupled plasma mass 
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spectrometry (ICPMS) as described previously [24]. Considering that biological samples have 
high levels of carbon and chloride in the matrix, the laboratory selected the appropriate isotopes 
for the requested elements to best avoid interferences where possible. The ICPMS was calibrated 
with a blank and a minimum of 4 standards for each element of interest. An R2 value of >0.995 
was the minimum criteria for an acceptable calibration curve. The calibration curves were verified 
by initial checks at three calibration points within the curve. Continuing calibration checks and 
blanks after every 10 samples were also utilized throughout the analytical run to ensure the ICPMS 
system was maintaining acceptable performance. Urinary specific gravity (SG) was measured at 
the University of Puerto Rico Medical Sciences Campus using a hand-held digital refractometer 
(Atago Co., Ltd., Tokyo, Japan) as an indicator of urine dilution.  
 
2.3. Questionnaire 
The product use questionnaire was adapted from questionnaires used in other studies of adults to 
capture information on potential exposure sources with which the pregnant women may have been 
in contact [20, 21]. At each visit, the questionnaire was administered by a study nurse to collect 
data on product and water use. The household/personal care product use section contained yes/no 
questions about the use of different products in the 48-h period preceding biological sample 
collection: bar soap, cologne/perfume, colored cosmetics, conditioner, deodorant, fingernail 
polish, hair cream, hairspray/ hair gel, laundry products, liquid soap, lotion, mouthwash, other hair 
products, shampoo, and shaving cream. In the water use section, participants were asked about the 
type of water utilized for drinking and cooking (municipal water, private well water, 
bottled/delivered water) as well as water storage behaviors (use of water cistern, filtration). In the 
second visit, participants also completed a food frequency questionnaire on the consumption of 
milk, cheese, fish, rice, yogurt, and other foods (never, <1 per month, 1 per month, 2–3 per month, 
1 per week, 2 per week, 3–4 per week, 5-6 per week, 1 per day and 2 or more per day) as well as 
yes/no questions regarding supplement use (iron, folic acid, multivitamin, etc.). 
 
2.4 Data pre-processing for statistical analyses 
To account for urinary dilution, metal(loid) concentrations in urine were corrected for SG using 
the equation: Pc = P[(SGp – 1)/(SGi – 1)]; where Pc is the SG corrected biomarker concentration 
(ng/mL), P is the measured biomarker concentration, SGp is the median urinary specific gravity in 
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this population (1.019), and SGi is the individual’s urinary specific gravity. Biomarker 
concentrations below the limit of detection (LOD) were replaced by LOD/√2. For statistical 
analysis, we included metal(loid)s with at least 50% of samples having concentrations above the 
LOD [25-27].  
 
2.5 Descriptive statistics and comparison to NHANES 
Descriptive statistics [geometric means (GM), geometric standard deviation (GSD), select 
percentiles] of urine and blood concentrations were calculated to describe distributions of 
metal(loid) concentrations among study participants and for comparison with previous reports. 
Using GM and selected percentiles, we compared concentrations measured in the present study 
with those measured in NHANES (2009-2010, 2011-2012, 2013-2014, 2015-2016), including 
women aged between 18 and 40 years (N for urine=1604, N for blood=3585).  
 
2.6 Correlations between and within blood and urine concentrations 
Spearman correlation coefficients and p values were calculated between blood and urine 
concentrations for 10 metal(loid)s (As, Cd, Co, Cs, Cu, Hg, Mn, Ni, Pb, and Zn) that were 
measured in both matrices and detected in >50% of samples; correlations were calculated using 
all samples that have measurements in both matrices. The ratio of urine concentration to blood 
concentration was constructed for each metal(loid) to further evaluate the relationship between the 
two biomarkers. Spearman rank correlations and p values were also calculated to assess 
relationships between different metal(loid)s within the same matrix; two sets of correlations were 
calculated using samples collected at each visit and using GM of metal(loid) concentrations over 
study visits. 
 
2.7 Change in biomarkers across pregnancy (ICCs) and over time 
To test for significant changes in biomarker concentrations across pregnancy (i.e., time points in 
gestation), linear mixed models (LMM) were used to account for repeated measurements from 
individuals. We also assessed the proportion of variance attributed to between-person variability 
across the three time points in pregnancy, using intra-class correlation coefficients (ICCs) and their 
95% confidence intervals [28]. Ranging between 0 (no reproducibility) and 1 (perfect 
reproducibility), ICCs reflect a poor degree of reliability when below 0.40, a moderate to good 
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reliability when between 0.40 and 0.75, and an excellent reliability when above 0.75 [29]. Next, 
to examine the changes in urinary and blood metal(loid) concentrations over time (2011-2017), 
tests of linear trends across study period were conducted by modeling the GM for each individual’s 
repeated measurements, including the year of visit as a continuous variable, and assessing 
statistical significance using the Wald test.  
 
2.8 Predictor selection 
Two approaches were taken to identify potential predictors of metal(loid) concentrations in urine 
and blood. Covariates (predictors) of interest (n=61) included demographic characteristics, 48-h 
recall of product use, dietary supplement intake, food consumption, and water use and sources. In 
the first approach, we regressed each covariate of interest against each measured biomarker, using 
linear mixed effects models (LMMs) with random intercepts. LMM accounts for the intra-
individual correlation and variation of repeated measures over time and lead to smaller and more 
precise standard errors around means. With LMMs, we assessed log-transformed metal(loid) 
concentrations individually as continuous dependent variables; for urinary metal(loid)s, log-
transformed concentrations were further corrected for SG. Potential predictors were modeled 
individually as independent variables. With the purpose of determining a subset of important 
predictor variables for each metal(loid), in the second approach, we fit multivariable LMMs with 
LASSO (least absolute shrinkage and selection operator) regularization (LMMLasso). LASSO 
regularization shrinks estimated regression coefficients corresponding to “weakly associated” 
covariates to zero, thereby embedding variable selection into the estimation procedure [30]. An 
optimal choice of the coefficient for the LASSO regularization (λ), corresponding with the lowest 
Bayesian Information Criterion (BIC), maximizes the probability of selecting the best model. In 
our analysis, for each metal, all predictor variables were entered in the LMMLasso models at the 
same time. The λ was identified using the R package glmmLasso version 1.3.3.  
 
Furthermore, we analyzed associations between log-transformed metal(loid)s concentrations and 
food frequency questionnaire information collected at the second visit, using linear regression. To 
use the same/close time period for biomarkers and supplement use to assess these relationships, 
urine metal(loid) concentrations measured at the second visit and blood metal(loid) concentrations 
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measured at the third visit were used, as blood samples were not collected during the second visit. 
Data were analyzed using R version 3.2.2 and SAS 9.4 (SAS Institute Inc., Cary, NC) 
 
3. Results 
3.1 Descriptive statistics 
A total of 1,285 urine samples and 1,183 blood samples from 1,040 women with measured 
metal(loid) concentrations in either blood and/or urine samples were included in this analysis. 
Among those 1040 women, 660 and 824 women provided urine and blood samples, respectively. 
Demographic characteristics of those women were described previously [23, 31] and are 
summarized in Table II.1. Most women in our study had private insurance, had an education above 
high school, were employed, and were married or in a domestic partnership. Nearly half of them 
had household incomes below $30,000/year. More than 80% of women never smoked while less 
than 2% smoked during pregnancy and 6% reported second-hand smoking exposure (>1 hour per 
day). Nearly all women reported no consumption of alcohol within the last few months. 
Demographic characteristics do not differ between women who provided urine samples (660 
women) and blood samples (842 women).  
 
Descriptive statistics (GM, GSD, select percentiles) are presented in Table II.2.  Nearly all of the 
samples had detectable concentrations for most of the metals (98-100% > LOD), while a majority 
had detectable Cd (74.5% > LOD), Pb (72.1% > LOD), and Sb (90% > LOD) in urine and half 
had detected As (49% > LOD) and Cd (61% > LOD) in blood. 14 urinary metal(loid)s (As, Ba, 
Cd, Co, Cs, Cu, Hg, Mn, Mo, Ni, Pb, Sb, Sn, and Zn) and 10 blood metal(loid)s (As, Cd, Co, Cs, 
Cu, Hg, Mn, Ni, Pb, and Zn) with at least 50% of samples having concentrations higher than LOD 
levels were included in the statistical analysis.  
 
The comparisons with distributions among women 18 to 40 years old from NHANES 2009-10, 
2011-12, 2013-14 and 2015-16 were included in Table II.3 and Table II.4. In the NHANES 
cohort, some metals (Cu, Ni, and Zn) were not measured in urine samples and only Cd, Hg, Mn, 
and Pb were measured in blood samples. When comparing uncorrected urinary metal(loid) 
distributions with women of childbearing age enrolled in NHANES, women in our study had 
higher GM concentrations of all urinary metal(loid)s except for Cd, which were lower among 
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PROTECT women, and Pb, which were similar in the two cohorts. Median concentrations of As, 
Ba, Co, Hg, Mo, and Sb were 2-fold greater among women in this study compared to NHANES. 
PROTECT women had a median concentration of Mn and Sn that were 13 and 5 times greater than 
NHANES, respectively. For blood samples, PROTECT women had higher concentrations of Hg 
and Mn compared to NHANES while NHANES women had Cd and Pb concentrations (GM) that 
were twice as high as PROTECT women. Among women of childbearing age enrolled in 
NHANES, a small portion was pregnant (85 and 185 women in the urine and blood analysis, 
respectively) and the metal concentrations measured among these pregnant women were similar 
to the levels measured among other women included in our NHANES comparison.  
 
3.2 Correlations between and within blood and urine concentrations 
Spearman correlations between metal(loid)s within the same matrix did not differ when we 
calculated using GM of metal(loid) concentrations over study visit or using samples collected at 
each visit. Therefore, we presented the correlations between GM concentrations in Figure II.1. 
When looking across metal(loid)s measured in urine, there were some moderate to strong 
correlations [r=0.47 (Pb and Ba), 0.55 (Cd and Pb), 0.55 (Ni and Co), 0.59 (Ni and Ba)]. There 
were also weak to moderate (r = 0.30 to 0.45) but statistically significant (p< 0.05) correlations 
between several metal(loid)s. The correlations between metal(loid)s in blood were generally 
weaker compared to urinary metal(loid)s with only a few pairs being moderately correlated (Mn 
and Co, r=0.36; Cd and Co, r=0.33; As and Hg, r=0.32).  
 
Spearman correlation coefficients for the same metal(loid)s across urine and blood matrices are 
presented in the last column of Table II.2. Most of the metal concentration in two matrices were 
significantly correlated, with Co (r=0.51) and Cs (r=0.43) having the highest coefficient followed 




Distribution of urine/blood ratios for 10 metals are presented in Figure II.2. GM and median of 
urine/blood ratios were <1 for Cu, Zn, Pb, Mn, and Hg, indicating generally higher concentration 
measured in blood vs urine. Inversely, GM and median of urine/blood ratios were >1 for As, Ni, 
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Cs, and Co, indicating higher concentrations measured in urine vs blood. Cd concentrations were 
similar in two matrices (median urine/blood ratio of 1).  
 
3.4 Change in biomarkers across pregnancy (ICCs) and over time 
Figure II.3 and II.4 show comparisons of urinary and blood concentration distributions for each 
biomarker between study visits. SG-corrected urinary concentrations of metal(loid)s were not 
significantly different between the three visits except for Co, Cs, Cu, Mo, and Zn (p<0.05 for all). 
First visit concentrations were higher compared to later visits for Cs, Mo, and Zn, while Co and 
Cu were higher at the third visit. Blood concentrations of Cs were higher at the first visit, while 
blood concentrations of Cd, Co, Cu, Mn, and Zn were lower, compared to the third visit.  
 
ICCs for urine and blood metal(loid) concentrations and the urine/blood ratio are presented in 
Table II.5. Metals with a urine/blood ratio <1 (Cu, Zn, Pb, Mn, Hg) presented good to excellent 
reliability in blood with ICCs ranging from 0.54-0.78. Among the four metals with only urine 
measurements available, Sn had moderate reproducibility (ICC=0.55), whereas Mo, Sb, and Ba 
had weak reproducibility (ranging from 0.15 to 0.19). Reproducibility varied widely for the 
urine/blood ratio for each metal(loid), with ICCs ranging from 0.07 to 0.48.   
 
Distributions of urinary and blood biomarker concentrations stratified by year are shown in SI 
Figure II.5 and II.6. Results from linear trend tests indicated that the distributions of some 
biomarkers changed slightly over the course of our study period. For example, median levels of 
urine Ba, Cd, Cr, Cs, and blood Cs increased by 20-50% (P for trend<0.05) when comparing earlier 
and later years in the study period; while urinary Mn, Pb, Sb, Sn, and blood Ni and Pb were 
characterized by smaller, 20-30% decreases (P for trend<0.05). 
 
3.5 Predictor selection 
Variable selection analysis revealed several important predictors of urine and blood metal(loid) 
levels. Considering the concentrations of metal(loid)s measured in two matrices and 
reproducibility of different metal(loid)s in our analysis, we presented results for urinary 
concentrations of As, Co, Cs, Mo, and Sb (urine/blood ratio>1) and blood concentrations of Cu, 
Hg, Mn, Pb, and Zn (urine/blood ratio <1). Results from both urinary and blood concentrations of 
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Cd were included as the average urine/blood ratio was 1.  No significant predictors were found for 
either blood or urine Ba, Ni, Sn (data not shown). Here we describe predictors identified by both 
univariable LMMs and multivariable LMMLasso, while Figure II.7 shows all the variables 
selected through either approach. The two statistical approaches gave very similar effect estimates, 
therefore, Figure II.7 presents effect estimates () and confidence intervals (CIs) obtained from 
the univariable LMMs. GM of urinary and blood metal(loid) concentrations in relation to different 
categories of demographic variables, self-reported product use, dietary supplement intake, food 
consumption, and water use are also shown in Table II.6 and Table II.7. 
 
3.5.1 Urine metals  
As: Consuming fish 48 h prior to sample collection had the strongest relationship to urinary As 
concentration, while “other hair product” use, perfume use, and pesticide storage were negatively 
associated with As. Cd: We found strong positive associations between using a metal cistern to 
store water and urine Cd concentration, there was a 0.04 ng/ml difference on Cd concentration 
between women reporting the use of metal cistern and those who used plastic cistern or did not 
use cistern. Weak but significant positive associations were identified between urinary Cd 
concentration with age, parity, pre-pregnancy BMI, and use of perfume. Co: Smoking and 
consuming milk was associated with significantly higher urinary Co; self-reported use of other 
hair product was negatively associated with Co. Cs: Consumption of milk, spinach, folic acid 
supplement and drinking bottled water (vs public water) were positive predictors of higher Cs 
levels in urine. Mo: We found positive associations between self-reported folic acid, iron 
supplement, and peanut butter consumption and urine Mo concentration, while fish consumption 
and drinking filtered water were negatively associated with Mo concentration. Sb: Use of hair 
spray and consumption of folic acid were associated with higher Sb levels, while education and 
use of cosmetics were associated with lower Sb levels. 
 
3.5.1 Blood metals  
Cd: For Cd, smoking (ever, current vs never) was significantly associated with blood levels among 
pregnant women in the study, and the GM concentration difference between current smoker vs 
never smoker (0.13 ng/mL) was stronger than ever smoker vs never smoker (0.02 ng/mL). Cd 
concentrations were higher for women who consumed meat, tomatoes, or collards, and lower for 
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women who consumed multi-vitamins, compared to women who did not consume these items. 
Cu: Self-reported use of shaving cream and other hair product were important predictors of lower 
Cu levels; There was a trend for increasing concentration of Cu with increasing pre-pregnancy 
categories of BMI. Hg: Consuming fish, canned foods (e.g. canned tuna) and tomatoes were the 
strongest predictors of blood Hg levels. Hg concentrations were also higher among women 
with >12 years of education. Mn: Mn concentrations were associated with parity, where 
concentrations among women who had one or more children were significantly higher compared 
to women who had not yet had children. Blood Mn concentrations were lower among women who 
reported using shampoo and other hair products. Water treatment was also negatively associated 
with Mn concentration. Pb: Using bottled water as main drinking source was identified as the most 
significant predictor of lower Pb levels- participants who reported using bottled water as their main 
drinking source had significantly lower concentrations of Pb (0.30 µg/dL) compared to participants 
who drink public supply water (0.36 µg/dL). There were decreasing Pb concentrations associated 
with higher education levels. Zn: Pre-pregnancy BMI and using other hair products were 
negatively associated with blood Zn concentration.  
 
3.6 Findings from the food frequency analysis 
Our analysis of food frequency questionnaire information and metal(loid) concentrations found a 
trend for increasing concentrations of urinary As with increasing rice consumption frequency 
(p<0.05) (Table II.8). The geometric mean concentration of As was 2 fold higher among women 
who consumed rice once per day or more compared to women who consumed rice 2-3 times per 
month or less. Fish consumption frequency was negatively associated with urinary Cd and Pb 
concentrations (Table II.8). A similar trend was also observed for yogurt consumption frequency 
and urinary Sb concentration. In line with the results from the main predictor analysis above, there 
were positive linear trend relationships between meat consumption frequency and blood Cd, and 
fish consumption frequency and blood As and Hg levels (Table II.9). Blood Cs levels also 
increased with increased fish consumption.    
 
4. Discussion 
Our study provided much needed information on exposures to metal(loid)s among pregnant 
women in Northern Puerto Rico. We quantified levels of toxic and essential metal(loid)s in 
 35 
maternal urine and blood, characterized variability of levels across pregnancy, and correlation 
between different metal(loid)s and matrices to better inform the use of metal(loid) biomarkers in 
epidemiology studies. We also identified important predictors of each metal(loid) in blood and 
urine which may suggest possible strategies and considerations for reducing exposure.  
 
4.1 Comparison with other studies  
Table II.10 provides an overview of reported metal(loid) concentrations in other studies of 
pregnant women. Urinary and blood concentrations of some essential metals such as Co, Cu, and 
Zn were within the range of what was reported in previous studies [32-37]. The concentrations of 
Cs in urine and blood were lower in this study compared with other studies of pregnant women in 
Australia and Spain [35, 38]. Urinary Mn concentrations (GM=1.2 ng/mL) in this study exceeded 
those seen in Australia [32] and Mexico [33], while blood Mn concentrations (GM=11.3 ng/mL) 
were comparable with those detected in other studies where the GM or median concentrations 
ranged from 6.5 to 16.1 ng/mL [32, 35, 37, 39].  
 
Ba was only measured in urine and concentrations (GM=2.5 ng/mL) were lower in this study 
compared with Mexican pregnant women (GM=4.0 ng/mL) [33].The levels of Mo and Ni present 
in the urine samples from Puerto Rican pregnant women were similar to the levels reported in 
other studies [32-35]. Studies of Sb and Sn among pregnant women have been much more limited 
in number compared with other essential metals. The concentrations of urine Sb in our study, 
GM=0.1 ng/mL, were lower than the levels reported among Spanish pregnant women [35]. Sn 
levels measured in urine (GM=2.1 ng/mL) were one order of magnitude higher than the Japan 
study [34], where the GM was 0.2 ng/mL; however, this comparison needs to be interpreted 
cautiously given that Sn was only detected among 53% of the samples in the Japan study [34]. 
 
The urinary As concentration reported in our study was comparable to other studies of pregnant 
women while blood As concentrations were lower. The discrepancy between two matrices may be 
attributable to the fact that As in blood is more susceptible to variation as the half-life of inorganic 
As in blood is a few hours compared with a few days in urine [40]. Our study found that the GM 
blood Hg value among Puerto Rican pregnant women was 1.2 ng/mL with 3 participants having 
levels exceeding 5.8 µg/L, U.S. EPA’s current reference dose for blood mercury [41]. 
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Pregnant women in this study had lower urine and blood concentrations of Cd and Pb, compared 
to previous studies mentioned above. This is particularly significant where blood Pb concentrations 
among this population, with GM of 0.33 µg/dL, is the lowest when compared to women in 
NHANES (GM=0.64 µg/dL), and pregnant women in Australia (median= 0.37 µg/dL) [42], Japan 
(GM=0.64 µg/dL) [39], Ohio, US (GM=0.7 µg/dL) [43], Norway (two studies: median=2.5 µg/dL 
and GM=0.75 µg/dL) [37, 44], and South Africa (two studies: median=1.4 µg/dL and median= 2.3 
µg/dL) [36, 45]. In epidemiological studies, higher Pb exposure may mask the effects of other 
exposures [46], therefore, having lower concentrations of Pb, this population may provide an 
opportunity to study the health effects of other metal(loid)s/exposures independent of Pb.  
 
None of the blood samples in our study had Pb concentrations that exceeded the level of concern 
set by CDC, a blood level of 5 µg/dL for pregnant women [47]. However, concerns have been 
raised that even at low levels, prenatal Pb exposure may pose a toxic effect on fetal development 
[48-54].  
 
These differences in metal(loid) concentrations among pregnant women could be mainly due to 
population differences, including different geographical and demographic environment, life style 
and dietary behaviors. The impact of demographic, dietary, and product use patterns during 
pregnancy on the variation of levels for metal(loid)s will be further discussed in this paper.  
 
4.2 Variability of metal(loid) exposures 
Limited studies have measured and/or compared metal(loid) concentrations at different times 
during pregnancy and mainly compared just a few metal(loid)s measured in blood or serum. As 
mentioned above, urinary concentrations of Co, Cs, Cu, Mo, and Zn among pregnant women in 
our study were statistically different between three visits. These different trends in concentration 
may due to an actual increase/decrease of metal(loid) concentrations in the body influenced by the 
change in fetal demand and maternal nutrient supply [55]. Metabolic changes during pregnancy, 
such as the change in glomerular filtration rate [56, 57] and plasma volume expansion [58] may 
also result in different filtration of metal(loid)s from blood into urine throughout pregnancy.  
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Our study reported a significant increase in blood Cd, Co, Cu, Mn, and Zn as gestation progresses. 
Similar increasing trends have been observed in previous studies considering concentrations of 
Co, Cu, and Mn in blood or serum [59-65]. The increasing levels of these metal(loid)s during 
pregnancy may be attributed to the increased intake and/or release of essential nutrients [66, 67]. 
For Cs, lower concentrations in the blood were observed during the third visit which may be 
explained by increasing plasma volume during pregnancy [58]. However, we would expect to see 
similar trends for all metals if the difference is due to metabolic changes during pregnancy.  
 
We also found that urine/blood ratio remained constant for most of the metal over the course of 
pregnancy, except for Cd and Mn where the ratio was higher at the first visit and for Cu which had 
a higher ratio at the third visit (Figure II.8). These trends may reflect the absolute concentration 
changes of the metals in either matrix (the results are consistent with the single matrix results 
described above) and/or the different adjustments of toxicokinetics (distribution, excretion) of 
those metals throughout pregnancy.   
 
Moderate to strong correlations were observed between urinary Pb and Ba (r=0.47) and Ni and Ba 
(r=0.59) (Figure II.1). Lewis et al also reported a strong correlation between urinary Pb and Ba 
(r=0.57) among Mexican pregnant women [33]. There were also a few blood metal(loid)s pairs 
that were moderately correlated (Mn and Co, r=0.36; As and Hg, r=0.32; Cd and Co, r=0.33) in 
our study (Figure II.1). Similar correlations between maternal blood Mn and Co, and As and Hg 
were reported among Norwegian pregnant women [37]. The correlation between As and Hg 
reflects the common source of exposures, seafood, which is consistent with results from our 
predictor analysis, whereas the pattern of correlations we observed between Pb and Ba, Ni and Ba, 
and Mn and Co concentrations could be due to combined use in products, demographic factors, 
and personal behaviors. 
 
Urine and blood are commonly used to measure metal(loid)s in humans [68-70]. For most 
metal(loid)s examined in our study, weak to moderate correlations were observed between 
concentrations measured in both matrices. Most studies use a single human specimen (blood or 
urine) to determine exposure to various metal(loid)s. However, each metal(loid) exhibits unique 
physiochemical properties and toxicokinetics, such as half-life, storage, or elimination rate from 
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the body. As such, the preference for either blood or urine concentration as a better indicator for 
exposure to a given metal(loid) must be coordinated with the predicted toxicokinetics of the 
metal(loid) involved, the time between exposure and specimen collection, and the goals for a 
particular study (e.g. health outcome). For example, since As is excreted relatively rapidly via 
urine, urinary concentration of As is used as an indicator of recent exposure [71, 72]. In 
contrast, blood is the preferred specimen for Pb because Pb has a long biological half-life, resulting 
in less variability of blood concentrations over time [73]. Blood is also the preferred specimen to 
identify exposure to methyl-mercury, the most toxic form of Hg, whereas urine excretion 
represents inorganic Hg exposure [74-76]. For Cd, both urine and blood are useful for detecting 
exposures, as blood Cd primarily reflects recent exposure and urine Cd represents long-term 
exposure [46, 76].  
 
Repeated measures of metal(loid) concentrations in both blood and urine samples enabled us to 
characterize metal(loid) exposures in different biological matrices, their interrelation, and 
variability during pregnancy, and select a better exposure indicator with higher reproducibility and 
abundance for each metal for application in epidemiology studies of pregnancy outcomes. 
Distributions of the ratio of urine/blood for non-essential metal(loid)s and ICCs for two matrices 
are consistent with previous knowledge; 1) the absolute concentrations of Pb and Hg were 
generally higher in blood than in urine (urine/ blood ratios<1 for most samples) and blood samples 
had good to excellent reproducibility (ICC for Pb=0.78, ICC for Hg=0.62); 2) concentrations of 
As were higher in urine (urine/blood ratio >1 for most samples); 3) concentrations of Cd were 
similar in both matrices (mean urine/blood ratio = 1). The concepts presented here for these non-
essential metals can be applied to other metals with similar ratio and reproducibility. It is evident 
from Figure II.2 that, metals with mean urine/blood ratio <1 (Cu, Zn, Mn, Hg, Pb) presented good 
to excellent reliability for blood measurements with ICC ranging from 0.54-0.78, this is consistent 
with studies indicating that blood Mn and Zn concentrations serve as a reasonable indicator of 
exposure [77-79]. The findings also indicate that repeated measurement of essential and non-




Our predictor analysis revealed that some demographics, dietary factors, product use/water use 
behaviors can affect the distribution of various metal(loid)s. Smoking was the most significant 
predictor of blood Cd. We also found that the consumption of several food items (meat, tomato, 
collard) were additional predictors of Cd exposure. These results were somewhat expected given 
that diet and smoking are known sources of human Cd exposure [80]. In this population, we 
identified the consumption of fish as a significant predictor of As levels; rice consumption 
frequency was also positively associated with As levels. These findings are consistent with studies 
reporting increased exposure and possible health hazards associated with consuming As 
contaminated rice [81-85]. The forms of As found in rice are mostly inorganic and far more toxic 
than the organic form found in the environment and food like fish [86]. Fish was also one of the 
main predictors of blood Hg levels along with canned food and tomatoes. Fish and canned food 
(especially canned tuna) are food groups known to be potentially high in Hg [87-89]. However, 
our finding on tomato consumption and blood Hg are contrary to what was reported in previous 
studies where the consumption of tomato products and tropical fruits were associated with 
lower blood Hg [90-92]. The reported use of supplements during pregnancy, including folic acid 
and iron supplements, were significant and positive predictors of urinary Cs, Mo, and Sb 
concentrations. Cs and Mo are often in multi-vitamin and multi-mineral dietary supplements [93, 
94]. It is also plausible that other specific supplementation that wasn’t included in our 
questionnaires may contain those essential metal(loid)s and women in our study may be consuming 
those supplementations along with folic acid and iron supplements. Prenatal multi-vitamin use 
significantly decreased both blood and urine levels of Cd among this population, and this 
observation is supported by findings on the protective effect of vitamin E on heavy metal(loid)s 
absorption among animals [95, 96].  
 
For blood concentrations of metal(loid)s, self-reported use of shaving cream and/or shampoo 
and/or other hair products were important predictors of lower Cu, Hg, Mn, and Zn levels. This 
inverse association may due to a higher frequency of washing behaviors (showering, face washing) 
which could help remove metals from the skin and reduce continued exposure.  
 
While Pb concentrations in the study population were relatively low overall, we found that those 
whose drink AAA public water have higher levels of blood Pb compared to those who mostly 
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drink from bottled water. According to a report published in 2017 by the Natural Resources 
Defense Council, drinking water violations in Puerto Rico had the highest rate among all the U.S. 
jurisdictions with the presence of Pb and other pollutants in the water coming out of the taps during 
2005-2015 [97]. Water treatment was inversely associated with blood Mn levels (among the 
questionnaire answers from women in our study, most treatments are referring to filtration). A 
study that assessed heavy metal(loid) concentrations in urban rivers of Puerto Rico found that Mn 
was the only metal found to exceed maximum contaminant levels established by the EPA for 
drinking water (US EPA: 5 μg/l) [98]. It is plausible that treatment of drinking water in homes 
may help reduce the levels of Mn in the water, therefore reducing exposure. Participants in our 
study who reported using metal cisterns to store water had elevated levels of urinary Cd. Various 
studies have found significantly higher levels of Cd in collected tank water and suggested that the 
main source of Cd in the tank water may be the corrosion of rooftop material since Cd is a common 
impurity in the Zn coating [99-101]. These findings suggest that proper and careful attention 
should be given to modifying household environments and water treatment behaviors when 
developing metal(loid) exposure remediation strategies.   
 
4.4 Strengths and Limitations 
To our knowledge, this is the first study to assess exposure to multiple metal(loid)s among 
pregnant women in Puerto Rico. PROTECT, a large prospective longitudinal cohort study in 
Puerto Rico, provides a unique opportunity to characterize metal(loid) exposure in this population. 
The study design allows for repeated collection of biological samples and questionnaire data to 
account for the varying levels of exposures during pregnancy, and LMM incorporated this full 
richness and structure of the data across pregnancy [21]. We measured a large panel of metal(loid)s 
in two biological matrices, urine and blood, which helps to inform future epidemiological analyses 
because different matrices may be more appropriate for assessing exposure to different 
metal(loid)s [35]. The study does have several limitations. We did not collect detailed information 
regarding the amount of personal product use, and the collection of maternal supplement use is not 
detailed as to specific ingredients and amount ingested. This may have caused non-differential 
misclassification and attenuated our results toward the null in the linear mixed models. Though 
our findings are possibly generalizable to the general pregnant population in Puerto Rico, they may 
not be generalizable to other pregnant women populations, considering that race/ethnicity, 
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personal care product use, dietary patterns, and toxicokinetics may be quite different compared to 
pregnant women in Puerto Rico. 
 
5. Conclusion 
In conclusion, we reported metal(loid)s exposure levels for 14 toxic and essential trace 
metal(loid)s in urine and blood samples from 1,040 pregnant women in Northern Puerto Rico. 
Exposure to many toxic and essential metal(loid)s are high among these women compared to 
women of reproductive age from the general US population. Blood concentrations of Cu, Zn, Mn, 
Hg, and Pb, and urinary concentrations of As, Ni, and Co, were shown to reflect reliable 
biomarkers of exposure. For other metal(loid)s, repeated samples are recommended for exposure 
assessment in epidemiology studies. We further examined a variety of predictors of prenatal 
metal(loid) exposure and found significant associations between potential predictors and 
biomarkers, including fish and rice consumption (urinary As), fish and canned food (blood Hg), 
drinking public water (blood Pb), smoking (blood Cd), and iron/folic acid supplement use (urinary 
Cs, Mo, and Sb). Improved understanding of biomarkers, sources, and pathways of metal(loid)s 
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Table II.1 Demographic characteristics of n = 1,040 pregnant women from Puerto Rico (2011− 2017) 
Variable Mean (SD) 
Maternal Age 26.7 (5.5) 
Parity (# Live Births) 0.7 (0.8) 
Characteristic Category Count (Percent) 
Insurance Type 
Private 607 (58.4%) 
Public (mi salud) 351 (33.8%) 
Missing 82 (7.9%) 
Maternal Education 
<=High school/GED 214 (22.5%) 
Some college or technical school 359 (37.8%) 
College degree 312 (32.8%) 
Master’s degree or higher 36 (3.8%) 
Missing 29 (3.1%) 
Household Income 
<$10,000  266 (25.6%) 
≥$10,000 to <$30,000  287 (27.6%) 
≥$30,000 to <$50,000  207 (19.9%) 
≥$50,000  117 (11.3%) 
Missing 163 (15.7%) 
Marital Status 
Single  206 (19.8%) 
Married or living together 801 (77%) 
Missing 33 (3.2%) 
Gravidity (# Pregnancies) 
0 415 (39.9%) 
1 363 (34.9%) 
>1 229 (22%) 
Missing 33 (3.2%) 
Pre-pregnancy BMI (kg/m2) 
≤25 535 (51.4%) 
>25 to ≤30 309 (29.7%) 
>30 166 (16%) 
Missing 30 (2.9%) 
Smoke During Pregnancy 
Yes 9 (1.1%) 
No 787 (98.6%) 
Employment Status 
Unemployed 626 (62.6%) 
Employed 337 (33.7%) 
Missing 37 (3.7%) 
Smoking 
Never 852 (81.9%) 
Ever 144 (13.8%) 
Current 12 (1.2%) 
Missing 32 (3.1%) 
Exposure to Second-hand Smoking 
None 860 (82.7%) 
Up to 1 hour 43(4.1%) 




Before pregnancy 434(41.7%) 













Table II.2 Urinary and blood concentration of metal(loid)s (ng/ml) in 1,040 pregnant women from Puerto Rico in 2011–2017 
Metal Specimen N (Sample) LOD % >LOD GM GSD 25% 50% 75% 95% rc 
As Urinea 1285 0.3 100 10.9 2.5 6.1 10.8 19.0 46.4 0.27** 
 
Bloodb 1183 0.3 48.9 0.34 1.8 0.21 0.21 0.48 0.99  
Ba Urinea 1285 0.1 99.3 2.5 2.9 1.3 2.5 5.0 12.9  
 
Bloodb 
         
 
Cd Urinea 1285 0.06 74.5 0.12 2.3 0.06 0.12 0.20 0.58 0.25** 
 
Bloodb 1183 0.1 60.9 0.12 1.7 0.07 0.12 0.16 0.27  
Co Urinea 1285 0.05 100 1.0 1.9 0.70 1.0 1.5 2.8 0.51** 
 
Bloodb 1183 0.2 98.2 0.34 1.4 0.28 0.34 0.41 0.57  
Cs Urinea 1285 0.01 100 4.9 1.7 3.7 5.3 7.1 10.7 0.43** 
 
Bloodb 1183 0.04 99.9 1.1 1.4 0.94 1.2 1.4 1.9  
Cu Urinea 1285 2.5 99.3 14.0 1.8 10.0 14.2 19.5 34.5 0.21** 
 
Bloodb 1183 9 99.9 1552 1.3 1393 1562 1740 2096  
Hg Urinea 1285 0.05 98.6 0.60 2.9 0.30 0.59 1.2 3.6 0.33** 
 
Bloodb 1183 0.2 99.9 1.2 1.7 0.85 1.2 1.7 3.0  
Mn Urinea 1285 0.08 100 1.2 1.6 0.95 1.2 1.6 2.3 0.01 
 
Bloodb 1183 2 99.9 11.3 1.4 9.0 11.3 14.0 19.4  
Mo Urinea 1285 0.3 100 58.9 2.0 38.9 62.9 92.2 166  
 
Bloodb 
         
 
Ni Urinea 1285 0.8 98.9 5.4 2.0 3.5 5.5 8.5 15.5 0.06 
 
Bloodb 1183 0.5 96.4 1.0 1.6 0.81 1.0 1.3 2.2  
Pb Urinea 1285 0.1 72.1 0.25 2.7 <LOD 0.27 0.51 1.2 0.17** 
 
Bloodb 1183 0.02 99.9 3.3 1.6 2.5 3.3 4.3 6.4  
Sb Urinea 1285 0.04 90 0.09 1.9 0.06 0.08 0.12 0.22  
 
Bloodb 
         
 
Sn Urinea 1285 0.1 100 2.1 3.0 1.0 1.9 4.0 14.0  
 
Bloodb 
         
 
Zn Urinea 1285 2 100 266 2.5 155 300 498 947 0.07 
 Bloodb 1183 24 99.9 4682 1.3 4248 4752 5252 6055  
Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese 
(Mn); molybdenum (Mo); nickel (Ni); lead (Pb); antimony (Sb); tin (Sn); zinc (Zn); limit of detection (LOD); geometric mean 
(GM); geometric standard deviation (GSD). 
a Includes uncorrected urinary metal concentrations for up to 3 repeated samples per woman (n = 1285 samples) 
b Includes blood metal concentrations for up to 2 repeated samples per woman (n = 1183 samples) 










Table II.3 Uncorrected urinary biomarker concentrations (ng/ml) in n = 660 pregnant women from Puerto Ricoa in 2011− 2017 
and comparison with U.S. population-based samples of women ages 18− 40 from NHANESb 
 Cohort N (Sample) LOD 
% 
>LOD 
GM GSD 25% 50% 75% 95% P valuec 
As PROTECT 1285 0.3 100 10.9 2.5 6.1 10.8 19.0 46.4 <0.01** 
 NHANES 1562 0.26-1.25 97.6 7.3 3.2 3.3 6.4 13.3 62.3  
Ba PROTECT 1285 0.1 99.3 2.5 2.9 1.3 2.5 5.0 12.9 <0.01** 
 NHANES 1561 0.06-0.12 99.5 1.1 2.8 0.58 1.1 2.3 5.6  
Cd PROTECT 1285 0.06 74.5 0.12 2.3 0.06 0.12 0.20 0.58 <0.01** 
 NHANES 1561 0.036-0.056 85.7 0.14 2.8 0.06 0.15 0.28 0.75  
Co PROTECT 1285 0.05 100 1.0 1.9 0.70 1.0 1.5 2.8 <0.01** 
 NHANES 1561 0.023-0.048 99.6 0.44 2.5 0.25 0.41 0.81 1.8  
Cs PROTECT 1285 0.01 100 4.9 1.7 3.7 5.3 7.1 10.7 <0.01** 
 NHANES 1561 0.066-0.12 100 3.8 2.1 2.3 4.1 6.4 11.4  
Cu PROTECT 1285 2.5 99.3 14.0 1.8 10.0 14.2 19.5 34.5  
 NHANES           
Hg PROTECT 1285 0.05 98.6 0.60 2.9 0.30 0.59 1.2 3.6 <0.01** 
 NHANES 1565 0.05-0.13 69.7 0.28 2.9 <LOD 0.25 0.55 1.8  
Mn PROTECT 1285 0.08 100 1.2 1.6 0.95 1.2 1.6 2.3 <0.01** 
 NHANES 1131 0.08-0.13 42.8 0.12 1.8 <LOD <LOD 0.16 0.34  
Mo PROTECT 1285 0.3 100 58.9 2.0 38.9 62.9 92.2 166 <0.01** 
 NHANES 1560 0.8-0.99 100 36.1 2.5 19.6 39.4 69.8 139  
Ni PROTECT 1285 0.8 98.9 5.4 2.0 3.5 5.5 8.5 15.5  
 NHANES           
Pb PROTECT 1285 0.1 72.1 0.25 2.7 <LOD 0.27 0.51 1.2 0.11 
 NHANES 1561 0.03-0.10 96.2 0.27 2.5 0.15 0.27 0.48 1.2  
Sb PROTECT 1285 0.04 90 0.09 1.9 0.06 0.08 0.12 0.22 <0.01** 
 NHANES 1561 0.022-0.041 69.4 0.05 2.3 <LOD 0.05 0.08 0.21  
Sn PROTECT 1285 0.1 100.0 2.1 3.0 1.0 1.9 4.0 14.0 <0.01** 
 NHANES 1130 0.09-0.22 86.2 0.43 3.2 0.18 0.38 0.88 3.3  
Zn PROTECT 1285 2 100 266 2.5 155 300 498 947  
 NHANES           
Abbreviations: National Health and Nutrition Examination Survey (NHANES); arsenic (As); barium (Ba); cadmium (Cd); cobalt 
(Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); molybdenum (Mo); nickel (Ni); lead (Pb); antimony (Sb); tin 
(Sn); zinc (Zn); limit of detection (LOD); geometric mean (GM); geometric standard deviation (GSD). 
a Includes biomarker concentrations for up to 3 repeated samples per woman (n = 1,285 samples) 
b Females 18−40 years of age; n = 1,604 for biomarkers measured in 2009-2010, 2011-2012, 2013-2014, and 2015-2016 NHANES 







Table II.4 Blood biomarker concentrations (ng/ml) in n = 842 pregnant women from Puerto Ricoa in 2011− 2017 and 
comparison with U.S. population-based samples of women ages 18− 40 from NHANESb 
 Cohort N (Sample) LOD 
% 
>LOD 
GM GSD 25% 50% 75% 95% P valuec 
As PROTECT 1183 0.3 48.9 0.34 1.8 0.21 0.21 0.48 1.0  
 NHANES           
Cd PROTECT 1183 0.1 60.9 0.12 1.7 0.07 0.12 0.16 0.27 <0.01** 
 NHANES 3393 0.1-0.16 83.0 0.31 2.2 0.17 0.28 0.48 1.4  
Co PROTECT 1183 0.2 98.2 0.34 1.4 0.28 0.34 0.41 0.57  
 NHANES           
Cs PROTECT 1183 0.04 99.9 1.1 1.4 0.94 1.2 1.4 1.9  
 NHANES           
Cu PROTECT 1183 9 99.9 1552 1.3 1393 1562 1740 2096  
 NHANES           
Hg PROTECT 1183 0.2 99.9 1.2 1.7 0.85 1.2 1.7 3.0 <0.01** 
 NHANES 3393 0.16-0.28 87.9 0.74 2.5 0.37 0.67 1.4 4.0  
Mn PROTECT 1183 2 99.9 11.3 1.4 9.0 11.3 14.0 19.4 <0.01** 
 NHANES 2174 0.99-1.06 100.0 10.7 1.4 8.4 10.6 13.6 19.2  
Ni PROTECT 1183 0.5 96.4 1.0 1.6 0.81 1.0 1.3 2.2  
 NHANES           
Pb PROTECT 1183 0.02 99.9 3.3 1.6 2.5 3.3 4.3 6.4 <0.01** 
 NHANES 3393 0.7-2.5 98.8 6.4 1.8 4.4 6.1 9.0 16.9  
Zn PROTECT 1183 24 99.9 4682 1.3 4248 4752 5252 6055  
 NHANES           
Abbreviations: National Health and Nutrition Examination Survey (NHANES); arsenic (As); cadmium (Cd); cobalt (Co); cesium 
(Cs); copper (Cu); mercury (Hg); manganese (Mn); nickel (Ni); lead (Pb); zinc (Zn); limit of detection (LOD); geometric mean 
(GM); geometric standard deviation (GSD). 
a Includes biomarker concentrations for up to 2 repeated samples per woman (n = 1,183 samples) 
b Females 18−40 years of age; n = 3,585 for biomarkers measured in 2009-2010, 2011-2012, 2013-2014, and 2015-2016 NHANES 















Figure II.1 Heat map of pairwise correlations between urine and blood GM concentrations among pregnant women in the 
PROTECT studyab 
   
                                               Urine                                                                                                Blood 
 
Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese 
(Mn); molybdenum (Mo); nickel (Ni); lead (Pb); antimony (Sb); tin (Sn); zinc (Zn). 
a The correlation heat map was created using natural log-transformed urinary or blood metal(loid) concentrations 








Figure II.2 Ratio of metal(loid) concentrations in urine and blood samples (n=509)a 
 
Abbreviations: arsenic (As); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); nickel (Ni); 
lead (Pb); zinc (Zn). 





































Figure II.3 SG-corrected urinary concentrations (ng/mL) of metal(loid)s by study visit (n=1285)a  
 
Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese 
(Mn); molybdenum (Mo); nickel (Ni); lead (Pb); antimony (Sb); tin (Sn); zinc (Zn). 

























Figure II.4 Blood concentrations(ng/mL) of metal(loid)s by study visit (n=1183)a  
 
Abbreviations: arsenic (As); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); nickel (Ni); 
lead (Pb); zinc (Zn). 


































Table II.5 Intraclass correlation coefficients (ICCs) and 95% confidence for natural log-transformed urinary and blood 
concentrations of biomarkers and ratio of urine and blood concentrations 
 Urineab Bloodc 
Urine/Blood 
Ratiode 
    
biomarker ICC (95% CI) ICC (95% CI) ICC (95% CI) 
As 0.21 (0.15,0.29) 0.25 (0.17,0.36) 0.20 (0.08,0.42) 
Ba 0.19 (0.13,0.28) - - 
Cd 0.18 (0.12,0.26) 0.48 (0.41,0.56) 0.18 (0.07,0.39) 
Co 0.27 (0.21,0.36) 0.16 (0.07,0.3) 0.07 (0.00,0.53) 
Cs 0.31 (0.25,0.38) 0.77 (0.72,0.8) 0.40 (0.25,0.56) 
Cu 0.21 (0.15,0.3) 0.68 (0.62,0.74) 0.22 (0.06,0.56) 
Hg 0.51 (0.46,0.57) 0.62 (0.56,0.68) 0.43 (0.29,0.59) 
Mn 0.13 (0.07,0.21) 0.54 (0.44,0.6) 0.31 (0.15,0.53) 
Mo 0.15 (0.09,0.23) - - 
Ni 0.13 (0.07,0.23) 0.13 (0.05,0.27) 0.22 (0.08,0.48) 
Pb 0.08 (0.03,0.2) 0.78 (0.73,0.81) 0.22 (0.07,0.48) 
Sb 0.17 (0.11,0.26) - - 
Sn 0.55 (0.49,0.61) - - 
Zn 0.39 (0.33,0.46) 0.75 (0.7,0.79) 0.48 (0.35,0.62) 
Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese 
(Mn); molybdenum (Mo); nickel (Ni); lead (Pb); antimony (Sb); tin (Sn); zinc (Zn). 
a Among 660 women who had urine samples available, 184 had data from all three visits, 257 had data from two visits, and 219 
had data from one visit 
b specific gravity corrected concentration 
c Among 842 women who had blood samples available, 341 had data from both visits, and 501 had data from one visit 
d Among 403 women who had both urine and blood samples available, 106 had data from both visits, and 297 had data from one 
visit 























Figure II.5 Distribution of urinary biomarker concentrations (ng/mL) among 660 pregnant women in Puerto Rico over study 
years (2011–2017)ab 
 
Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese 
(Mn); molybdenum (Mo); nickel (Ni); lead (Pb); antimony (Sb); tin (Sn); zinc (Zn). 
a 2011 and 2012, 2015 and 2016 are combined to have even numbers of samples in each box 






















Figure II.6 Distribution of blood biomarker concentrations (ng/mL) among 842 pregnant women in Puerto Rico over study years 
(2011–2017)ab 
 
Abbreviations: arsenic (As); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); nickel (Ni); 
lead (Pb); zinc (Zn). 
a 2011 and 2012, 2016 and 2017 are combined to obtain a balanced number of samples in each box 





































































Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); molybdenum (Mo); nickel (Ni); lead (Pb); 
antimony (Sb); tin (Sn); zinc (Zn). 
△ Variables also selected as predictors of metal(loid) exposure from multivariable LMMLasso models 
a In this figure, covariates that were not associated with any metal(loid) concentrations in the univariable and multivariable analysis were not included in the y-axis 











































Table II.6 Geometric means of urinary (SG-corrected) and blood concentrations of metal(loid)s according to demographic, and maternal factorsab 
 Urinary metal(loid)s Blood metal(loid)s 
Variable As Cd Co Cs Mo Sb Cd Cu Hg Mn Pb Zn 
overall 10.9 0.12 1.0 4.9 1.2 0.09 0.12 1552 1.2 11.3 3.3 4682 
maternal age (years)             
<25  0.11  5.0  0.10 0.11  1.1    
25-30  0.13  5.4  0.09 0.11  1.3    
>30  0.17  5.8  0.09 0.13  1.3    
p value  <0.001**  <0.001**  <0.001** 0.02**  <0.001**    
maternal education              
<=high school/ged    4.8  0.10   1.1 11.7 4.05  
some college or  
technical school 
   5.3  0.10   1.2 11.4 3.20  
college degree    5.6  0.08   1.3 10.9 2.99  
master’s degree or higher    5.7  0.08   1.5 11.0 3.28  
p value    <0.001**  <0.001**   <0.001** 0.01** <0.001**  
parity (# pregnancies)             
0  0.12     0.11 1516  10.8 3.09  
1  0.13     0.11 1589  11.3 3.34  
>1  0.14     0.13 1560  12.2 3.75  
p value  0.003**     0.01** 0.03**  <0.001** <0.001**  
prepregnancy BMI  
(kg /m2) 
            
≤25  0.12     0.12 1477  10.9  4585 
>25 to ≤30  0.14     0.12 1603  11.7  4759 
>30  0.14     0.10 1684  11.6  4825 
p value  0.004**     <0.001** <0.001**  0.01**  0.005** 
smoking             
never   1.1    0.11    3.23  
ever   1.2    0.13    3.75  
current   0.9    0.25    4.21  
p value (ever vs never)   <0.001**    <0.001**    0.001**  
p value (current vs never)       <0.001**      
Abbreviations: arsenic (As); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); molybdenum (Mo); lead (Pb); antimony (Sb); zinc (Zn). 
a Results shown for food items with association detected 








Table II.7 Frequencies of product use, dietary supplement intake, food consumption, and water use and sources in the 48-h recall questionnaire and geometric mean urinary (SG-
corrected) and blood concentrations of metal(loid)s (ng/mL) associated with self-reported use or non-useab 
 
  Urinary metal(loid)s Blood metal(loid)s 
Variable Use n=660 
N= 
1285 





Cd Cu Hg Mn Pb Zn 
Products                  
cosmetic yes 435 845      0.09 568 787  1531 1.3 11.0 3.2  
 no 146 308      0.10 185 259  1604 1.1 11.7 3.6  
p value         0.01**    0.01** 0.02** 0.01** 0.01**  
perfume yes 484 965 11.5 0.13 1.1  62.7  628 868       
 no 97 188 13.1 0.12 1.2  69.9  124 176       
p value    0.05* 0.05* 0.04**  0.02**          
shaving cream yes 48 94   1.1 5.5   67 90  1471 1.2    
 no 533 1060   1.1 5.4   687 957  1556 1.2    
p value      0.77 0.93      0.16 0.23    
shampoo yes 409 815       541 743    11.0   
 no 172 338       213 302    11.6   
p value               0.10   
hairspray yes 196 395      0.10 243 337       
 no 384 759      0.09 507 705       
p value         0.12         
other hair 
product 
yes 81 81 10.2  1.0    109 112  1457  10.1 3.1 4366 
 no 499 1073 11.9  1.1    645 934  1560  11.3 3.3 4716 
p value    0.21  0.06*       0.01**  <0.001** 0.01** 0.002** 
store pesticide yes 342 668 11.1      467 643    10.9 3.1  
 no 238 483 12.7      285 401    11.5 3.6  













Table II.7 continued 
 
  Urinary metal(loid)s Blood metal(loid)s 
Variable Use n=660 
N= 
1285 





Cd Cu Hg Mn Pb Zn 
Food items                  
milk yes 485 979   1.1 5.5   622 873       
 no 96 174   1.0 4.7   133 175       
p value      0.02** <0.001**           
meat yes 360 729       470 654 0.12      
 no 221 424       285 394 0.11      
p value            0.01**      
fish yes 106 211 14.99    59.3  144 182  1485 1.5    
 no 475 942 11.11    64.8  611 866  1563 1.2    
p value    <0.001**    0.03**     0.03** <0.001**    
cold cuts yes 360 719 11.2 0.13     476 663    11.2   
 no 221 433 12.7 0.14     279 385    11.0   
p value    0.04** 0.05*          0.46   
peanut butter  yes 45 101   1.2  69.1  64 90       
 no 535 1051   1.1  63.3  690 957       
p value      0.04**  0.10          
can foods yes 303 601       393 557   1.3    
 no 277 551       362 491   1.1    
p value              <0.001**    
spinach yes 35 69    6.1   46 57       
 no 545 1083    5.3   709 991       
p value       0.01**           
tomatoes yes 218 442       293 409 0.12  1.3    
 no 362 710       462 639 0.11  1.2    
p value            0.02**  0.01**    
collard 
yes 42 72       31 40 0.14      
no 538 1080       724 1008 0.12      











Table II.7 continued 
 
  Urinary metal(loid)s Blood metal(loid)s 
Variable Use n=660 
N= 
1285 





Cd Cu Hg Mn Pb Zn 
Supplements 
                 
folic acid 
yes 172 344   1.2 5.7 67.4 0.10 213 298       
no 434 864   1.1 5.2 62.3 0.09 606 856       
p value      0.05* <0.001** 0.03** 0.001**         
multi-vitamin 
yes 570 1145  0.13     775 1089 0.12      
no 38 68  0.15     45 66 0.13      
p value     0.27       0.19      
iron supplement 
yes 36 64     73.07  36 48       
no 569 1142     63.19  779 1101       






























Table II.7 continued 
 
  Urinary metal(loid)s Blood metal(loid)s 
Variable Use n=660 
N= 
1285 





Cd Cu Hg Mn Pb Zn 
Water usage 
                 
water source  
for drinking a 
bottled  236 479    5.7   361 507     3.0  
public  382 742    5.2   446 629     3.6  
p value 
      0.001**         <0.001**  
water treatment  
yes 147 299       162 231    10.7   
no 471 923       650 913    11.3   
p value 
              0.04**   
water filtration  
frequency b 
~ never 235 469     65.7  289 398       
~ 1/4 of the time 51 97     61.2  60 86       
~ 1/2 of the time 51 93     60.3  66 99       
~ 3/4 of the time 22 42     63.3  59 80       
always 247 496     62.6  327 465       
p value (yes/no) 
       0.13          
cistern material  
plastic 193 370  0.12     211 307       
metal 10 18  0.16     12 18       
other 13 32  0.13     14 21       
p value  
   0.02**             
Abbreviations: number of participants (n); number of samples (N); arsenic (As); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); 
molybdenum (Mo); lead (Pb); antimony (Sb); zinc (Zn). 
a Results shown for food items with association detected 















Table II.8 Frequencies of selected food type consumption reported in second visit and sg-corrected urinary geometric mean concentrations of metal(loid) biomarkers (ng/ml) 
associated with self-reported frequencya 
Food Item Frequency category nc As Ba Cd Co Cs Cu Hg Mn Mo Ni Pb Sb Sn Zn 
fish 
Never 22 11.3 2.9 0.22 1.3 5.2 14.8 0.63 1.2 76.9 5.9 0.34 0.10 2.0 349 
<1 per month 46 11.7 2.8 0.13 1.1 5.5 14.7 0.66 1.4 73.0 6.5 0.29 0.09 2.5 272 
1 per month 44 10.5 3.0 0.14 1.3 5.6 15.2 0.60 1.3 65.9 6.6 0.25 0.09 2.6 236 
2–3 per month 55 11.6 2.5 0.12 1.1 5.2 13.5 0.59 1.3 57.4 5.9 0.26 0.09 1.9 245 
1 per week 12 12.3 3.0 0.08 1.1 5.7 18.8 0.94 1.3 67.5 8.8 0.18 0.08 4.3 248 
3–4 per week and more 13 16.6 2.5 0.1 1.0 5.4 14.6 0.44 1.2 76.2 5.4 0.20 0.09 1.9 400 
P valueb     0.20 0.61 0.02** 0.06* 0.96 0.95 0.51 0.62 0.37 0.90 0.04** 0.52 0.89 0.90 
rice 
2–3 per month or less 19 8.7 2.9 0.12 1.1 4.9 13.9 0.72 1.4 60.6 5.6 0.29 0.09 2.1 257 
1 per week 11 10.5 2.2 0.08 1.1 5.3 12.0 0.49 1.3 57.3 5.4 0.23 0.09 1.9 185 
2 per week 25 11.2 3.3 0.23 1.3 5.7 14.6 0.73 1.2 67.3 6.2 0.20 0.07 2.0 240 
3–4 per week 65 10.5 2.6 0.12 1.2 5.9 15.7 0.52 1.4 65.4 7.4 0.23 0.10 2.5 288 
5-6 per week 30 15.2 2.7 0.14 1.0 5.4 15.0 0.80 1.3 74.1 5.6 0.30 0.09 2.6 253 
1 per day and more 37 13.4 3.5 0.15 1.2 4.8 14.5 0.58 1.2 69.3 6.4 0.37 0.10 2.6 332 
P valueb   0.02** 0.50 0.55 0.77 0.65 0.51 0.83 0.35 0.25 0.57 0.09* 0.20 0.27 0.09* 
Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); molybdenum (Mo); nickel (Ni); lead (Pb); 
antimony (Sb); tin (Sn); zinc (Zn). 
a Results shown for food items with association detected 
b p-values are from linear mixed effects models accounting for within-person correlations: *P from 0.1 to 0.05, **P <0.05 






















Table II.9 Frequencies of selected food type consumption reported in second visit and blood geometric mean concentrations of metal(loid) biomarkers (ng/ml) measured in third 
visit associated with self-reported frequencya 
Food item Frequency category nc As Cd Co Cs Cu Hg Mn Ni Pb Zn 
Meat 
<1 per month 40 0.40 0.11 0.38 1.0 1614 1.3 12.3 1.1 3.3 4638 
1 per month 41 0.31 0.12 0.36 1.1 1623 1.2 12.6 1.1 3.2 4815 
2–3 per month 89 0.31 0.11 0.39 1.1 1613 1.1 12.7 1.0 3.4 4776 
1 per week 32 0.32 0.14 0.36 1.1 1489 1.2 11.5 0.94 3.3 4698 
2 per week 29 0.31 0.13 0.38 1.2 1571 1.2 11.6 1.0 3.3 4681 
3–4 per week and more 26 0.31 0.14 0.43 1.0 1669 1.1 11.9 1.2 3.2 4628 
P valueb     0.16 0.02** 0.27 0.35 0.78 0.26 0.26 0.80 0.76 0.69 
fish 
Never 51 0.29 0.11 0.40 1.0 1635 0.9 12.5 1.0 3.3 4856 
<1 per month 46 0.35 0.12 0.38 1.0 1596 1.1 12.3 1.1 3.4 4726 
1 per month 62 0.30 0.13 0.38 1.1 1667 1.2 12.7 1.0 3.3 4780 
2–3 per month 69 0.32 0.12 0.36 1.1 1547 1.3 11.6 1.0 3.1 4561 
1 per week 14 0.43 0.12 0.35 1.2 1525 1.3 12.6 1.0 3.4 4717 
3–4 per week and more 18 0.43 0.11 0.45 1.4 1514 1.4 13.5 0.94 3.8 4925 
P valueb   0.02** 0.54 0.71 <0.01** 0.06 <0.01** 0.91 0.20 0.73 0.60 
Abbreviations: arsenic (As); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); nickel (Ni); lead (Pb); zinc (Zn). 
a Results shown for food items with association detected 
b p-values are from linear mixed effects models accounting for within-person correlations: **P <0.05 





















Table II.10 Urinary and blood metal(loid) concentrations among pregnant women in PROTECT and previous studiesa 




















































Kalloo et al, 2018 Ohio, US 
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0.2
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Table II.10 Continued 
 





















































Kalloo et al, 2018 Ohio, US 
2003-
2006 
389 -  - - - - - -   
0.7
0 
  - - GM 
ng/m
L 
Callan et al. 2013 Australia 
2008-
2011 
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172 -  
0.3
8 
- - - 
0.4
6 
-  - 
0.3
7 
  - - Median 
ng/m
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172 -  - - 
1.
9 
- - -  - -   - - Median 
ng/m
L 
Birgisdottir et al 
2013 
Norway 2003 184 5.9  
0.4
5 
- - - 4.0 -  - 2.5   - - Median 
ng/m
L 
Hansen et al, 2011 Norway 
2007-
2009 




















Mathee et al, 2014 South Africa 2010 307 8.0  
0.2
0 
- - - 
0.6
0 
-  - 1.4   - - Median 
ng/m
L 





































  - - GM 
ng/m
L 
Abbreviations: sample size (n); arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese (Mn); molybdenum (Mo); nickel (Ni); 
lead (Pb); antimony (Sb); tin (Sn); zinc (Zn); geometric mean (GM); trimester (trim); not reported (nr). 
a To allow for comparison on same scale, the urine concentrations were converted to ng/mL for unadjusted urine, µg/g for creatinine adjusted urine, and blood concentrations were 
converted to ng/mL 
b - No correction applied, SG corrected for specific gravity Crt corrected for creatinine 








Figure II.8 Urine/blood ratio distribution by study visit (n=509)a 
 
Abbreviations: arsenic (As); barium (Ba); cadmium (Cd); cobalt (Co); cesium (Cs); copper (Cu); mercury (Hg); manganese 
(Mn); molybdenum (Mo); nickel (Ni); lead (Pb); antimony (Sb); tin (Sn); zinc (Zn). 









Chapter III  
Maternal Blood Metal and Metalloid Concentrations in Association with Birth 




Background: In previous studies, exposures to heavy metals such as Pb and Cd have been 
associated with adverse birth outcomes; however, knowledge on effects at low levels of exposure 
and of other elements remain limited. Method: We examined individual and mixture effects of 
metals and metalloids on birth outcomes among 812 pregnant women in the Puerto Rico Testsite 
for Exploring Contamination Threats (PROTECT) cohort. We measured 16 essential and non-
essential metal(loid)s in maternal blood collected at 16–20 and 24–28 weeks gestation. We used 
linear and logistic regression to independently examine associations between geometric mean 
(GM) concentrations of each metal across visits and gestational age, birthweight z-scores, preterm 
birth, small for gestational age (SGA), and large for gestational age (LGA). We evaluated effect 
modification with infant sex*metal interaction terms. To identify critical windows of 
susceptibility, birth outcomes were regressed on visit-specific metal concentrations. Furthermore, 
average metal concentrations were divided into tertiles to examine the potential for non-linear 
relationships. We used elastic net (ENET) regularization to construct Environmental Risk Score 
(ERS) as a metal risk score and Bayesian Kernel Machine Regression (BKMR) to identify 
individual metals most critical to each outcome, accounting for correlated exposures. Results: In 
adjusted models, an interquartile range (IQR) increase in GM lead (Pb) was associated with 1.63 
higher odds of preterm birth (95%CI=1.17, 2.28) and 2 days shorter gestational age (95% CI=-3.1, 
-0.5). Manganese (Mn) and zinc (Zn) were also associated with higher odds of preterm birth and 
shorter gestational age; the associations were strongest among the highest tertile for Mn and among 








of pregnancy. Ni measured later in pregnancy was associated with lower odds of SGA. ENET and 
BKMR models selected similar metals as “important” predictors of birth outcomes. The 
association between ERS and preterm birth was assessed and the third tertile of ERS was 
significantly associated with an elevated odds ratio of 2.13 (95% CI= 1.12, 5.49) for preterm birth 
compared to the first tertile. Conclusion: As the PROTECT cohort has lower Pb concentrations 
(GM=0.33 μg/dL) compared to the mainland US, our findings suggest that low-level prenatal lead 
exposure, as well as elevated Mn and Zn exposure, may adversely affect birth outcomes. Improved 
understanding on environmental factors contributing to preterm birth, together with sustainable 
technologies to remove contamination, will have a direct impact in Puerto Rico and elsewhere. 
 
1. Introduction 
Preterm birth (<37 completed weeks of gestation) is a significant public health concern as it is the 
leading cause of infant mortality [1-4]. Other important adverse birth outcomes including low 
birthweight (<2500g) and being small for gestational age (SGA), which may result directly from 
preterm labor and/or growth restriction due to detrimental factors occurring during pregnancy, also 
contribute substantially to childhood and adult morbidity [5-7]. 
 
Puerto Rico has one of the highest incidences of adverse birth outcomes among all US 
jurisdictions. In 2016, there were 3,248 preterm births in Puerto Rico, representing 11.5% of live 
births, compared to the national US average of 9.8% [8]. In addition, Puerto Rico has higher rates 
of childhood obesity and asthma [9-11] as well as obesity, metabolic syndrome, and diabetes in 
adults [12, 13] compared to the rest of the U.S., all of which have been associated with higher rates 
of preterm birth and/or low birthweight. Moreover, traditional risk factors do not explain this high 
rate of adverse birth outcomes and associated consequences in Puerto Rico. Even though there is 
growing epidemiological [14-17] and toxicological [18-21] evidence that environmental factors 
may play a key role, these factors remain understudied and underappreciated. Therefore, it is 
important to understand the role of environmental chemicals in adverse health outcomes and to 









Ubiquitous in the environment, metals and metalloids have been widely detected among the U.S. 
population [22], including pregnant women and their fetuses because of the trans-placental metal 
transfer [23-25]. While many human and animal studies have focused on elucidating the effects 
associated with heavy metals cadmium (Cd), mercury (Hg), arsenic (As), and lead (Pb), less 
attention has been given to the other metals. However, a growing body of evidence suggests 
that certain essential or trace metals, including copper (Cu) [26] and Nickel (Ni) [27], may be 
associated with an increased risk of preterm delivery. A few other studies also reported inverted 
U-shaped dose-response curves for the associations between birth weight and maternal metal 
exposures, including cobalt (Co) [28] and manganese (Mn) [29, 30]. Therefore, there is a pressing 
need to study the effects of excessive exposure to essential trace elements on adverse pregnancy 
outcomes. In addition, most previous reports on the effects of metals on pregnancy are from studies 
usually involving high doses (e.g., studies on Pd before the elimination in paint and gas), not 
commonly encountered by pregnant women and fetus [31, 32]. Due to the widespread exposure of 
humans and known toxicity of these metals, concern is growing that low-level exposure may also 
adversely affect birth outcomes and several birth cohorts have evaluated the health effects of low-
level exposure to metals during pregnancy [30, 33-37].  
 
As humans are continuously exposed to a mixture of environmental toxicants, there is a pressing 
need to study the relationship of exposures both individually and as mixtures [38]. While most 
studies on metals have assessed metal exposures individually rather than in combination, a few 
have explored metal mixtures in relation to adverse birth outcomes [26, 39-42]. Compared to these 
earlier studies, our study has one of the largest numbers of toxic and trace metal analytes. 
Therefore, we investigated the effects of metal(loid)s on adverse birth outcomes both individually 
and as mixtures. Identifying modifiable environmental risk factors for adverse birth outcomes 
could have a positive public health impact if future exposures can be reduced through contaminant 
remediation or other exposure reduction strategies in an effort to reduce rates of preterm birth and 










2.1 Study population   
This study used data collected from 812 pregnant women participating in the ongoing prospective 
cohort project “the Puerto Rico Testsite for Exploring Contamination Threats (PROTECT)” [43-
46]. The PROTECT study launched in 2010 with funding from the NIEHS Superfund Research 
Program and conducted in Puerto Rico because of its high preterm birth rate and the extent of 
hazardous waste contamination on the island. PROTECT aims to explore environmental toxicants 
and other factors contributing to preterm birth risk and other adverse birth outcomes in Puerto 
Rico.   
 
Study participants were recruited at approximately 14 ± 2 weeks of gestation at seven prenatal 
clinics and hospitals throughout Northern Puerto Rico and followed until birth. [43, 44]. Inclusion 
criteria for this study were: maternal age between 18 to 40 years; residence inside of the Northern 
Karst aquifer region; disuse of oral contraceptives within the three months prior to pregnancy; 
disuse of in vitro fertilization to become pregnant; and free of any major medical or obstetrical 
complications, including pre-existing diabetes. Each woman participated in a total of up to three 
study visits (18 ± 2 weeks, 22 ± 2 weeks, and 26 ± 2 weeks of gestation). Detailed information on 
medical and pregnancy history were collected at the initial visit. During an in-home visit (second 
visit), nurse-administered questionnaires were used to gather information on housing 
characteristics, employment status, and family situation. Blood samples were collected from 
women at the first and third visits. The present analysis reflects 812 women who delivered live 
singleton births in PROTECT and had metal biomarker measurements available. 
 
The research protocol was approved by the Ethics and Research Committees of the University of 
Puerto Rico and participating clinics, the University of Michigan, Northeastern University, and the 
University of Georgia. The study was described in detail to all participants, and informed consent 
was obtained prior to study enrollment. 
 








Blood samples were collected in metal-free whole blood tubes and frozen at −80°C, and shipped 
on dry ice to NSF International (Ann Arbor, MI, USA) for analysis. Concentrations of 16 metals 
and metalloids: As, barium (Ba), beryllium (Be), Cd, Co, chromium (Cr), cesium (Cs), Cu, Hg, 
Mn, Ni, Pb, titanium (Ti), uranium (U), vanadium (V), and zinc (Zn) were measured in blood 
samples, using a Thermo Fisher (Waltham, MA, USA) ICAPRQ inductively coupled plasma mass 
spectrometry (ICPMS) and CETAC ASX-520 autosampler, as described previously [26]. 
Standards of known purity and identity were used during the preparation of the calibration, quality 
control, and internal standards. The ICPMS was calibrated with a blank and a minimum of 4 
standards for each element of interest. The calibration curve response versus concentration was 
evaluated for goodness of fit. All validated analyte correlation coefficients (R) were ≥ 0.995.  
 
2.3 Gestational Age and Preterm Birth Calculation 
All the birth outcome data were extracted from medical records. The American Congress of 
Gynecologists (ACOG) recommendations for best obstetrical estimate to calculate the gestational 
age for complete pregnancies [47] were used in our study to as previously described [48, 49]. Per 
common practice, preterm birth (premature labor) was defined as delivery < 37 completed weeks 
of gestation. Based on the presentation of preterm delivery, preterm birth was further classified as 
spontaneous preterm birth (presentation of premature rupture of the membranes, spontaneous 
preterm labor, or both) and non-spontaneous preterm birth (preterm births with preeclampsia or 
with both artificial membrane rupture and induced labor). We included overall and spontaneous 
preterm birth as two of the birth outcomes in our analysis.  
 
2.4 Birthweight calculations 
Birthweight z-scores (defined as the number of standard deviations by which a birthweight is 
above or below the mean) are commonly used to compare individual birthweights with the cohort 
[50, 51]. Gestational age- and sex- specific birthweight z-score were constructed according to the 
INTERGROWTH-21st standards [52]. Small for gestational age (SGA) births were defined as 
below the 10th percentile of birthweight z-scores. Large for gestational age (LGA) births were 









2.5 Data pre-processing for statistical analyses 
Biomarker concentrations below the limit of detection (LOD) were replaced by LOD/√2 (LOD). 
For statistical analysis, we included metal(loid)s with at least 70% of samples having 
concentrations above the LOD as continuous variables, and metal(loid)s with less than 70% of 
samples above the LOD (As and Cd) as binary variables (above vs below LOD). Metals with low 
detection rate (<30%) were excluded from the analyses. Descriptive statistics were calculated for 
all exposure and outcome variables. Log-transformed t-test was performed to compare the 
maternal metal concentrations between preterm and term births. 
 
2.6 Single-Pollutant Models 
Logistic regression models were used to examine the associations between metal exposure and 
binary adverse birth outcomes, including preterm birth (overall and spontaneous preterm birth), 
SGA, and LGA. As SGA and LGA may have similar complications, SGA models excluded LGA 
births, and LGA models excluded SGA births. Multiple linear regression was used to model metal 
exposures with continuous outcomes, gestational age and birthweight z-score. All outcomes are 
regressed on the geometric averages of participant concentrations across the two visits (when 
missing concentrations at one visit, the “average” concentration was equal to the single available 
concentration), with separate models for each exposure biomarker. Metal concentrations were 
natural log-transformed as they had right skewed distributions. 
 
The crude models only included the geometric average blood metal concentration. The final set of 
covariates were selected in a stepwise procedure if they altered the beta coefficient of metal 
exposure by 10% or more. The covariates considered were maternal age, insurance type, maternal 
education level (an indicator of socioeconomic status), marital status, employment status, 
gravidity, pre-pregnancy BMI, smoking, exposure to second-hand smoking and alcohol 
consumption. The final models were controlled for maternal age, maternal education level, pre-









To assess potential windows of vulnerability in pregnancy, we fit separate multiple linear 
regression models for each visit using visit-specific metal concentrations. In another analysis, we 
divided average metal concentrations into tertiles to examine the potential for non-linear 
relationships. For non-essential metals, effect estimates were calculated for each of the top two 
tertiles in comparison to the lowest tertiles of exposure. For essential metals, effect estimates were 
calculated for the highest and lowest tertiles in comparison to the middle tertile of exposure [26]. 
Finally, to understand whether the effect estimates for metals on birth outcomes differed according 
to infant sex, all previously mentioned single-pollutant models were refitted with the addition of 
an interaction term between infant sex and metal concentration, and the interaction term coefficient 
was tested for significance. 
 
The results were presented as change in days of gestational age and birthweight z-score (95% 
confidence intervals), and odds ratio of preterm birth, SGA and LGA (95% confidence intervals), 
per interquartile range (IQR) increase in metal concentrations. The alpha level was set at 0.05. We 
also considered significance after adjusting for multiple testing using the Benjamini-Hochberg 
method [53]. Since birth outcomes were correlated, we calculated q values (adjusted p values) 
treating each outcome as a family of tests (10 tests per outcome). A cutoff of 0.1 for q value was 
used to further interpret main results with greater confidence.  
 
2.7 Mixture Analysis 
In addition to analyzing each metal separately, we explored the effect of the metal mixture on birth 
outcomes with two approaches. 
 
2.7.1 Elastic Net (ENET) and Metal Risk Score 
In the first method, we constructed a metal risk score --Environmental Risk Score (ERS). An ERS 
is conceptualized as a weighted summary measure of the effects of multiple exposures where the 
weights are regression coefficients derived from a model of the association between chemical 
mixtures and the outcome of interest. We utilized elastic net (ENET) to identify the important 








is a regularized regression method that combines the penalties of the least absolute shrinkage and 
selection operator (LASSO)  and ridge regression [55]. The objective function for a continuous 
outcome can be expressed as: 
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where 𝑖 = 1, … , 𝑛 indexes the subjects, 𝑥𝑖
𝑇 ∈ ℝ𝑝 is the vector of 𝑝 covariates for the 𝑖-th subject, 
and 𝑦𝑖 is the continuous health outcome for the 𝑖-th subject. ENET utilizes two tuning parameters 
(𝜆, 𝛼). Intuitively, 𝜆 ∈ [0, ∞) controls the overall strength of the shrinkage while 𝛼 ∈ [0,1] 
controls the tradeoff between automatic variable selection (L1 penalty) and stabilization of the 
solution path in the presence of collinear exposures (L2 penalty) [56]. Therefore, ENET is 
generally considered a useful penalized regression approach for variable selection in the presence 
of highly collinear predictor variables [54]. 
 
We fit ENET on all the metals (IQR standardized) in relation to each birth outcome of interest 
adjusted for the same covariates from the single-pollutant analysis (retained in the model, not 
subject to shrinkage). Tuning parameters were selected using 10-fold cross-validation. ERS was 
computed as a weighted sum of the selected non-zero predictor coefficients from each model. We 
further categorized ERS by tertiles and refit the regression models to examine the associations 
between categorical ERS and birth outcomes and compared results to those from individual tertile 
models.  
 
2.7.2 Bayesian kernel machine regression (BKMR) 
The second approach for conducting mixture analysis was Bayesian kernel machine regression 
(BKMR) [57], which enabled us to evaluate the joint effect of multiple metals, interactions 
between metals, and potential non-linear relationships between metals and outcomes of interest 
[58]. Because exposures in our study are correlated, we implemented BKMR with hierarchical 
variable selection (10,000 iterations by a Markov Chain Monte Carlo (MCMC) algorithm). This 








potential mechanisms of action (e.g. toxic metals vs essential metals). Therefore, we grouped As, 
Cd, Hg, and Pb into group 1 (toxic metals), Co and Mn into group 2 (correlated essential metals), 
and Cs, Cu, Ni, and Zn (essential metals) into group 3. Posterior inclusion probabilities (PIP) were 
extracted from each BKMR model, which provides a measure of variable importance for each 
exposure group (groupPIP) and how each exposure in that group is driving that group-outcome 
association (condPIP). To determine the importance of each group/exposure for each study 
outcome a threshold of PIP>0.5 was used [59, 60]. Data were analyzed using R version 3.6.2 and 
SAS 9.4 (SAS Institute Inc., Cary, NC) 
 
3. Results 
3.1 Descriptive statistics 
Demographic characteristics of 812 women in our analysis were described previously [46, 48] and 
summarized in Table III.1. The mean age of participants was 26.7 and nearly half of the women 
had a BMI less than 25kg/m2 prior to pregnancy. Approximately two-thirds of the women in our 
study had private insurance providers and were employed. 30% had reported graduating from 
college or higher. Nearly half of them had annual household incomes less than $30,000. 80% of 
the women never smoked while very few (6.8%) reported consumption of alcohol within the last 
few months. Mean gestational age was 38.8 (SD=2.1) weeks for 812 singleton births included in 
this analysis, among which 80 (10%) were preterm and 48 (6%) were spontaneous preterm; the 
rates of SGA and LGA were both 9%.  
 
Descriptive statistics and Spearman correlations between different metals were previously reported 
elsewhere [61]. Briefly, 1) all metals were detected in the majority of samples, with the exception 
of As (49% > LOD) and Cd (61% > LOD) and Ba, Be, Cr, Ti, U, and V, which were detected in 
very few samples (<30%) (Table III.2); 2) mean concentrations of Cu, Mn, Pb, and Zn were higher 
for preterm birth cases compared to other births. 3) there were weak to moderate correlations 
between different blood metal concentrations (Mn and Co, r=0.36; As and Hg, r=0.32; Cd and Co, 
r=0.33, SI Figure S1); 4) the first visit had lower concentrations of Cd, Co, Cu, Mn, and Zn, and 








presented good to excellent reliability in repeated blood samples with intraclass correlation 
coefficients (ICCs) ranging from 0.54-0.78. 
 
3.2 Single-pollutant Metal Analyses 
The full models included 731 women who had complete data on the four demographic covariates 
(age, maternal education, pre-pregnancy BMI, and second-hand smoking). Table III.3 presents 
the associations between average metal concentrations and birth outcomes, while Figure III.1 and 
Table III.4 show the visit specific associations. 
 
Average Pb concentration was strongly associated with gestational age, for which an IQR increase 
was associated with 2 days (95% CI=-3.1, -0.5; q value=0.09) shorter gestational age; the effect 
estimates did not differ by study visit. Average Zn was also suggestively associated with decreased 
gestational age (△/IQR= -0.7, 95% CI= -1.5, 0.2) and the association with third visit Zn remained 
significant, after stratification of the results by study visit (Figure III.1 and Table III.4). No 
significant relationships were observed between birthweight z-score and average metal 
concentrations (data not shown). However, as shown in Figure 1, when stratified on study visit, 
third visit Co, Cs, Ni concentrations were significantly positively associated with birthweight z-
score, with an increase of 0.14 (95% CI=0.03, 0.25), 0.14 (95% CI= 0.00, 0.28), and 0.11 (95% 
CI= 0.01, 0.21) in birthweight z-score per IQR increase in the metal concentrations, respectively 
(Table III.4).  
 
In line with results from gestational age analysis, average Pb, Mn, and Zn concentrations were 
associated with elevated odds of preterm birth (both overall and spontaneous), with OR ranging 
from 1.32 to 1.83 per IQR increase in metal concentration (Table III.3). In the stratified analysis, 
Pb and Zn were associated with increased odds of spontaneous preterm birth at only visit 1 (Pb: 
OR/IQR= 1.75, 95% CI: 1.12, 2.73; Zn: OR/IQR= 2.04, 95% CI= 1.23, 3.39). In a sensitivity 
analysis where metal concentrations were entered in models as tertiles, the change in gestational 
age and odds of having a preterm birth was only significant among the highest tertile for Pb and 









Though geometric mean average models for Hg did not find any association with birth outcomes, 
Hg was associated with 1.5- and 2.3-fold increased odds of overall and spontaneous preterm birth 
at visit 3 (overall: OR/IQR= 1.46, 95% CI= 0.97, 2.19; spontaneous: OR/IQR= 2.30, 95% CI= 
1.32, 4.02), respectively (Figure III.1); interestingly, this association appeared stronger when 
comparing women in lower two tertiles of exposure rather than higher two tertiles (Figure III.2 
and Table III.5). For SGA, Ni concentration was associated with decreased OR, although only 
significant when comparing the highest tertile to the middle tertile (OR/IQR= 0. 33, 95% CI= 0.16, 
0.66). Visit specific analysis also revealed that higher Mn concentration at the third visit was 
associated with decreased odds of SGA (OR/IQR= 0.62, 95% CI= 0.42, 0.93). No metal 
concentrations were associated with LGA in average and visit stratified models (Table III.4).  
 
After correcting for multiple testing, the associations of both average and first visit Pb and Zn with 
overall preterm birth, third visit Hg with spontaneous preterm birth, as well as the association of 
average Ni with SGA had q-values < 0.1 (Table III.3, Figure III.1), providing greater confidence 
in these associations.  
 
3.3 Mixture analyses 
Table III.6 shows the variable selection results from ENET models. The estimated weights 
(regression coefficients) presented in Table III.6 are from models where metal concentrations 
were log transformed and IQR standardized. Preterm birth (overall) models had more than one 
metal with non-zero weights; Pb (β = 0.057, OR=1.06) and Zn (β = 0.011, OR=1.01) were selected 
as important predictors and all other metals were shrunk to zero. Therefore, we constructed ERS 
using estimated weights for Pb and Zn and regressed preterm birth by this score. The OR for 
preterm birth comparing the highest vs. the lowest tertiles of ERS was 2.13 (95% CI= 1.12, 5.49, 
p=0.02) (Figure III.2). In the BKMR hierarchical variable selection models for preterm birth, all 
three metal groups had posterior inclusion probabilities higher than 0.5 and the important metals 
selected from the groups included Zn (condPIP=0.83), Pb (condPIP=0.68), and Mn 








birth while only including Mn, Zn, Pb to explore the potential non-linearity and interaction 
between the predictors. The single metal-response curves in Figure III.3 A show that 1) Pb and 
Zn had a positive linear relationship with preterm birth at higher levels (the confidence intervals 
at lower distributions are wide due to sparse data); 2) the overall trend for Mn was also positive 
and generally linear. Further, the associations between each metal and preterm birth did not differ 
by varying quantiles of the other two metals, indicating a lack of interaction between different 
metals (Figure III.3 B). 
 
3.4 Sex interaction 
When interactions between infant sex and metal concentrations were added to single-pollutant 
models, the interaction terms were not statistically significant, except for the associations between 
Zn and gestational age (p value=0.01), and Cu and LGA (p value=0.03). Stratified analysis by 
infant sex showed that the effect of Zn on gestational age was only significant among female 
infants (p value=0.006) but not male infants (p value=0.62); one IQR increase in Zn was associated 
with 3 days (95% CI= -5.2, -0.9) shorter gestational age among women who delivered female 
infants. Figure III.4 shows the interaction effect of infant sex on the association between the 
average Zn concentration and gestational age. The impact of Cu on LGA also varied by infant sex, 
where odds of LGA were reduced among female infants (OR/IQR= 0.62, 95% CI= 0.39, 0.99, p 
value=0.04). However, differences in associations between metals and birth outcomes by sex were 
not observed when we conducted the mixture analyses stratified by infant sex. Only Pb was 
identified as the important predictor of preterm birth/gestational age from ENET and BKMR 
models, among both female and male infants. The results from tertile analyses stratified by infant 
sex and study visit were similar to the main tertile analyses results we reported; sex-specific 
interactions were not observed. 
 
4. Discussion 
In this study, we evaluated the individual effects of prenatal essential and non-essential metal(loid) 
exposure on adverse birth outcomes among a Puerto Rico population. Our analyses demonstrated 








age and higher odds of preterm birth, while Ni was associated with higher birthweight and lower 
odds of SGA. Some associations were observed only when considering exposure at specific 
prenatal timepoints, which may reflect windows of exposure vulnerability. Additionally, we 
estimated the cumulative effect of metal mixtures using ENET and BKMR. ENET identified Pb 
and Zn as the most important predictors of preterm birth, while BMKR selected Pb, Zn, and Mn 
as most predictive of preterm birth. Findings from our study highlight that several metals are 
associated with adverse birth outcomes and stress the importance of assessing the effects of 
chemical mixtures on health outcomes, using multiple statistical methods and in comparison with 
single-pollutant models.  
 
A few studies previously reported associations between prenatal metal mixtures and birth 
outcomes. Signes-Pastor et al. reported that Pb, Mn, and As combined were associated with 
reduced head circumference, weight, and length of newborns [39], Lee et al. found that the joint 
effects of Pb and Hg were related to birthweight reduction [42], and Luo et al. confirmed a negative 
association between Cd and As and birthweight [41]. In our study, negative effects were 
consistently observed for Pb in combination with other metals. Pregnant women in this Puerto 
Rico cohort had particularly low blood Pb concentrations (GM=0.33 μg/dL) when comparing 
across other studies of pregnant women, including studies conducted in Australia (median= 0.37 
μg/dL)[62], Japan (GM=0.64 μg/dL) [63], Ohio, US (GM=0.7 μg/dL) [64], Norway (two studies: 
median=2.5 μg/dL and GM=0.75 μg/dL) [65, 66], South Africa (two studies: median=1.4 μg/dL 
and median= 2.3 μg/dL) [67, 68] and China (median=3.2 μg/dL) [69]. In addition, all blood 
samples in our study had Pb concentration lower than the level of concern set by CDC for pregnant 
women (5 μg/dL) [70]. However, our analysis revealed that maternal blood Pb, even at very low-
levels, was the most strongly associated with increased risk of preterm birth and shorter gestational 
age of all the metals assessed. In recent years, concerns have also been raised that even at low 
levels, prenatal Pb exposure may pose toxic effects on fetal development [35-37, 71-75]. Our 
results are consistent with these studies and provide further evidence that blood Pb at low levels, 
and potentially below current reference levels, may be associated with preterm birth. However, we 








an inverse association with Pb and infant size when explored individually and in combination with 
other metals [40-42]. 
 
Zn was also a key exposure associated with birth outcomes in this study. Blood concentrations of 
Zn (GM=4682.4 ng/mL) were similar to levels reported in previous studies of pregnant women 
[66, 68, 76]. We found that associations between Zn and birth outcomes varied by infant sex, such 
that blood Zn was negatively associated with gestational age among female infants, whereas the 
association was not significant for male infants. It is unclear whether the infant sex-specific 
association we observed with Zn and gestational age could be indicative of vulnerability for 
women carrying a female fetus. The comparatively rapid growth of male fetuses may require more 
Zn compared to females, thus increased Zn may be less likely to produce adverse effects among 
males. Elevated blood Zn levels may also reflect the state of various processes in the body, 
including inflammation, oxidative stress and other key functions [77-79] that can play a role in 
gestation length. 
 
Our negative findings with increased Zn are contrary to animal studies, observational and 
randomized trials on humans where maternal Zn deficiency is often associated with adverse birth 
outcomes, including preterm birth [80, 81]. Because one of many important biological functions 
of Zn is in the development and function of cells involved in the immune system, it is hypothesized 
that Zn deficiency may contribute to maternal or intrauterine infection and therefore affect 
premature birth [82]. Some reviews on the topic have suggested that the association observed 
between Zn deficiency and adverse birth outcomes could result from poor nutrition [82-85]. 
 
Mn is also an essential nutrient that plays a vital role in the body but can be toxic at excessive 
levels. In this population, Mn concentrations in blood (GM=11.3 ng/mL) were higher than those 
seen in Australian (GM=6.5 ng/mL) [76] and Norwegian pregnant women (GM=10.7ng/mL) [66]. 
We found that average Mn concentrations across pregnancy were associated with elevated odds of 
preterm birth and shorter gestational age; the association was significant for higher levels of blood 








showed a generally linear relationship between Mn and preterm birth at higher levels. These 
findings are supported by reports on high dose Mn-related maternal and fetal toxicities [86-89] 
and the U-shaped Mn dose-response curve [29, 33] observed in animal studies and epidemiologic 
studies.  
 
Mechanistically, the group of metals explored in our study likely impact various biological 
pathways associated with preterm delivery and fetal development. One leading hypothesis of the 
mechanism of action is through inducing oxidative stress, defined as the homeostatic imbalance 
between reactive oxygen species (ROS) formation and antioxidants [90]. Several in vivo and in 
vitro studies have linked metal toxicity to the formation of ROS [91, 92]. The excessive free radical 
species can induce oxidative stress and cause damage to lipids, proteins and DNA in the placental 
tissue that eventually lead to pregnancy complications [90, 93, 94]. Reproductive hormones also 
play an important role in maintaining pregnancy; in turn, disruption of the complex interplay 
between hormones may lead to adverse effects during gestation. A number of metals are 
reproductive toxicants and suspected endocrine disruptors [95-98]. Evidence suggests that metals 
can influence reproductive hormone levels through several pathways, including hormone 
synthesis, regulation, transport and metabolism, and/or interference with receptors [99-106], with 
potential implications for pregnancy outcomes. 
 
Our approaches for analyzing the effects of combined metal exposures provide evidence that Pb, 
Zn, and Mn are likely key exposures during pregnancy contributing to adverse birth outcomes. 
The weak correlations between the three metals are not likely to reflect common sources of 
exposure. Although BKMR analysis did not suggest interaction between the three metals, future 
studies constructing mechanistically based exposure mixtures are needed. 
 
Our study is the first to assess the impact of metals on birth outcomes among pregnant women in 
Puerto Rico. The PROTECT study, a large prospective longitudinal cohort study in Puerto Rico, 
provided an opportunity to study the relationships between environmental pollutants and adverse 








of biological samples to account for the varying levels of exposures during pregnancy. Few 
epidemiology studies have evaluated metal exposures collectively in relation to birth outcomes, 
giving the proposed study a unique opportunity to test the impact of more realistic exposure 
profiles on birth outcomes.  
 
The present study does have some limitations. The metal levels measured in blood depict 
circulating levels, which may not reflect levels in the uterine and fetal compartments that may be 
more biologically relevant. However, blood biomarkers may be indicative at least in part of the 
activity at the maternal-fetal interface, and collection of blood is much more feasible than placenta 
tissue or fluid samples from the uterus during pregnancy. We used the same data to calculate ERS 
and then to fit ERS models which has the potential for overfitting. Metal risk score needs to be 
validated in an independent cohort before being used as a prognostic tool by other studies. Another 
challenge with constructing ERS is that the ENET models assume a linear relationship between 
metals and the birth outcomes, and does not capture potential non-linear relationships and 
interactions between metals which maybe important when considering essential metals that may 
be toxic at high levels of exposure. However, BKMR analysis does allow for the possibility of 
nonlinearity and interactions between metals. There are also other statistical strategies for 
incorporating nonlinearity and interactions into constructing ERS that should be explored in future 
applications of this method [54, 107-109]. 
 
5. Conclusion 
We considered different statistical methods to examine the effect of 10 toxic and essential trace 
metal(loid)s and metal risk score on various birth outcomes among pregnant women in Northern 
Puerto Rico. Although the PROTECT cohort has lower Pb concentrations (GM=0.33 μg/dL) 
compared to the mainland US and other studies of pregnant women in different countries, our 
findings suggest that low-level prenatal Pb exposure, as well as elevated Mn and Zn exposure, may 
adversely affect birth outcomes. These findings provide further support for the need to reduce Pb 
exposure as much as possible among pregnant women. Improved understanding of environmental 
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Table III.1  Demographic characteristics of n = 812 pregnant women from Puerto Rico (2011− 2017) 
Variable Mean (SD) 
Maternal Age 26.7 (5.7) 
Characteristic Category Count (Percent) 
Insurance Type 
Private 478 (58.9%) 
Public (mi salud) 304 (37.4%) 
Missing 30 (3.7%) 
Maternal Education 
<=High school/GED 175 (21.6%) 
Some college or technical school 284 (35%) 
College degree 246 (30.3%) 
Master’s degree or higher 95 (11.7%) 
Missing 12 (1.5%) 
Household Income 
<$10,000  226 (27.8%) 
≥$10,000 to <$30,000  230 (28.3%) 
≥$30,000 to <$50,000  156 (19.2%) 
≥$50,000  93 (11.5%) 
Missing 107 (13.2%) 
Marital Status 
Single  162 (20%) 
Married or living together 641 (78.9%) 
Missing 9 (1.1%) 
Gravidity (# Pregnancies) 
0 296 (36.5%) 
1 307 (37.8%) 
>1 98 (12.1%) 
Missing 111 (13.7%) 
Pre-pregnancy BMI (kg/m2) 
≤25 413 (50.9%) 
>25 to ≤30 211 (26%) 
>30 145 (17.9%) 
Missing 43 (5.3%) 
Infant Gender 
Female 382 (47%) 
Male 426 (52.5%) 
Missing 4 (0.5%) 
Employment Status 
Unemployed 489 (60.2%) 
Employed 310 (38.2%) 
Missing 13 (1.6%) 
Smoking 
Never 678 (83.5%) 
Ever 115 (14.2%) 
Current 11 (1.4%) 
Missing 8 (1%) 
Exposure to Second-hand Smoking 
None 696 (85.7%) 
Up to 1 hour 25 (3.1%) 
More than 1 hour 51 (6.3%) 
Missing 40 (4.9%) 
Alcohol Consumption 
None 388 (47.8%) 
Before pregnancy 355 (43.7%) 
Within the last few months 57 (7%) 










Table III.2 Blood biomarker concentrations (µg/L) in N = 812 pregnant women from Puerto Ricoa in 2010− 2017 (stratified by 
preterm birth status) and comparison with U.S. population-based samples of women ages 18− 40 from NHANESb 
Metals LOD %>LOD 
Preterm Birth (n=112) Term Birth (n=1034) NHANES 
GM GSD Median GM GSD Median GM GSD Median 
Co 0.2 
98.3 0.35 1.4 0.34 0.34 1.4 0.34    
Cs 0.04 
99.9 1.2 1.4 1.2 1.1 1.4 1.2    
Cu* 9 
99.9 1623 1.2 1620 1544 1.3 1556    
Mn* 2 
99.9 11.9 1.4 12.0 11.2 1.4 11.2 10.7 1.4 10.6 
Ni 0.5 
96.4 1.0 1.7 1.0 1.0 1.6 1.0    
Zn* 24 
99.9 5004 1.1 5030 4641 1.3 4712    
As 0.3 
49.3 0.32 1.70 0.21 0.34 1.82 0.21    
Cd 0.1 60.8 0.11 1.61 0.11 0.12 1.66 0.12 0.31 2.2 0.28 
Hg 0.2 99.9 1.3 1.7 1.3 1.2 1.7 1.2 0.74 2.5 0.67 
Pbc* 0.02 99.9 0.39 1.6 0.36 0.32 1.5 0.32 0.64 1.8 0.61 
Abbreviations: National Health and Nutrition Examination Survey (NHANES); cobalt (Co); cesium (Cs); copper (Cu); 
manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); limit of detection (LOD); 
geometric mean (GM); geometric standard deviation (GSD). 
a Includes biomarker concentrations for up to 2 repeated samples per woman (n = 1,146 samples) 
b Females 18−40 years of age; n = 3,585 for biomarkers measured in 2009-2010, 2011-2012, 2013-2014, and 2015-2016 
NHANES 
c concentration unit for blood Pb is µg/dL 
* metals with significantly higher concentration among women in the preterm birth subgroup compared to the term birth 








Table III.3 Change in gestational age, preterm birth, and SGA associated with average exposure biomarker concentration across 
two time points during pregnancy. Effect estimates presented as changes or odds ratio (OR) for IQR increase in exposure 




Gestational age (N=731) 





 Change in days 
p 
value OR (95% CI) 
p 
value OR (95% CI) 
p 
value OR (95% CI) 
p 
value 
Co -1.1 (-2.3, 0.1) 0.06 1.21 (0.93, 1.56) 0.16 1.33 (0.96, 1.84) 0.09 0.90 (0.68, 1.21) 0.49 
Cs -0.3 (-1.6, 1.1) 0.69 1.19 (0.84, 1.68) 0.33 1.10 (0.72, 1.69) 0.66 0.82 (0.62, 1.08) 0.15 
Cu -0.4 (-1.2, 0.4) 0.36 1.32 (0.98, 1.78) 0.07 1.20 (0.82, 1.76) 0.34 0.99 (0.83, 1.19) 0.94 
Mn -1.1 (-2.4, 0.3) 0.12 1.32 (0.96, 1.80) 0.08 1.45 (0.98, 2.15) 0.07 0.85 (0.62, 1.16) 0.30 
Ni 0.8 (-0.3, 1.9) 0.15 0.85 (0.65, 1.11) 0.24 0.85 (0.60, 1.21) 0.36 0.67 (0.49, 0.90) 0.01* 
Zn -0.7 (-1.5, 0.2) 0.11 1.83 (1.28, 2.60) 0.001* 1.53 (0.99, 2.38) 0.06 1.00 (0.82, 1.21) 1.00 
Asa 1.8 (-0.4, 3.9) 0.10 0.72 (0.44, 1.18) 0.19 0.65 (0.34, 1.24) 0.19 0.75 (0.45, 1.25) 0.28 
Cda -1.3 (-3.5, 0.9) 0.26 1.00 (0.60, 1.65) 0.99 1.24 (0.63, 2.43) 0.53 0.76 (0.45, 1.27) 0.29 
Hg 0.8 (-0.6, 2.2) 0.27 1.05 (0.75, 1.48) 0.76 1.27 (0.82, 1.95) 0.28 0.86 (0.62, 1.21) 0.40 
Pb -1.8 (-3.1, -0.5) 0.009* 1.63 (1.17, 2.28) 0.004* 1.53 (1.00, 2.35) 0.05 0.91 (0.69, 1.20) 0.51 
 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); 
mercury (Hg); lead (Pb); Odds ratio (OR); confidence interval (CI); interquartile range (IQR); small for gestation age (SGA). 
a As, Cd were compared between two categories of above LOD and below LOD  
































Figure III.1 Change in birth outcomes associated with visit specific exposure biomarker concentration. Effect estimates 
presented as changes or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for 

















































Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); 
mercury (Hg); lead (Pb); Odds ratio (OR); confidence interval (CI); interquartile range (IQR); small for gestation age (SGA); 
large for gestational age (LGA). 
a As, Cd were compared between two categories of above LOD and below LOD  








Table III.4 Change in birth outcomes associated with exposure biomarker concentration at each visit during pregnancy. Effect 
estimates presented as changes or odds ratio (OR) for IQR increase in exposure biomarker concentration. Models were adjusted 
for maternal age, maternal education, pre-pregnancy BMI, and exposure to secondhand smoking 
 
Metals Gestational age  Birthweight z-score  
 Visit 1 (n=583) 
 Visit 3 (n=453)  Visit 1 (n=566)  Visit 3 (n=442)  
 Change in days 
p 
value 
Change in days 
p 
value 
Change in z-score 
p 
value 
Change in z-score 
p 
value 
  (95% CI)   (95% CI)  (95% CI) (95% CI)  
Co -0.7 (-2.0, 0.6) 0.32 -0.8 (-2.1, 0.6) 0.28 0.02 (-0.08, 0.11) 0.75 0.14 (0.03, 0.25) 0.01 
Cs 0.2 (-1.4, 1.7) 0.84 -1.5 (-3.2, 0.3) 0.10 0.01 (-0.11, 0.12) 0.92 0.14 (0.00, 0.28) 0.05 
Cu -0.3 (-1.3, 0.7) 0.54 -0.3 (-1.7, 1.1) 0.66 0.00 (-0.06, 0.07) 0.91 0.08 (-0.03, 0.19) 0.14 
Mn -0.8 (-2.4, 0.8) 0.31 -0.9 (-2.5, 0.8) 0.29 0.03 (-0.08, 0.15) 0.57 0.12 (-0.01, 0.25) 0.08 
Ni 0.2 (-1.0, 1.5) 0.72 0.4 (-0.9, 1.7) 0.53 0.01 (-0.07, 0.10) 0.74 0.11 (0.01, 0.21) 0.03 
Zn -0.7 (-1.7, 0.2) 0.13 -1.4 (-2.9, 0.0) 0.05 0.01 (-0.06, 0.07) 0.79 -0.03 (-0.14, 0.09) 0.62 
Asa 2.5 (0.1, 5.0) 0.04 0.0 (-2.4, 2.5) 0.98 0.08 (-0.09, 0.26) 0.35 -0.05 (-0.25, 0.15) 0.61 
Cda -1.9 (-4.4, 0.6) 0.14 0.2 (-2.4, 2.7) 0.91 -0.04 (-0.21, 0.14) 0.70 0.08 (-0.13, 0.29) 0.45 
Hg 0.7 (-0.9, 2.4) 0.38 -0.5 (-2.1, 1.1) 0.54 0.02 (-0.10, 0.14) 0.72 0.09 (-0.03, 0.21) 0.16 
Pb -1.8 (-3.3, -0.4) 0.01 -1.7 (-3.4, -0.1) 0.04 0.05 (-0.06, 0.15) 0.40 0.06 (-0.07, 0.20) 0.36 
 Preterm birth (overall) Preterm birth (spontaneous) 
 Visit 1 (n=583)  Visit 3 (n=453)  Visit 1 (n=561)  Visit 3 (n=431)  
 OR (95% CI) 
p 
value 
OR (95% CI) 
p 
value 
OR (95% CI) 
p 
value 
OR (95% CI) 
p 
value 
Co 1.10 (0.83, 1.47) 0.50 1.05 (0.74, 1.50) 0.77 1.25 (0.89, 1.76) 0.20 1.20 (0.75, 1.91) 0.46 
Cs 1.11 (0.76, 1.63) 0.59 1.50 (0.94, 2.40) 0.09 1.01 (0.65, 1.58) 0.96 1.29 (0.70, 2.36) 0.41 
Cu 1.21 (0.85, 1.73) 0.30 1.22 (0.85, 1.76) 0.28 1.15 (0.74, 1.79) 0.52 1.04 (0.65, 1.69) 0.86 
Mn 1.22 (0.86, 1.74) 0.26 1.17 (0.77, 1.77) 0.46 1.35 (0.89, 2.06) 0.16 1.17 (0.67, 2.02) 0.58 
Ni 0.93 (0.70, 1.23) 0.59 0.98 (0.70, 1.38) 0.91 0.95 (0.67, 1.34) 0.77 1.01 (0.65, 1.58) 0.95 
Zn 2.01 (1.34, 3.00) 0.001* 1.6 0(1.06, 2.41) 0.02 2.04 (1.23, 3.39) 0.01* 1.23 (0.73, 2.08) 0.44 
Asa 0.64 (0.37, 1.13) 0.12 1.10 (0.59, 2.07) 0.76 0.72 (0.35, 1.44) 0.35 0.97 (0.41, 2.30) 0.95 
Cda 1.26 (0.71, 2.25) 0.43 0.68 (0.36, 1.30) 0.25 1.75 (0.81, 3.77) 0.15 0.72 (0.30, 1.72) 0.45 
Hg 1.06 (0.72, 1.54) 0.78 1.46 (0.97, 2.19) 0.07 1.19 (0.75, 1.89) 0.47 2.3 0(1.32, 4.02) 0.003* 
Pb 1.73 (1.20, 2.50) 0.004* 1.54 (1.03, 2.32) 0.04 1.75 (1.12, 2.73) 0.01* 1.32 (0.75, 2.31) 0.33 
 SGA LGA 
 Visit 1 (n=505)  Visit 3 (n=403)  Visit 1 (n=517)  Visit 3 (n=394)  
 OR (95% CI) 
p 
value 
OR (95% CI) 
p 
value 
OR (95% CI) 
p 
value 
OR (95% CI) 
p 
value 
Co 0.98 (0.71, 1.34) 0.88 0.76 (0.53, 1.10) 0.15 0.98 (0.73, 1.31) 0.90 1.29 (0.92, 1.81) 0.15 
Cs 0.92 (0.66, 1.29) 0.62 0.73 (0.48, 1.10) 0.13 1.03 (0.73, 1.47) 0.85 1.46 (0.89, 2.39) 0.13 
Cu 0.99 (0.81, 1.21) 0.92 0.97 (0.70, 1.33) 0.84 0.96 (0.82, 1.13) 0.61 1.25 (0.85, 1.84) 0.25 
Mn 0.88 (0.60, 1.28) 0.49 0.62 (0.42, 0.93) 0.02 1.04 (0.73, 1.47) 0.85 1.13 (0.73, 1.76) 0.58 
Ni 0.72 (0.51, 1.00) 0.05 0.64 (0.46, 0.90) 0.01 0.86 (0.65, 1.14) 0.29 1.18 (0.86, 1.63) 0.31 
Zn 1.02 (0.79, 1.32) 0.88 1.10 (0.76, 1.60) 0.60 1.07 (0.80, 1.44) 0.65 0.96 (0.65, 1.41) 0.84 
Asa 0.63 (0.35, 1.15) 0.14 0.96 (0.52, 1.77) 0.90 1.19 (0.68, 2.05) 0.54 0.69 (0.35, 1.37) 0.29 
Cda 0.73 (0.40, 1.34) 0.31 0.58 (0.31, 1.09) 0.09 0.61 (0.36, 1.06) 0.08 0.98 (0.49, 1.98) 0.96 
Hg 0.93 (0.62, 1.39) 0.71 0.74 (0.50, 1.11) 0.14 1.13 (0.79, 1.62) 0.51 1.24 (0.82, 1.89) 0.31 
Pb 0.92 (0.67, 1.27) 0.62 0.82 (0.53, 1.25) 0.35 0.98 (0.71, 1.34) 0.89 0.79 (0.50, 1.25) 0.32 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); 
mercury (Hg); lead (Pb); Odds ratio (OR); confidence interval (CI); interquartile range (IQR); small for gestation age (SGA); 
large for gestational age (LGA). 
a As, Cd were compared between two categories of above LOD and below LOD  










Figure III.2 Preterm birth (overall) odds ratio (95% confidence interval) associated with tertiles of geometric average exposureab 
Models were adjusted for maternal age, maternal education, pre-pregnancy BMI, and exposure to secondhand smoking 
 
 
Abbreviations: copper (Cu); manganese (Mn); zinc (Zn); mercury (Hg); lead (Pb); environmental risk score (ERS). 
a Referent levels were set at tertile 2 for essential metals (Cu, Mn, Zn) 
b Referent levels were set at tertile 1 for non-essential metals (Hg, Pb), and ERS 
























Table III.5 Change in birth outcomes associated with tertiles of average exposureabc. Effect estimates presented as changes or odds ratio (OR) for IQR increase in exposure 
biomarker concentration. Models were adjusted for maternal age, maternal education, pre-pregnancy BMI, and exposure to secondhand smoking 
Metals 
Gestational age (N=731) Birthweight z-score (N=710) 
Change in days 
p value 
Change in days 
p value 
Change in z-score 
p value 
Change in z-score 
p value 
(95% CI) (95% CI) (95% CI) (95% CI) 
Essential metals Tertile 1 vs 2 Tertile 3 vs 2 Tertile 1 vs 2 Tertile 3 vs 2 
Coa -1 (-3.6, 1.6) 0.46 -1.7 (-4.3, 0.9) 0.20 -0.04 (-0.24, 0.15) 0.66 0.03 (-0.17, 0.22) 0.79 
Csb -0.7 (-3.3, 1.9) 0.61 -0.9 (-3.5, 1.8) 0.52 -0.04 (-0.23, 0.16) 0.72 0.08 (-0.12, 0.27) 0.45 
Cua -1.6 (-4.2, 1.1) 0.24 -2.2 (-4.9, 0.5) 0.11 -0.21 (-0.4, -0.01) 0.04 -0.23 (-0.43, -0.03) 0.02 
Mna -1.6 (-4.2, 1) 0.22 -2.7 (-5.4, -0.1) 0.04 0.07 (-0.13, 0.27) 0.49 0.22 (0.02, 0.41) 0.03 
Nia 0.9 (-1.8, 3.5) 0.51 2.2 (-0.4, 4.8) 0.10 -0.03 (-0.23, 0.16) 0.74 0.02 (-0.17, 0.21) 0.84 
Zna 1 (-1.6, 3.6) 0.47 -1.1 (-3.8, 1.5) 0.39 -0.01 (-0.2, 0.19) 0.94 -0.05 (-0.24, 0.15) 0.64 
Non-essential metals Tertile 2 vs 1 Tertile 3 vs 1 Tertile 2 vs 1 Tertile 3 vs 1 
Hgc -1.2 (-3.8, 1.4) 0.38 1.4 (-1.3, 4) 0.31 0.17 (-0.02, 0.37) 0.08 0.06 (-0.14, 0.25) 0.58 
Pbc -0.2 (-2.9, 2.4) 0.86 -2.9 (-5.5, -0.2) 0.03 -0.12 (-0.32, 0.07) 0.23 0.09 (-0.11, 0.29) 0.38 
Metals 
Preterm birth (overall, N=731) Preterm birth (spontaneous, N=700) 
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
Essential metals Tertile 1 vs 2 Tertile 3 vs 2 Tertile 1 vs 2 Tertile 3 vs 2 
Coa 0.81 (0.44, 1.51) 0.51 1.18 (0.65, 2.12) 0.59 0.59 (0.25, 1.41) 0.24 1.35 (0.65, 2.81) 0.42 
Csb 1.06 (0.58, 1.97) 0.84 1.25 (0.67, 2.3) 0.48 1.22 (0.55, 2.7) 0.62 1.19 (0.53, 2.65) 0.68 
Cua 1.03 (0.53, 2.02) 0.92 1.66 (0.9, 3.05) 0.11 1.12 (0.48, 2.62) 0.79 1.63 (0.74, 3.59) 0.23 
Mna 1.33 (0.69, 2.55) 0.40 1.87 (1.01, 3.45) 0.05 2.85 (1.07, 7.59) 0.04 3.91 (1.52, 10.03) 0.005* 
Nia 0.89 (0.5, 1.57) 0.69 0.49 (0.26, 0.93) 0.03 0.96 (0.47, 1.97) 0.91 0.4 (0.17, 0.95) 0.04 
Zna 0.52 (0.26, 1.04) 0.06 1.38 (0.79, 2.4) 0.26 0.55 (0.24, 1.28) 0.17 1.02 (0.49, 2.11) 0.95 
Non-essential metals Tertile 2 vs 1 Tertile 3 vs 1 Tertile 2 vs 1 Tertile 3 vs 1 
Hgc 1.86 (1.02, 3.4) 0.04 1.2 (0.62, 2.32) 0.60 3.23 (1.34, 7.78) 0.009* 1.9 (0.73, 4.92) 0.19 



















Table III.5 Continued 
Metals 
SGA (N=637) LGA (N=642) 
OR (95% CI) p value OR (95% CI) p value OR (95% CI) P value OR (95% CI) p value 
Essential metals Tertile 1 vs 2 Tertile 3 vs 2 Tertile 1 vs 2 Tertile 3 vs 2 
Coa 1.35 (0.72, 2.54) 0.34 1.15 (0.61, 2.19) 0.67 0.69 (0.38, 1.27) 0.23 0.79 (0.44, 1.42) 0.43 
Csb 1.5 (0.82, 2.75) 0.18 0.85 (0.44, 1.66) 0.63 1.08 (0.57, 2.03) 0.82 1.31 (0.72, 2.38) 0.37 
Cua 2.13 (1.09, 4.18) 0.03 1.83 (0.91, 3.69) 0.09 1.28 (0.71, 2.32) 0.41 0.81 (0.43, 1.54) 0.53 
Mna 0.85 (0.47, 1.54) 0.60 0.56 (0.29, 1.08) 0.08 0.92 (0.5, 1.72) 0.80 1.12 (0.62, 2.02) 0.71 
Nia 0.79 (0.45, 1.39) 0.41 0.33 (0.16, 0.66) 0.002* 0.65 (0.35, 1.21) 0.18 0.72 (0.4, 1.28) 0.26 
Zna 1.08 (0.58, 2.02) 0.80 1.05 (0.56, 1.97) 0.88 0.72 (0.4, 1.3) 0.28 0.63 (0.34, 1.14) 0.13 
Non-essential metals Tertile 2 vs 1 Tertile 3 vs 1 Tertile 2 vs 1 Tertile 3 vs 1 
Hgc 0.63 (0.33, 1.2) 0.16 0.87 (0.48, 1.58) 0.64 1.59 (0.86, 2.93) 0.14 1.2 (0.63, 2.29) 0.58 
Pbc 1.58 (0.88, 2.83) 0.12 0.62 (0.3, 1.26) 0.18 1.13 (0.63, 2.03) 0.67 0.74 (0.4, 1.4) 0.36 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); Odds ratio (OR); confidence 
interval (CI); interquartile range (IQR); small for gestation age (SGA); large for gestational age (LGA). 
a Referent levels were set at tertile 2 for essential metals (Co, Cu, Mn, Ni, Zn). 
b Cs is not regarded as essential to the health of plants or animals, nor does it present a hazard to them. For this analysis, Cs was considered as essential metal, therefore, referent 
levels were set at tertile 2. 
c Referent levels were set at tertile 1 for non-essential metals (Hg, Pb). 




















Table III.6 Estimated environmental risk score (ERS) weights (regression coefficient) for metals selected for each birth outcome. Models were adjusted for maternal age, maternal 
education, pre-pregnancy BMI, and exposure to secondhand smoking 
 Weights 
Metal Gestational Age Birthweight z-score Preterm birth (overall) Preterm birth (spontaneous) SGA LGA 
Co       
Cs       
Cu       
Mn       
Ni       
Zn   0.011    
As 
  
    
Cd 
  
    
Hg 
  
    
Pb -0.056 
 
0.057 0.102   
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestation age 



















Table III.7 Posterior inclusion probabilities (PIPs) for group inclusion and conditional inclusion into birth outcome models, using Bayesian kernel machine regression (BKMR) 










groupPIPa condPIPb groupPIPa condPIPb groupPIPa condPIPb groupPIPa condPIPb groupPIPa condPIPb groupPIPa condPIPb 
As 1 0.64 0.01 0.44 0.24 0.64 0.19 0.57 0.14 0.50 0.29 0.36 0.25 
Cd 1 0.64 0.17 0.44 0.23 0.64 0.06 0.57 0.12 0.50 0.30 0.36 0.35 
Hg 1 0.64 0.04 0.44 0.27 0.64 0.07 0.57 0.18 0.50 0.16 0.36 0.19 
Pb 1 0.64 0.78 0.44 0.26 0.64 0.68 0.57 0.56 0.50 0.25 0.36 0.21 
Co 2 0.37 0.79 0.57 0.63 0.56 0.40 0.68 0.42 0.49 0.51 0.47 0.58 
Mn 2 0.37 0.21 0.57 0.37 0.56 0.60 0.68 0.58 0.49 0.49 0.47 0.42 
Cs 3 0.13 0.01 0.46 0.31 0.94 0.02 0.64 0.14 0.78 0.09 0.43 0.24 
Cu 3 0.13 0.06 0.46 0.20 0.94 0.08 0.64 0.13 0.78 0.08 0.43 0.28 
Ni 3 0.13 0.70 0.46 0.24 0.94 0.07 0.64 0.27 0.78 0.76 0.43 0.22 
Zn 3 0.13 0.23 0.46 0.25 0.94 0.83 0.64 0.46 0.78 0.07 0.43 0.26 
 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestation age 
(SGA); large for gestational age (LGA); Posterior Inclusion Probabilities (PIPs). 
a GroupPIP provides group importance scores for pre-defined mutually-exclusive groups of variables 

















Figure III.3 Univariate and bivariate predictor-response function for the effect of metal mixture (Mn, Pb, Zn) on preterm birth estimated by Bayesian Kernal Machine Regression 
(BKMR)a. Models were adjusted for maternal age, maternal education, pre-pregnancy BMI, and exposure to secondhand smoking 
 
A                                                                                                                                                    B 
Abbreviations: manganese (Mn); zinc (Zn); lead (Pb); 
a estimate* may be interpreted as a latent continuous marker of the binary outcome-overall preterm birth  
A Univariate exposure–response functions and 95%confidence for each metal with the other pollutants fixed at the median 
B   Bivariate exposure–response functions for: Mn when Pb is fixed at either the 10th, 50th, or 90th percentile and Zn is fixed at the median (middle left panel); Mn when Zn is fixed 
at either the 10th, 50th, or 90th percentile and Pb is fixed at the median (bottom left panel); Pb when Mn is fixed at either the 10th, 50th, or 90th percentile and Zn is fixed at the 
median (top middle panel); Pb when Zn is fixed at either the 10th, 50th, or 90th percentile and Mn is fixed at the median (bottom middle panel); Zn when Mn is fixed at either the 






Figure III.4 Interaction effect of infant sex on the association between the average zinc (Zn) blood concentration and gestational 
























Chapter IV  
Psychosocial Status Modifies the Effect of Maternal Blood Metal and 
Metalloid Concentrations on Birth Outcomes 
 
Abstract 
Background: Metal exposure and psychosocial stress in pregnancy have each been associated 
with adverse birth outcomes, including preterm birth and low birth weight, but no study has 
examined the potential interaction between them. Objective: We examined the modifying effect 
of psychosocial stress on the association between metals and birth outcomes among pregnant 
women in Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) birth cohort 
study. Methods: In our analysis of 682 women from the PROTECT study, we measured 16 
essential and non-essential metals in blood samples at two time points. We administered 
questionnaires to collect information on depression, perceived stress, social support, and life 
experience during pregnancy. Using K-means clustering, we categorized pregnant women into one 
of two groups: “good” and “poor” psychosocial status. We then evaluated whether the effect of 
blood metals (geometric average) on adverse birth outcomes (gestational age, preterm birth 
[overall and spontaneous], birth weight z-score, small for gestation [SGA], large for gestation 
[LGA]) vary between two clusters of women, adjusting for maternal age, maternal education, pre-
pregnancy body mass index (BMI), and second-hand smoke exposure. Results: Blood manganese 
(Mn) was associated with an increased odds ratio (OR) of overall preterm birth (OR/interquartile 
range [IQR] = 2.76, 95% confidence interval [CI] = 1.25, 6.12) and spontaneous preterm birth 
(OR/IQR: 3.68, 95% CI: 1.20, 6.57) only among women with “poor” psychosocial status. The 
association between copper (Cu) and SGA was also statistically significant only among women 
having “poor” psychosocial status (OR/IQR: 2.81, 95% CI: 1.20, 6.57). We also observed 
associations between nickel (Ni) and preterm birth and SGA that were modified by psychosocial 
status during pregnancy. Conclusions: Presence of “poor” psychosocial status intensified the 








Metals are ubiquitous in the environment, and they can enter the human body through ingestion of 
food and water, dietary supplement intake, contact with contaminated environments, and use of 
metal-containing products through inhalation, skin contact, and/or inadvertent ingestion [1-6]. 
Exposure to metals impacts various biological pathways that contribute to adverse birth outcome, 
including preterm delivery and low birthweight [1, 7-20]. Our recent analysis in the Puerto Rico 
Testsite for Exploring Contamination Threats (PROTECT) cohort study also suggested 
associations between elevated levels of maternal essential and non-essential metals and various 
birth outcomes [21]. We found a decrease in gestational length and increased odds of preterm birth 
in association with higher maternal blood lead (Pb) concentration; increased odds of preterm birth 
in association with blood copper (Cu), manganese (Mn), and zinc (Zn) concentrations; and that 
blood nickel (Ni) was associated with lower odds of small for gestational age (SGA). Prenatal 
psychosocial stress has also been found to be associated with an increased risk of adverse 
pregnancy outcomes—psychological distress, perceived stress, anxiety, depression symptoms, and 
low social support among pregnant women were associated with an increased risk of pre-eclampsia 
[22], preterm birth [23-28], and low birth weight [23, 27].  
 
The majority of epidemiologic studies evaluate the impact of individual chemical and non-
chemical exposures. However, pregnant women are exposed to both environmental chemicals and 
psychosocial stress, and psychosocial factors may influence how a particular environmental 
chemical is experienced or what the physical response to it may be. Recently, there has been a 
general acknowledgment that there is likely to be joint effects of environmental chemicals (e.g. 
phthalates, black carbon, lead [Pb]) and psychosocial stress exposure on pregnancy and child 
development outcomes [29-37]. The identification of modifiable psychosocial factors may lead to 
interventions during pregnancy to reduce the harmful effects of metals on birth outcomes. 
Therefore, the current study aimed to examine whether the psychosocial status of the mothers 
during pregnancy modifies the effects of metals on gestational length/preterm delivery and 




associations between metal exposure and adverse birth outcomes in pregnant women with poorer 
psychosocial status compared to mothers with better psychosocial status.  
 
2. Methods 
2.1 Study population  
This study used data collected from 682 pregnant women participating in the PROTECT study, an 
ongoing, prospective birth cohort [38-41]. The PROTECT study was launched in 2010 with 
funding from the National Institute of Environmental Health Sciences (NIEHS) Superfund 
Research Program to investigate Puerto Rico’s high preterm birth rate and the extent of hazardous 
waste contamination on the island. PROTECT aims to explore environmental exposures and other 
factors contributing to preterm birth risk and other adverse birth outcomes in Puerto Rico.   
 
Study participants were recruited at approximately 14 ± 2 weeks of gestation at seven prenatal 
clinics and hospitals throughout Northern Puerto Rico and followed until delivery. [38, 39]. 
Inclusion criteria for this study were: maternal age between 18 to 40 years; residence inside of the 
Northern Karst aquifer region; planning to deliver in the collaborating hospitals. Exclusion of 
participants included the use of oral contraceptives within the three months prior to pregnancy; use 
of in vitro fertilization to become pregnant; or any major medical or obstetrical complications, 
including pre-existing diabetes. Each woman participated in a total of up to three study visits (18 
± 2 weeks, 22 ± 2 weeks, and 26 ± 2 weeks of gestation). Detailed information on medical and 
pregnancy history was collected at the initial visit. During an in-home visit (second visit), nurse-
administered questionnaires were used to gather information on housing characteristics, 
employment status, and family situation. Questionnaires assessing the psychosocial status of study 
participants were administered at the second and third visits. Blood samples were collected during 
the first and third visits. The present analysis reflects 682 women who delivered a live singleton 
birth with measured metal(loid) concentrations in maternal blood and information on 
demographics and psychosocial variables available (Figure IV.1).  
 
The research protocol was approved by the Ethics and Research Committees of the University of 




University of Georgia. The study was described in detail to all participants, and informed consent 
was obtained prior to study enrollment. 
 
2.2 Measurement of metals 
Blood samples were collected in metal-free whole blood tubes. Whole blood samples were frozen 
and stored at -80°C and shipped on dry ice. The analysis was performed at NSF International (Ann 
Arbor, MI, USA), where concentrations of 16 metals and metalloids were measured in blood: 
arsenic (As), barium (Ba), beryllium (Be), cadmium (Cd), cobalt (Co), chromium (Cr), cesium 
(Cs), copper (Cu), mercury (Hg), manganese (Mn), nickel (Ni), Pb, titanium (Ti), uranium (U), 
vanadium (V), and zinc (Zn). Metal(loid) concentrations were measured using inductively coupled 
plasma mass spectrometry (ICPMS) as described previously [11]. Considering that biological 
samples have high levels of carbon and chloride in the matrix, the laboratory selected the 
appropriate isotopes for the requested elements to best avoid interferences where possible. The 
ICPMS was calibrated with a blank and a minimum of four standards for each element of interest. 
An R2 value of >0.995 was the minimum criteria for an acceptable calibration curve. The 
calibration curves were verified by initial checks at three calibration points within the curve. 
Continuing calibration checks and blanks after every 10 samples were also utilized throughout the 
analytical run to ensure the ICPMS system was maintaining acceptable performance.  
 
2.3 Birth outcomes   
All birth outcome data were extracted from medical records. The American Congress of 
Gynecologists (ACOG) recommendations for gestational age at birth calculations [42] were used 
in our study as previously described [43, 44]. As per common practice, preterm birth was defined 
as delivery < 37 completed weeks of gestation. Based on the clinical presentation of preterm 
delivery, preterm birth was further classified as spontaneous preterm birth (presentation of 
premature rupture of the membranes, spontaneous preterm labor, or both) and non-spontaneous 
preterm birth (preterm births with preeclampsia, or with both artificial membrane rupture and 
induced labor). We included overall and spontaneous preterm birth as two of the birth outcomes 
in our analysis.  
Birthweight z-scores (defined as the number of standard deviations by which a birthweight is 




[45, 46]. Gestational age- and sex-specific birthweight z-score were constructed according to the 
INTERGROWTH-21st standards [47]. Small for gestational age (SGA) births were defined as 
below the 10th percentile of birthweight z-scores. Large for gestational age (LGA) births were 
defined as above the 90th percentile of birthweight z-scores. 
 
2.4 Psychosocial variables and life events 
Four questionnaires were administered in PROTECT to assess the psychosocial status of study 
participants [48-50]. They include (1) Center for Epidemiological Studies-Depression (CES-D), a 
20-item score that measures depression symptoms according to the Diagnostic Statistical Manual-
IV[51]; (2) Perceived Stress Scale (PSS) [52], a 10-item score that aims to determine the 
participants’ perceived stress levels within the last month; (3) Enhancing Recovery in Coronary 
Heart Disease Patients (ENRICHD) Social Support Instrument (ESSI), a 7-item score measuring 
functional social support [53, 54]; (4) Life Experiences Survey (LES) a 39-item score which 
provides information on positive and negative life events that the participants experienced since 
becoming pregnant [55]. The CES-D, PSS, and ESSI surveys were administered at the third visit 
in the clinic and the LES questionnaires were completed at the second visit at home; All 
questionnaires were translated and administered in Spanish. Previous studies among large and 
diverse samples of Hispanics/Latinos have evaluated the reliability and validity of the scales and 
recommended their use in Spanish among Hispanics/Latinos [56-58]. 
 
Responses from the four questionnaires were summed to create separate continuous measures of 
the four scales, depression (CES-D: range 0–48), perceived stress (PSS: range 0–40), social 
support (ESSI: range 0–34), and life events (LES: range -39 to 39). If the response to any individual 
question within a questionnaire was missing, the corresponding scale was coded as missing for 
that individual. The higher scores for CES-D and PSS corresponded to higher depression and stress 
level for all scales, whereas lower ESSI indicated low social support (i.e., high stress). A positive 
LES score represented the occurrence of relatively more positive events and vice versa. 
 
2.5 Data pre-processing for statistical analyses 
Metal concentrations below the limit of detection (LOD) were replaced by LOD/√2. For statistical 




LOD as continuous variables, and metal(loid)s with less than 70% of samples above the LOD (As 
and Cd) as binary variables (above vs below LOD). Metals with low detection rate (<30%), Ba, 
Be, Cr, Ti, U, and V were excluded from the analyses. Descriptive statistics were calculated for 
all exposure, modifier, and outcome variables. Distributions of all metals measured in blood were 
right-skewed and thus, were natural log-transformed for all analyses. 
 
2.6 K-means Clustering 
The four psychosocial scales we measured are correlated [48] and yet each reflects a unique aspect 
of the psychosocial well-being and together collectively represents a mothers’ overall well-being. 
Therefore, in our main analysis, instead of assessing the modifying effect of each scale separately, 
we evaluated them simultaneously by grouping women based on their overall psychosocial well-
being attributable to each scale. We used K-means clustering with the input of scores from the four 
psychosocial scales to identify subgroups of PROTECT participants with different overall 
measurements of psychosocial well-being. K-means clustering is one of the most commonly used 
unsupervised machine learning algorithms which allow us to split the dataset into k groups such 
that the observations in the same cluster are more similar than observations from different clusters 
[59]. Each cluster is represented by its center which corresponds to the mean of points assigned to 
the cluster. All four scales were standardized to make variables comparable. The number of 
optimal clusters (k) was determined based on (1) Elbow method [60] (2) average silhouette method 
[61], and (3) gap statistics method [62]. 
 
2.7 Main Analysis 
In our previous work, we examined the associations between each birth outcome and each average 
metal exposure biomarker [21]. Logistic regression models were used to examine the associations 
between metal exposure and binary adverse birth outcomes, including preterm birth (overall and 
spontaneous preterm birth), SGA, and LGA, whereas multiple linear regression was used to model 
metal exposures with the continuous outcomes gestational age and birthweight z-score. In this 
analysis, we constructed separate regression models (n=k) for each association with an interaction 
term of (exposure biomarker* cluster indicator variable) to determine the effects of metal exposure 
on birth outcomes. We considered interaction p <0.1 as statistically significant. All outcomes were 




missing concentrations at one visit, the “average” concentration was equal to the single available 
concentration), with separate models for each exposure biomarker. In the interaction models, the 
effect estimates of the covariates are still assessed using the whole dataset when a metal’s effect is 
estimated within each cluster. The covariate selection process was described previously [21]. 
Briefly, a pool of potential confounders was selected based on a priori knowledge and the final set 
of covariates were selected in a stepwise procedure if their inclusion appreciably changed the beta 
coefficient of metal exposure. The final models were controlled for maternal age, maternal 
education level, pre-pregnancy BMI, and exposure to second-hand smoking.  
 
In an effort to detect potential non-linear relationships between metals and birth outcomes within 
different clusters, we used generalized additive models (GAM) to graphically depict the metal and 
birth outcome associations within each cluster, adjusting for the same covariates.  
 
2.8 Sensitivity Analysis 
We ran additional linear models including income categories as an indicator of socio-economic 
status (SES) instead of maternal education categories. Another analysis was performed excluding 
women with reported maternal complications, preeclampsia (n=22) and gestational diabetes 
(n=14). To test whether the interactions between metal biomarkers and psychosocial clusters 
varied by study visits, we utilized indicator variables for study visits and included a three-way 
interaction term of (exposure biomarker* cluster indicator*study visit indicator) in the main 
models substituting the original two-way interaction. The interaction terms were tested for 
significance and the visit-cluster-specific metal effect estimates were also abstracted from the 
models. Finally, to further explore the contributions of individual psychosocial scales on effect 
modification, each of the psychosocial scale variables was evaluated separately as potential 
modifiers of the associations between metals and birth outcomes. For this analysis, binary 
psychosocial scale variables were created for CES-D, PSS, and ESSI score using cutoffs based on 
a priori knowledge and considering cluster balance. A score of 16 was used for CES-D as a cutoff 
(>=16 vs <16) as it is typically used to determine depression [63]. As there is no established cut-
off for PSS, we set the cut-off for PSS at the 75th percentile (score of 18, maximum score= 39) 
[48]. Participants with scores >=18 were considered to have high perceived stress. Similarly, a cut 




from women with lower social support (<31). The total LES score was categorized into three 
groups (labeled ‘‘negative”, ‘‘neutral” and ‘‘positive”) to consider the overall negative and 
positive scores. The cut-off points were below -1, between -1 and 1, and above 1 [48]. 
 
All results were presented as changes in birth outcomes (95% confidence intervals per interquartile 
range (IQR) increase in metal concentrations. We also considered significance after adjusting for 
multiple testing. In order to be able to identify as many significant comparisons as possible while 
still maintaining a low false positive rate, False Discovery Rate (FDR) and its analog the q value 
are utilized implementing the Benjamini-Hochberg method [64]. Q value (adjusted p value) is the 
expected proportion of false positives among all features as or more extreme than the observed 
one. Since birth outcomes were correlated, we calculated q values treating each outcome as a 
family of tests. A cutoff of 0.1 for q value was used to further interpret the main results with greater 
confidence. Data were analyzed using R version 3.6.2 [65] and the clustering calculation was 
performed by using the R package “cluster” [66]. 
 
3. Results 
3.1 Descriptive statistics 
The demographic characteristics of 682 women in this analysis are summarized in Table IV.1 and 
were described previously [41, 67]. Participants had a mean age of 27 years with approximately 
half of the women having a BMI less than 25kg/m2 prior to pregnancy. The majority of women 
(62%) had private medical insurance and were employed (61%). Nearly half of them had annual 
household incomes less than $30,000 while 88% reported graduating from college or higher. The 
prevalence of current smokers was very low (1%). Very few (7%) of the women reported 
consumption of alcohol within the last few months. Mean gestational age was 38.9 (standard 
deviation=1.9) weeks for 682 singleton births included in this analysis, among which 61 (9%) were 
preterm and 36 (5%) were spontaneous preterm; the rates of SGA and LGA were both 10%.  
 
Descriptive statistics (geometric mean [GM], geometric standard deviation [GSD], select 
percentiles) of blood metals were summarized in Table IV.2 and were previously described in 
detail [6]. Levels of most metals in pregnant Puerto Rican women were higher than levels observed 




[6]. There were weak to moderate correlations between different blood metal concentrations (Mn 
and Co, r=0.36; As and Hg, r=0.32; Cd and Co, r=0.33). Distributions of the ESSI, PSS, CES-D, 
and LES scales across demographic characteristics were included in Table IV.2 and were 
described in detail previously [50]. Overall, most psychosocial variables were associated with 
lower SES indicators, such as unemployment, lower income, and lower education. 
 
3.2 Clustering 
The optimal number of clusters was two (k=2) for the k- means clustering analysis based on the 
elbow method, average silhouette method, and gap statistics method. Therefore, women in this 
study were divided into two groups, labeled as having “good” psychosocial status (N=526) and 
“poor” psychosocial status (N=156). Figure IV.2 shows the mean of each standardized log-
transformed score of depression (CES-D), perceived stress (PSS), social support (ESSI), and life 
events (LES). Note that women in the “good” psychosocial status cluster had a lower standardized 
mean score (<0) for depression and perceived stress and higher mean score (>0) for social support 
and life events, whereas women in the “poor” psychosocial status cluster had a higher mean score 
(>0) for depression and perceived stress and lower mean score (<0) for social support and life 
events.  
 
We also calculated the geometric mean and geometric standard deviation of blood metal (loid) 
concentrations (ng/ml) among women within “good” and “poor” psychosocial status clusters and 
tested whether the metal concentrations vary between the two clusters (Table IV.3). There were 
no differences, except for Pb, where the concentrations were statistically higher in the “poor” 
psychosocial cluster compared to the “good” psychosocial cluster (p <0.001). 
 
3.3 Main Analysis 
Figure IV.3 presents the associations between blood metal concentrations and birth outcomes 
within “good” and “poor” psychosocial status clusters. The effect estimates, confidence intervals, 
and p values are also given in Table IV.4. Co was associated with shorter gestational age among 
both clusters of mothers having “good” and “poor” psychosocial status and the effect estimates 
did not vary between the two clusters (p for interaction =0.17). We found a statistically significant 




(p for interaction=0.01). Within the “poor” psychosocial status cluster, an interquartile range (IQR) 
increase in blood Mn concentration was associated with 5 days shorter gestational age (95% CI: -
7.2, -1.9, p<0.001) whereas the association was not significant among mothers with “good” 
psychosocial status. After correcting for multiple testing, the associations between blood Mn and 
gestational age among “poor” psychosocial status cluster, as well as the interaction had q-values 
< 0.1 (Figure IV.3, Table IV.4), providing greater confidence in these associations. Similar 
interactions were observed for overall (p for interaction=0.05) and spontaneous preterm birth (p 
for interaction=0.09); there were strong associations between blood Mn and significantly increased 
odds of overall preterm birth (OR/IQR= 2.76, 95%CI: 1.25, 6.12, p=0.01, q=0.06) and spontaneous 
preterm birth (OR/IQR= 3.68, 95%CI: 1.17, 11.61, p=0.03, q>0.1) only among mothers classified 
with “poor” psychosocial status. Ni was associated with 0.43 and 0.33 times lower odds of preterm 
birth (95%CI=0.22, 0.81, p=0.01, q=0.06) and spontaneous preterm birth (95%CI=0.13, 0.83, 
p=0.02, q>0.1) among mothers with “poor” psychosocial status which was statistically different 
(p for interaction=0.01 and 0.02, respectively) compared to the null associations among mothers 
classified in the “good” psychosocial status cluster.  
 
Although associations between blood Pb and blood Zn and preterm birth/gestational age were 
statistically significant among mothers having “good” psychosocial status but not significant 
within the “poor” psychosocial status cluster, the interaction terms for the differences were not 
statistically significant. Cu was significantly associated with higher odds of SGA (OR/IQR= 2.81, 
95%CI=1.20, 6.57, p=0.02) among mothers classified in the “poor” psychosocial status cluster; 
however, the association was not found among mothers having “good” psychosocial status and 
this difference was statistically significant (p for interaction =0.01). An IQR increase in Ni was 
associated with 0.55 times lower odds of SGA only among mothers with “good” psychosocial 
status (p<0.001, q=0.02) and this protective effect was significantly different from the null effect 
observed within the “poor” psychosocial status cluster (p for interaction =0.04). Associations 
between the metal biomarkers and birthweight z-score and LGA were not statistically significant 
within either cluster. Results from GAM including metal concentrations as splines and the GAM 
output graphics showed that when the smoothing estimator is significant the observed associations 




Figure IV.4: Relationship between blood Mn concentration and preterm birth within “good” and 
“poor” psychosocial status clusters.) 
 
3.4 Sensitivity Analysis 
The results from additional analysis including income as a covariate were similar to the main 
analysis results we reported (Table IV.5). Excluding women with conditions such as preeclampsia 
and gestational diabetes also yielded similar results (data not shown). The binary birth outcome 
(preterm birth, SGA, LGA) models including interactions between metal concentrations, 
psychosocial cluster, and study visit failed to converge due to small sample size in each stratum. 
The results of models evaluating associations between metal concentrations and gestational age 
(continuous) by study visit and psychosocial clusters are presented in Table IV.6 (Birthweight z-
score models did not yield significant results, data not shown). The direction of the cluster-specific 
associations within each study visit remained the same. The interactions between metal 
concentrations and psychosocial cluster did not statistically vary between two study visits (three-
way interaction p values>0.1). Results from additional analyses evaluating individual psychosocial 
scales as potential effect modifiers were included in Table IV.7, IV.8, IV.9, and IV.10. There 
were inverse interactions between Mn and depression score (p for interaction [gestational age] 
=0.05), perceived stress (p for interaction [overall preterm] =0.09) social support (p for interaction 
[gestational age, overall and spontaneous preterm birth] =0.09, 0.01, and 0.03). Mn concentration 
was associated with shortened gestation and higher odds of preterm birth only among women who 
had higher perceived stress and higher depression score, and lower social support.  
 
4. Discussion 
This study uses data collected in the PROTECT birth cohort to examine the modifying effect of 
overall psychosocial status on the relationships between blood concentrations of essential and non-
essential metals and birth outcomes. We found increased odds of preterm birth (overall and 
spontaneous) associated with higher blood Mn concentration only among women with “poor” 
psychosocial status. Higher prenatal Cu was associated with increased odds of SGA among women 
concurrently at “poor” psychosocial status. Conversely, higher Ni was found to be associated with 
lower odds of preterm birth among women with “poor” psychosocial status, but lower odds of 





Previous studies have suggested that elevated levels of essential metals Mn, Cu, and Ni may be 
associated with increased risk of intrauterine growth restriction [68], preterm delivery [11, 12, 69], 
and low birthweight [13, 14]. It is also well established that maternal psychosocial stress during 
pregnancy is associated with adverse birth outcomes [22-28]. Moreover, a growing body of recent 
epidemiological studies has reported the modifying effect of prenatal psychosocial stress on the 
associations between environmental chemical exposure, including metals (Pb, Cd, Mn, and 
Chromium [Cr]), and pregnancy outcomes [48, 70-75], and childhood developmental outcomes 
[32, 76-81].  
 
Psychosocial stress scales were not associated with any birth outcomes in this cohort [48] or a 
prospective cohort of US women (TIDES study) that used similar psychosocial scales [82]. 
Therefore, it is unlikely that the modifying effects are attributable to mediation through 
psychosocial stress. However, it is possible that double hits could lead to a joint effect; a form of 
“double jeopardy” has been used to describe this potential interaction of environmental chemicals 
and stress [83, 84]. Chemical and psychosocial exposure may both interfere with complex 
mechanisms that impair individual resistance and capability to recover when there is more than 
one “hit” and eventually lead to exacerbation of physiological response to the cumulative “hits” 
[84-86].  
 
Several important biological pathways have also been hypothesized for the interaction between 
environmental chemicals and psychosocial stress on the association with pregnancy outcomes. 
Oxidative stress and inflammation, two interrelated biological pathways, have generated attention 
as they are impacted by both prenatal metal exposure and the psychosocial status of the mother. 
One important finding we showed here in PROTECT is that associations between Mn and preterm 
birth were statistically significant and greater in magnitude among women with “poor” 
psychosocial status (OR/IQR=2.76, 95%CI=1.25, 6.12, p=0.01) but not among women with 
“good” psychosocial status (OR/IQR=1.12, 95%CI=0.75, 1.68, p=0.57, p for interaction=0.01). 
Cu was also associated with higher odds of SGA only among women with “poor” psychosocial 
status (OR/IQR= 2.81, 95%CI=1.20, 6.57, p=0.02, p for interaction=0.01). Although both Mn and 




found a relationship between elevated Mn and Cu levels and biomarkers of oxidative stress and 
inflammation [89-99]. Being at a “poor” psychosocial status during pregnancy may induce similar 
oxidative stress and inflammatory immune reactions to that of exposure to metals [100]. It is 
possible that oxidative stress induced by psychosocial factors can result in vulnerability at the 
mother fetus interface to metals, such as Mn and Cu. However, psychosocial variables have not 
been significantly associated with increased markers of oxidative stress in this cohort [49] but have 
in other cohorts [86]. 
 
The interactive effect of metal and psychosocial stress on birth outcomes may also be working 
through modulating fetal hypothalamic–pituitary–adrenal (HPA) activities [101]. A previous study 
on this cohort examining the relationship between maternal metal and hormone concentrations 
reported a strong positive association between Mn and corticotropin-releasing hormone (CRH) 
[102]. CRH is produced by the hypothalamus and placenta and has an important role in setting the 
biological clock of pregnancy duration. CRH is also produced by the hypothalamus in response to 
maternal stress to stimulate the production of cortisol, which plays a fundamental role during 
pregnancy and fetal development. Thus, it may be possible that the combined effect of an increase 
in CRH via Mn as well as an increase in cortisol via psychosocial stress caused an increase in 
allostatic load, leading to a significant decrease in gestational length. This hypothesis for metals 
in general is also supported by evidence from animal and human studies showing changes in 
glucocorticoid hormones (i.e., cortisol) by metals [103, 104] and psychosocial stress [105, 106], 
or both in unison [107, 108]. Several epigenome-wide association studies have linked neurotoxic 
metals, including Mn, to increased placental glucocorticoid receptors (majority on NR3C1) 
methylation [109-111]. Likewise, prenatal stress has been reported to contribute to the epigenetic 
alteration of the same receptors, both independently [112-114] as well as when combined with 
metal exposure [115, 116]. Taken together, epigenetic mechanisms may explain the interaction 
between metal and psychosocial stress on the disruption of fetal HPA axis functioning, which may 
result in adverse birth outcomes. Nevertheless, our results suggest that the prenatal mechanisms 
by which changes in gestational age and fetal growth are impacted by the co-exposure to metals 





It is worth noting that, contrary to our hypothesis, we observed protective modifying effects of 
being classified as having “poor” psychosocial status on the association between maternal blood 
Ni and preterm birth. The mechanism underlying this result is unclear as the health effects 
associated with prenatal Ni are sparsely investigated in the literature. While higher levels of blood 
Ni are generally reflective of women’s exposure to Ni in air, water, or food [117], women can be 
occupationally exposed to Ni from certain workplaces/occupations, such as manufacturing of 
jewelry, medical devices, and stainless steel [118]. Although our previous research within 
PROTECT did not find significant and specific predictors or sources of the Ni exposure in this 
population [6], it is possible that there are unmeasured confounders and/or sources of Ni exposure 
among this population that were driving the results. Our findings on Ni may also be a chance 
finding warranting the need for future research to either support or refute this observation. 
 
Blood Pb levels were significantly higher among women within the “poor” psychosocial status 
cluster compared to the “good” psychosocial status cluster. It is possible that Pb levels may 
influence the association of other metals in this study. Metals like Pb and Mn share transporters 
and targets in the body [119] and there are multiple mechanisms and pathways through which Pb 
and Mn may interact [120]. Therefore, the differential impacts of Mn in the two psychosocial 
clusters observed in this study may be attributed in part to possible additive interaction and effect 
modification between the Pb and Mn on gestational length. Our sample sizes were limited to detect 
such interactions, future studies are needed to consider the framework of metal dyshomeostasis 
and look for patterns in metal fluctuations across studies.  
 
Perceived stress, life events, social support, and depression are highly interlinked in many 
populations [121, 122] including PROTECT [50]. Studies have reported an increase in the rate of 
depression with higher levels of perceived stress and stressful events [123, 124], and others have 
reported a protective effect of social support on depression [125, 126]. However, potential 
bidirectional pairwise associations are likely among these four psychosocial variables. For 
example, whereas some studies examined social support as a mediator between stress and maternal 
depression [127], others examined the mediating effect of stress on social support and maternal 
depression [128]. The first study reported a mediating and moderating effect of social support on 




[127]. The second study reported a mediating effect of perceived stress in a longitudinal study on 
1,316 U.S. women, such that lower levels of social support led to higher levels of perceived stress 
and higher rates of postpartum depression. Additional well-designed studies are needed to 
disentangle these relationships and the causal framework involved. 
 
In this study, we had data on a total of four psychosocial scales that allowed us to capture different 
aspects of psychosocial well-being. We utilized a clustering method on the four psychosocial 
scales to divide women into two groups of having “poor” and “good” psychosocial status during 
pregnancy. Using a novel example of dimension reduction on the effect of modifier space, we then 
evaluated the modifying effect of this overall psychosocial status on the association between 
metals and pregnancy instead of examining each scale separately. This study is also highlighted 
by the quantification of interaction between metal exposure and psychosocial stress and an 
extensive panel of blood metal biomarkers that assessed essential metals, such as Cu, which have 
not been studied with non-chemical exposures in detail to date. 
 
While our study is among the first to explore the interaction between prenatal metal exposure and 
psychosocial stress during pregnancy, there were a few limitations. Measurements in this study, 
including metal biomarkers, psychosocial variable scores, and covariates (i.e. pre-pregnancy BMI) 
may be affected by measurement error. Considering the potential for non-differential measurement 
error in exposures, covariates, and outcome variables, the effects were likely to be attenuated 
towards the null. Nonetheless, the repeated collection of blood samples enabled us to examine 
metal biomarkers at two time points across pregnancy to more fully characterize prenatal metals 
exposure. Repeated exposure measurements help reduce measurement error and provide greater 
statistical power, relative to studies with single time point measurements. Although we adjusted 
for a variety of covariates, possible residual or additional unmeasured confounders of metal 
exposure and/or psychosocial variables may be unaccounted for in our analysis. In addition, the 
small sample size in the “poor” psychosocial status cluster limited the assessment power of effects 
estimates in the cluster, therefore, future studies are needed to validate our findings. While this 
work studied the effects of multiple metals, other metals that are not explored in this study such as 
iron (Fe) may also interact with these metals because Fe-deficiency increases divalent metal 




other environmental exposures, including phthalates and PAHs, were not explored. Future work 
to investigate the interaction between a more extensive range of metals and multiple chemical 
mixtures and psychosocial stress is needed. Finally, as psychosocial variable distributions are 
bound to material and social factors in the countries/regions being studied, they may vary from 
this cohort to others. Therefore, our results may not be generalizable to the overall U.S. pregnant 
population or pregnant women populations in other countries.  
 
5. Conclusion 
We examined the interaction between environmental metals and maternal psychosocial status on 
birth outcomes among pregnant women in Northern Puerto Rico. We observed associations 
between Mn and increased odds of preterm birth (overall and spontaneous), Ni and decreased odds 
of preterm birth, and Cu and increased odds SGA, that were modified by whether a mother was at 
a “poor” psychosocial status during pregnancy. Our findings provide evidence for the modifying 
role of psychosocial status on the effect of prenatal metal exposure among pregnant women and 
further suggest prenatal stress and social support could be modifiable psychosocial assets that may 
help mitigate risk. This study also highlights the need for future research in this area to examine 
the effects of co-exposure to both environmental and psychosocial conditions, particularly during 
sensitive developmental stages. 
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Table IV.1 Demographic characteristics of n = 682 pregnant women from Puerto Rico 
Variable Mean (SD) 
Maternal Age 26.8 (5.6) 
Characteristic Category Count (Percent) 
Insurance Type 
Private 425 (62.3%) 
Public (mi salud) 238 (34.9%) 
Missing 19 (2.8%) 
Maternal Education 
<=High school/GED 143 (21.0%) 
Some college or technical school 238 (34.9%) 
College degree 214 (31.4%) 
Master’s degree or higher 87 (12.8%) 
Missing 0 (0.0%) 
Household Income 
<$10,000  185 (27.1%) 
≥$10,000 to <$30,000  191 (28.0%) 
≥$30,000 to <$50,000  141 (20.7%) 
≥$50,000  85 (12.5%) 
Missing 80 (11.7%) 
Marital Status 
Single  136 (19.9%) 
Married or living together 544 (79.8%) 
Missing 2 (0.3%) 
Gravidity (# Pregnancies) 
0 289 (42.4%) 
1 249 (36.5%) 
>1 143 (21.0%) 
Missing 1 (0.1%) 
Pre-pregnancy BMI (kg/m2) 
≤25 372 (54.5%) 
>25 to ≤30 183 (26.8%) 
>30 127 (18.6%) 
Missing 0 (0.0%) 
Infant Gender 
Female 328 (48.1%) 
Male 352 (51.6%) 
Missing 2 (0.3%) 
Employment Status 
Unemployed 417 (61.1%) 
Employed 259 (38.0%) 
Missing 0 (0.0%) 
Smoking 
Never 581 (85.2%) 
Ever 93 (13.6%) 
Current 8 (1.2%) 
Missing 0 (0.0%) 
Exposure to Second-hand Smoking 
None 623 (91.3%) 
Up to 1 hour 18 (2.6%) 
More than 1 hour 41 (6.0%) 
Missing 0 (0.0%) 
Alcohol Consumption 
None 331(48.5%) 
Before pregnancy 299 (43.8%) 
Within the last few months 48 (7.0%) 










Table IV.2 Blood concentrations of metal(loid)s (ng/ml) and psychosocial variables in 682 pregnant women from Puerto Rico 
 
Metal 
LOD % >LOD GM GSD 25% 50% 75% 95% Max 
(loid)a 
Co 0.2 98.2 0.35 1.3 0.29 0.34 0.41 0.55 1.3 
Cs 0.04 99.9 1.1 1.3 0.9 1.1 1.4 1.9 2.9 
Cu 9 99.9 1592 1.2 1428 1616 1779 2133 3798 
Mn 2 99.9 11.2 1.4 9.0 11.2 13.9 19.0 34.9 
Ni 0.5 96.4 1.0 1.6 0.77 1.0 1.3 2.2 16.7 
Zn 24 99.9 4736 1.2 4248 4780 5314 6269 8043 
As 0.3 48.9 0.32 1.7 <LOD <LOD 0.45 1.0 3.0 
Cd 0.1 60.9 0.12 1.6 <LOD 0.11 0.16 0.27 0.9 
Hg 0.2 99.9 1.2 1.7 0.85 1.2 1.7 3.1 5.4 
Pbb 0.02 99.9 3.1 1.5 2.3 3.1 4.1 6.5 15.1 
Psychosocial stress  Range Mean Min 25% 50% 75%  Max 
scales 
CESD    0-48 11 0 5 9 15  48 
PSS  0-40 14 0 8 13 18  39 
ESSI  0-34 32 8 31 33 34  34 
LES    -39-39 0 -35 -2 0 2  19 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); 
mercury (Hg); lead (Pb); limit of detection (LOD); geometric mean (GM); geometric standard deviation (GSD); Center for 
Epidemiological Studies-Depression (CESD); Perceived Stress Scale (PSS); Enhancing Recovery in Coronary Heart Disease 
Patients (ENRICHD) Social Support Instrument (ESSI); Life Experience Survey (LES). 
a Includes blood metal concentrations for up to 2 repeated samples per woman (n = 1035 samples); 



















Figure IV.2 Cluster means of the four standardized psychosocial variable scales using k-means in the PROTECT dataab 
 
 
Abbreviations: Center for Epidemiological Studies-Depression (CESD); Perceived Stress Scale (PSS); Enhancing Recovery in 
Coronary Heart Disease Patients (ENRICHD) Social Support Instrument (ESSI); Life Experience Survey (LES). 
a Y-axis (cluster means) represents the mean standardized psychosocial variable scale 
b Cluster 1: “good” overall psychosocial status pattern with low depression score and perceived stress and high social support and 
overall positive life events; cluster 2: “poor” overall psychosocial status pattern with high depression score and perceived stress 



























Table IV.3 Geometric mean and geometric standard deviation of blood metal (loid) concentrations (ng/ml) among women within 
“good” and “poor” psychosocial status clusters  
 
 Cluster 1: “good” psychosocial status Cluster 2: “poor” psychosocial status  
Metal ((loid) GM GSD GM GSD P valueb 
Co 0.36 1.4 0.37 1.3 0.14 
Cs 1.2 1.4 1.2 1.3 0.31 
Cu 1554 1.3 1614 1.2 0.14 
Mn 11.0 1.4 11.6 1.4 0.16 
Ni 1.1 1.8 1.1 1.7 0.36 
Zn 4780 1.3 4760 1.2 0.82 
As 0.37 1.8 0.38 1.7 0.25 
Cd 0.12 1.6 0.13 1.8 0.11 
Hg 1.1 1.9 1.1 1.8 0.68 
Pba 3.0 15.9 3.5 15.0 <0.001** 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); 
mercury (Hg); lead (Pb); geometric mean (GM); geometric standard deviation (GSD). 
a Pb concentration unit is µg/dL 








Figure IV.3 Change in birth outcomes associated with geometric mean exposure biomarker concentration within two psychosocial status clusters. Effect estimates presented as 
changes in gestation or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal education, pre-pregnancy BMI, 
and exposure to secondhand smoking 
 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb). 
aAs, Cd were compared between two categories of above LOD and below LOD.  




Table IV.4 Change in birth outcomes associated with geometric mean exposure biomarker concentration within two psychosocial status clusters. Effect estimates presented as 
changes or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal education, pre-pregnancy BMI, and exposure 
to secondhand smoking  
 
Metals Gestational age  Birthweight z-score  
 
Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
 Change in days p value Change in days p value Int p Change in z-score p value Change in z-score p value Int p 
  (95% CI)   (95% CI)   (95% CI) (95% CI) 
 
 
Co -1.2 (-2.4, 0.0) 0.05* -3 (-5.3, -0.7) 0.01** 0.17 0.1 (0.0, 0.2) 0.16 0.0 (-0.2, 0.2) 0.76 0.71 
Cs -0.2 (-1.6, 1.1) 0.72 0.2 (-2.7, 3.2) 0.87 0.77 0.1 (0.0, 0.2) 0.08 -0.1 (-0.4, 0.1) 0.37 0.12 
Cu -0.3 (-1.0, 0.5) 0.47 -1.7 (-4.3, 0.9) 0.20 0.30 0.0 (0.0, 0.1) 0.54 -0.1 (-0.3, 0.1) 0.26 0.21 
Mn -0.4 (-1.9, 1.0) 0.54 -4.6 (-7.2, -1.9) <0.001** 0.01** 0.0 (-0.1, 0.2) 0.41 0.0 (-0.2, 0.3) 0.74 0.94 
Ni 0.3 (-0.8, 1.4) 0.61 1.5 (-0.8, 3.8) 0.19 0.34 0.1 (0.0, 0.2) 0.08 0.0 (-0.2, 0.1) 0.65 0.24 
Zn -0.8 (-1.5, 0.0) 0.06 -0.8 (-3.3, 1.6) 0.51 0.96 0.0 (-0.1, 0.1) 0.89 0.0 (-0.2, 0.2) 0.88 0.92 
Asa 0.6 (-1.2, 2.4) 0.50 1.8 (-1.2, 4.9) 0.24 0.50 0.1 (-0.1, 0.3) 0.35 -0.1 (-0.4, 0.3) 0.62 0.38 
Cda -0.3 (-2.5, 2.0) 0.82 -4.0 (-8.1, 0.2) 0.06 0.12 -0.1 (-0.3, 0.1) 0.39 0.3 (-0.1, 0.6) 0.12 0.17 
Hg 0.5 (-0.9, 1.9) 0.51 1.5 (-1.7, 4.7) 0.35 0.56 0.0 (-0.1, 0.2) 0.45 0.1 (-0.2, 0.4) 0.43 0.68 
Pb -1.9 (-3.2, -0.6) 0.004** -1.3 (-4.0, 1.5) 0.38 0.67 0.1 (0.0, 0.2) 0.11 -0.1 (-0.3, 0.2) 0.47 0.18 
     
 
    
 
Metals Preterm birth (overall) Preterm birth (spontaneous) 
 Cluster 1  
(“good psychosocial status”) 
Cluster 2  
(“poor psychosocial status”)  
Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 1.22 (0.89, 1.68) 0.21 1.65 (0.90, 3.03) 0.11 0.39 1.29 (0.87, 1.91) 0.20 2.52 (1.02, 6.27) 0.05* 0.18 
Cs 1.19 (0.78, 1.81) 0.42 1.03 (0.48, 2.23) 0.93 0.75 1.13 (0.69, 1.88) 0.62 1.30 (0.44, 3.88) 0.63 0.82 
Cu 1.20 (0.84, 1.71) 0.32 1.61 (0.78, 3.31) 0.19 0.46 1.16 (0.75, 1.78) 0.51 1.18 (0.46, 3.03) 0.73 0.97 
Mn 1.12 (0.75, 1.68) 0.57 2.76 (1.25, 6.12) 0.01** 0.04* 1.29 (0.80, 2.09) 0.29 3.68 (1.17, 11.61) 0.03* 0.09* 
Ni 1.07 (0.79, 1.46) 0.65 0.43 (0.22, 0.81) 0.01** 0.01* 1.13 (0.78, 1.63) 0.53 0.33 (0.13, 0.83) 0.02* 0.02* 
Zn 1.98 (1.24, 3.14) 0.004** 1.40 (0.70, 2.78) 0.34 0.41 1.77 (1.02, 3.08) 0.04* 0.86 (0.37, 2.03) 0.74 0.17 
Asa 0.71 (0.38, 1.34) 0.30 0.58 (0.19, 1.72) 0.32 0.74 0.66 (0.30, 1.45) 0.30 0.47 (0.10, 2.22) 0.34 0.70 
Cda 0.87 (0.46, 1.63) 0.66 1.06 (0.35, 3.21) 0.92 0.76 0.85 (0.39, 1.87) 0.69 1.80 (0.63, 5.12) 0.27 0.18 
Hg 1.11 (0.74, 1.66) 0.63 0.99 (0.42, 2.33) 0.98 0.81 1.47 (0.90, 2.41) 0.13 0.74 (0.22, 2.47) 0.63 0.30 







Table IV.4 Continued 
 
Metals SGA LGA 
 Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 0.84 (0.61, 1.17) 0.30 1.18 (0.61, 2.28) 0.62 0.37 1.13 (0.81, 1.57) 0.48 0.94 (0.57, 1.56) 0.81 0.56 
Cs 0.76 (0.57, 1.02) 0.07 1.25 (0.53, 2.93) 0.61 0.28 1.13 (0.74, 1.70) 0.57 1.01 (0.52, 1.94) 0.98 0.77 
Cu 0.96 (0.83, 1.10) 0.54 2.81 (1.20, 6.57) 0.02* 0.01* 1.01 (0.80, 1.27) 0.93 0.97 (0.56, 1.66) 0.90 0.88 
Mn 0.81 (0.57, 1.15) 0.24 1.03 (0.49, 2.16) 0.94 0.57 0.94 (0.63, 1.40) 0.75 1.58 (0.85, 2.94) 0.14 0.16 
Ni 0.55 (0.38, 0.78) <0.001** 1.25 (0.62, 2.49) 0.54 0.04* 1.01 (0.73, 1.40) 0.95 0.93 (0.57, 1.52) 0.77 0.78 
Zn 0.99 (0.82, 1.19) 0.90 1.02 (0.52, 2.01) 0.95 0.93 1.05 (0.77, 1.44) 0.76 1.01 (0.60, 1.69) 0.97 0.90 
Asa 0.68 (0.38, 1.22) 0.20 1.19 (0.36, 3.89) 0.77 0.41 0.91 (0.48, 1.72) 0.78 1.16 (0.46, 2.93) 0.75 0.67 
Cda 0.79 (0.44, 1.40) 0.42 0.59 (0.18, 1.90) 0.38 0.66 0.72 (0.38, 1.37) 0.32 1.16 (0.46, 2.92) 0.75 0.40 
Hg 0.88 (0.61, 1.28) 0.51 0.87 (0.35, 2.17) 0.77 0.98 1.06 (0.71, 1.59) 0.78 1.49 (0.72, 3.10) 0.29 0.42 
Pb 0.86 (0.65, 1.14) 0.30 1.49 (0.67, 3.33) 0.33 0.21 0.89 (0.64, 1.23) 0.49 1.10 (0.57, 2.10) 0.78 0.57 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 
(SGA); large for gestational age (LGA). 
a As, Cd were compared between two categories of above LOD and below LOD  
*p value <0.05 considered significant for effect estimates, **indicate q value <0.1& p value <0.05 
























Figure IV.4 Relationship between blood manganese (Mn) concentration and preterm birth among women within “good” and “poor” psychosocial status clusters, generated from 

























Table IV.5 Change in birth outcomes associated with geometric mean exposure biomarker concentration within two psychosocial status clusters. Effect estimates presented as 
changes or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal income, pre-pregnancy BMI, and exposure to 
secondhand smoking 
Metals Gestational age  Birthweight z-score  
 
Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
 Change in days p value Change in days p value Int p Change in z-score p value Change in z-score p value Int p 
  (95% CI)   (95% CI)   (95% CI) (95% CI) 
 
 
Co -0.1 (-1.4, 1.3) 0.93 -2.9 (-5.4, -0.5) 0.02* 0.04* 0.0 (-0.1, 0.1) 0.51 0.0 (-0.2, 0.2) 0.89 0.85 
Cs -0.4 (-1.8, 1.0) 0.60 -0.2 (-3.6, 3.2) 0.92 0.92 0.1 (0.0, 0.2) 0.11 -0.1 (-0.4, 0.2) 0.49 0.21 
Cu -0.3 (-1.1, 0.5) 0.47 -2.4 (-5.2, 0.4) 0.09 0.15 0.0 (0.0, 0.1) 0.58 -0.2 (-0.4, 0.1) 0.21 0.17 
Mn -0.2 (-1.7, 1.3) 0.79 -5.1 (-8.0, -2.3) <0.001** 0.003** 0.0 (-0.1, 0.2) 0.64 0.0 (-0.3, 0.2) 0.92 0.77 
Ni 0.3 (-0.9, 1.6) 0.59 2.3 (-0.2, 4.7) 0.07 0.17 0.1 (0.0, 0.2) 0.02 0.0 (-0.2, 0.2) 0.84 0.22 
Zn -0.7 (-1.6, 0.1) 0.07 -0.6 (-3.3, 2.0) 0.64 0.94 0.0 (-0.1, 0.1) 0.98 0.0 (-0.2, 0.3) 0.70 0.72 
Asa 0.9 (-1.5, 3.2) 0.48 4.2 (-0.3, 8.7) 0.07 0.20 0.1 (-0.1, 0.3) 0.35 -0.1 (-0.5, 0.3) 0.55 0.33 
Cda -0.3 (-2.8, 2.1) 0.80 -3.4 (-8.0, 1.1) 0.14 0.23 -0.1 (-0.3, 0.1) 0.43 0.3 (-0.1, 0.7) 0.15 0.10 
Hg 0.5 (-1.1, 2.0) 0.57 1.8 (-1.7, 5.2) 0.32 0.50 0.0 (-0.1, 0.2) 0.60 0.1 (-0.2, 0.4) 0.50 0.69 
Pb -1.9 (-3.3, -0.6) 0.01** -1.6 (-4.5, 1.3) 0.28 0.83 0.1 (0.0, 0.2) 0.20 -0.1 (-0.3, 0.2) 0.59 0.30 
     
 
    
 
Metals Preterm birth (overall) Preterm birth (spontaneous) 
 Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
Cluster 1  
(good psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 1.02 (0.72, 1.44) 0.93 1.56 (0.85, 2.88) 0.15 0.23 1.18 (0.78, 1.78) 0.43 2.32 (0.93, 5.75) 0.07 0.18 
Cs 1.24 (0.80, 1.93) 0.33 0.96 (0.42, 2.16) 0.91 0.57 1.14 (0.69, 1.91) 0.61 1.27 (0.41, 3.97) 0.68 0.87 
Cu 1.24 (0.86, 1.79) 0.24 1.63 (0.79, 3.34) 0.18 0.50 1.21 (0.78, 1.89) 0.39 1.20 (0.47, 3.09) 0.70 0.99 
Mn 1.11 (0.74, 1.66) 0.62 3.13 (1.35, 7.27) 0.01** 0.03* 1.29 (0.80, 2.08) 0.30 4.16 (1.22, 14.15) 0.02* 0.08* 
Ni 1.12 (0.81, 1.56) 0.49 0.42 (0.22, 0.81) 0.01** 0.01* 1.19 (0.80, 1.75) 0.39 0.33 (0.13, 0.84) 0.02* 0.01* 
Zn 2.04 (1.26, 3.31) 0.004** 1.36 (0.67, 2.77) 0.39 0.36 1.86 (1.05, 3.28) 0.03 0.85 (0.36, 2.00) 0.71 0.14 
Asa 0.74 (0.38, 1.42) 0.36 0.58 (0.19, 1.76) 0.34 0.72 0.71 (0.32, 1.59) 0.41 0.48 (0.10, 2.27) 0.35 0.65 
Cda 0.89 (0.46, 1.71) 0.73 0.95 (0.31, 2.92) 0.93 0.92 0.96 (0.43, 2.16) 0.93 3.57 (0.41, 31.12) 0.25 0.26 
Hg 1.23 (0.80, 1.91) 0.35 1.10 (0.46, 2.64) 0.83 0.82 1.65 (0.97, 2.82) 0.07 0.82 (0.24, 2.78) 0.75 0.30 








Table IV.5 Continued 
 
Metals SGA LGA 
 Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
Cluster 1  
(“good” psychosocial status) 
Cluster 2  
(“poor” psychosocial status)  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 0.80 (0.57, 1.13) 0.21 1.08 (0.56, 2.09) 0.81 0.43 1.07 (0.74, 1.54) 0.72 0.85 (0.49, 1.47) 0.57 0.50 
Cs 0.78 (0.58, 1.05) 0.10 1.26 (0.53, 3.01) 0.60 0.30 1.23 (0.79, 1.93) 0.36 1.09 (0.51, 2.31) 0.83 0.77 
Cu 0.96 (0.83, 1.12) 0.63 2.81 (1.20, 6.57) 0.02* 0.01* 1.07 (0.77, 1.48) 0.68 0.96 (0.53, 1.73) 0.89 0.75 
Mn 0.82 (0.57, 1.17) 0.27 1.09 (0.52, 2.30) 0.82 0.50 0.95 (0.63, 1.45) 0.82 1.41 (0.73, 2.73) 0.31 0.33 
Ni 0.54 (0.38, 0.78) 0.001** 1.31 (0.64, 2.67) 0.46 0.03* 1.06 (0.75, 1.49) 0.75 1.00 (0.58, 1.70) 0.99 0.86 
Zn 1.02 (0.81, 1.30) 0.85 1.03 (0.51, 2.07) 0.93 0.99 1.10 (0.74, 1.63) 0.64 1.16 (0.64, 2.10) 0.63 0.89 
Asa 0.59 (0.32, 1.08) 0.09 1.15 (0.35, 3.80) 0.82 0.32 0.95 (0.49, 1.85) 0.89 0.80 (0.30, 2.15) 0.66 0.78 
Cda 0.72 (0.40, 1.31) 0.28 0.51 (0.16, 1.66) 0.26 0.61 0.71 (0.37, 1.38) 0.32 0.90 (0.33, 2.45) 0.84 0.70 
Hg 0.81 (0.55, 1.20) 0.29 0.96 (0.38, 2.46) 0.94 0.74 1.03 (0.67, 1.59) 0.88 1.61 (0.71, 3.65) 0.25 0.34 
Pb 0.87 (0.65, 1.16) 0.35 1.43 (0.65, 3.16) 0.38 0.25 0.91 (0.65, 1.29) 0.61 1.19 (0.59, 2.38) 0.63 0.51 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 
(SGA); large for gestational age (LGA). 
a As, Cd were compared between two categories of above LOD and below LOD  
*p value <0.05 considered significant for effect estimates, **indicate q value <0.1& p value <0.05 
























Table IV.6 Change in gestational age (days) associated with geometric mean exposure biomarker concentration within two psychosocial status clusters stratified by study visits. 
Effect estimates presented as changes for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal education, pre-pregnancy BMI, and 
exposure to secondhand smoking 
 
Gestational age  
Cluster 1 (“good” psychosocial status) Cluster 2 (“poor” psychosocial status) 
 
 
Visit 1 Visit 3 
 




Change in days p 
value 




Change in days p 
value 






 (95% CI) 
 
 (95% CI) 
  
(95% CI)  (95% CI) 
   
Co -0.8 (-2.3, 0.7) 0.28 -0.5 (-2.2, 1.2) 0.57 0.80 -2 (-4.8, 0.7) 0.15 -2 (-5.2, 1.3) 0.23 0.98 0.47 
Cs -0.4 (-1.8, 1.1) 0.63 -1 (-2.8, 0.8) 0.27 0.58 -0.1 (-3.3, 3.1) 0.95 0.7 (-3, 4.4) 0.69 0.73 0.92 
Cu 0 (-0.9, 0.8) 0.94 0 (-1.6, 1.6) 0.98 0.95 -3 (-6, 0) 0.05* -1 (-4, 2.1) 0.53 0.34 0.21 
Mn -0.5 (-2.1, 1) 0.50 0.2 (-1.8, 2.2) 0.86 0.58 -2.7 (-5.7, 0.3) 0.08 -4.9 (-8.6, -1.3) 0.01* 0.35 0.59 
Ni -0.3 (-1.5, 0.9) 0.66 0.5 (-0.9, 1.9) 0.46 0.40 0.7 (-1.7, 3.2) 0.56 0.3 (-2.6, 3.2) 0.82 0.84 0.17 
Zn -0.7 (-1.5, 0.1) 0.08 -1.8 (-3.6, 0) 0.05* 0.28 -1.2 (-4.1, 1.7) 0.41 -0.6 (-3.4, 2.2) 0.69 0.76 0.40 
Asa 1.1 (-1.3, 3.6) 0.37 -0.1 (-2.9, 2.7) 0.92 0.51 3 (-1.7, 7.8) 0.21 3.2 (-1.8, 8.3) 0.21 0.95 0.71 
Cda -0.5 (-3, 2) 0.70 0.3 (-2.6, 3.1) 0.85 0.69 -5.9 (-10.5, -1.2) 0.01* 0.1 (-5.3, 5.4) 0.98 0.10 0.21 
Hg 0.3 (-1.2, 1.8) 0.73 -0.6 (-2.4, 1.2) 0.54 0.48 1.7 (-1.7, 5.1) 0.34 1.2 (-2.6, 4.9) 0.54 0.85 0.11 
Pb -1.8 (-3.2, -0.4) 0.01* -1.7 (-3.6, 0.2) 0.08 0.96 -1.1 (-4.4, 2.2) 0.51 -1 (-4.3, 2.4) 0.57 0.95 0.59 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb). 
a As, Cd were compared between two categories of above LOD and below LOD  
*p value <0.05 considered significant for effect estimates 






















Table IV.7 Change in birth outcomes associated with geometric mean exposure biomarker concentration within two groups of high and low Depression score (CES-D). Effect 
estimates presented as changes or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal education, pre-
pregnancy BMI, and exposure to secondhand smoking 
Metals Gestational age  Birthweight z-score  
 CES-D Depression Score (<16) CES-D Depression Score (>=16 )  CES-D Depression Score (<16) CES-D Depression Score (>=16 )  
 Change in days p value Change in days p value Int p Change in z-score p value Change in z-score p value Int p 
  (95% CI)   (95% CI)   (95% CI) (95% CI) 
 
 
Co -1.4 (-2.5, -0.2) 0.02* -2.3 (-4.7, 0.2) 0.07 0.69 0.0 (-0.1, 0.1) 0.36 0.1 (-0.1, 0.4) 0.17 0.47 
Cs -0.2 (-1.5, 1.1) 0.77 0.1 (-3, 3.2) 0.94 0.85 0.1 (0.0, 0.2) 0.12 -0.1 (-0.4, 0.1) 0.33 0.12 
Cu -0.4 (-1.2, 0.4) 0.32 -0.6 (-2.8, 1.5) 0.56 0.79 0.0 (0.0, 0.1) 0.44 -0.1 (-0.3, 0.1) 0.17 0.12 
Mn -0.8 (-2.2, 0.5) 0.23 -4.3 (-7.1, -1.4) 0.004** 0.05* 0.1 (-0.1, 0.2) 0.30 0.0 (-0.2, 0.2) 0.99 0.62 
Ni 0.3 (-0.8, 1.4) 0.61 1.7 (-0.8, 4.2) 0.18 0.35 0.1 (0.0, 0.2) 0.13 0.0 (-0.2, 0.2) 0.90 0.40 
Zn -0.7 (-1.5, 0.1) 0.08 -1.3 (-3.4, 0.8) 0.23 0.58 0.0 (-0.1, 0.1) 0.82 0.0 (-0.2, 0.2) 0.97 0.91 
Asa 0.1 (-2.1, 2.3) 0.93 5.7 (1.6, 9.7) 0.01** 0.02* 0.0 (-0.2, 0.2) 0.80 0.0 (-0.3, 0.4) 0.82 0.94 
Cda -0.4 (-2.6, 1.9) 0.76 -2.9 (-7, 1.1) 0.16 0.27 -0.1 (-0.3, 0.1) 0.52 0.2 (-0.1, 0.6) 0.18 0.13 
Hg 0.3 (-1.2, 1.8) 0.73 1.4 (-1.1, 3.9) 0.29 0.44 0.0 (-0.1, 0.2) 0.47 0.1 (-0.1, 0.3) 0.38 0.66 
Pb -2.0 (-3.3, -0.6) 0.004** -0.9 (-3.6, 1.8) 0.50 0.50 0.1 (-0.1, 0.2) 0.29 0.0 (-0.2, 0.3) 0.79 0.82 
     
 
    
 
Metals Preterm birth (overall) Preterm birth (spontaneous) 
 CES-D Depression Score (<16) CES-D Depression Score (>=16 )  CES-D Depression Score (<16) CES-D Depression Score (>=16 )  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 1.25 (0.92, 1.70) 0.16 1.54 (0.84, 2.82) 0.17 0.67 1.34 (0.91, 1.98) 0.14 1.83 (0.93, 3.60) 0.08 0.36 
Cs 1.21 (0.80, 1.82) 0.37 0.91 (0.40, 2.09) 0.83 0.54 1.13 (0.69, 1.84) 0.62 0.88 (0.25, 3.03) 0.84 0.70 
Cu 1.24 (0.86, 1.79) 0.24 1.48 (0.79, 2.77) 0.22 0.53 1.25 (0.79, 1.99) 0.34 1.15 (0.48, 2.77) 0.75 0.93 
Mn 1.21 (0.83, 1.75) 0.33 2.85 (1.14, 7.10) 0.02* 0.11 1.41 (0.90, 2.21) 0.13 3.12 (0.94, 10.39) 0.06 0.22 
Ni 1.02 (0.76, 1.37) 0.91 0.50 (0.25, 1.00) 0.05* 0.07* 1.03 (0.71, 1.50) 0.86 0.49 (0.21, 1.17) 0.11 0.10 
Zn 1.95 (1.24, 3.05) 0.004** 1.51 (0.78, 2.94) 0.22 0.61 1.77 (1.03, 3.02) 0.04* 0.90 (0.40, 2.05) 0.80 0.18 
Asa 0.77 (0.42, 1.42) 0.40 0.50 (0.16, 1.54) 0.23 0.51 0.66 (0.31, 1.41) 0.28 0.31 (0.05, 1.77) 0.19 0.44 
Cda 0.95 (0.52, 1.76) 0.88 0.69 (0.23, 2.13) 0.52 0.62 1.02 (0.47, 2.20) 0.97 1.29 (0.22, 7.44) 0.77 0.80 
Hg 1.13 (0.74, 1.71) 0.57 1.02 (0.50, 2.11) 0.95 0.84 1.48 (0.92, 2.36) 0.10 0.80 (0.25, 2.58) 0.71 0.31 
Pb 1.65 (1.10, 2.50) 0.02* 1.53 (0.72, 3.27) 0.27 0.88 1.46 (0.87, 2.44) 0.15 1.34 (0.44, 4.08) 0.60 0.92 
          
 
Metals SGA LGA 
 CES-D Depression Score (<16) CES-D Depression Score (>=16 )  CES-D Depression Score (<16) CES-D Depression Score (>=16 )  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 0.85 (0.62, 1.18) 0.35 1.07 (0.56, 2.04) 0.83 0.51 1.08 (0.78, 1.48) 0.66 1.08 (0.60, 1.93) 0.80 0.97 
Cs 0.79 (0.59, 1.05) 0.11 1.15 (0.44, 3.00) 0.77 0.43 1.17 (0.81, 1.71) 0.40 0.81 (0.34, 1.91) 0.62 0.40 
Cu 0.97 (0.83, 1.12) 0.66 2.09 (0.90, 4.85) 0.09 0.08* 1.02 (0.82, 1.26) 0.88 0.86 (0.52, 1.40) 0.54 0.53 
Mn 0.80 (0.57, 1.11) 0.18 1.24 (0.58, 2.63) 0.58 0.28 0.93 (0.65, 1.34) 0.70 1.96 (1.02, 3.78) 0.04* 0.05* 
Ni 0.61 (0.43, 0.86) 0.004** 0.89 (0.47, 1.68) 0.72 0.28 1.04 (0.76, 1.41) 0.82 0.87 (0.53, 1.42) 0.58 0.55 
Zn 0.99 (0.83, 1.18) 0.92 1.06 (0.53, 2.13) 0.87 0.86 1.04 (0.79, 1.38) 0.78 1.05 (0.62, 1.76) 0.87 0.98 
Asa 0.71 (0.40, 1.25) 0.23 1.30 (0.40, 4.21) 0.67 0.36 0.74 (0.41, 1.36) 0.34 1.80 (0.64, 5.03) 0.26 0.15 
Cda 0.80 (0.45, 1.41) 0.43 0.64 (0.20, 2.03) 0.45 0.74 0.71 (0.39, 1.29) 0.26 1.40 (0.52, 3.79) 0.51 0.25 
Hg 0.87 (0.59, 1.27) 0.47 0.95 (0.44, 2.04) 0.89 0.85 1.01 (0.69, 1.47) 0.95 1.73 (0.85, 3.52) 0.13 0.20 




Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 
(SGA); large for gestational age (LGA). 
a As, Cd were compared between two categories of above LOD and below LOD  
*p value <0.05 considered significant for effect estimates, **indicate q value <0.1& p value <0.05 
































Table IV.8 Change in birth outcomes associated with geometric mean exposure biomarker concentration within two groups of high and low perceived stress score (PSS). Effect 
estimates presented as changes or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal education, pre-
pregnancy BMI, and exposure to secondhand smoking 
Metals Gestational age  Birthweight z-score  
 PSS-Perceived Stress (<75th) PSS-Perceived Stress (>=75th )  PSS-Perceived Stress (<75th) PSS-Perceived Stress (>=75th )  
 Change in days p value Change in days p value Int p Change in z-score p value Change in z-score p value Int p 
  (95% CI)   (95% CI)   (95% CI) (95% CI) 
 
 
Co -1.4 (-2.6, -0.3) 0.02** -1.9 (-4.2, 0.4) 0.10 0.78 0.1 (0.0, 0.2) 0.18 0.1 (-0.1, 0.3) 0.42 0.95 
Cs -0.3 (-1.7, 1.0) 0.64 0.5 (-2.1, 3.1) 0.70 0.57 0.1 (0.0, 0.2) 0.06 -0.2 (-0.4, 0.1) 0.15 0.03* 
Cu -0.3 (-1.1, 0.5) 0.43 -1.3 (-3.4, 0.8) 0.22 0.37 0.0 (0.0, 0.1) 0.56 0.0 (-0.2, 0.1) 0.68 0.55 
Mn -0.8 (-2.2, 0.5) 0.24 -3.3 (-5.9, -0.8) 0.01** 0.12 0.1 (0.0, 0.2) 0.26 0.0 (-0.2, 0.2) 0.78 0.73 
Ni 0.4 (-0.7, 1.5) 0.53 1.0 (-1.1, 3.1) 0.36 0.66 0.0 (0.0, 0.1) 0.32 0.1 (-0.1, 0.2) 0.42 0.88 
Zn -0.8 (-1.6, -0.1) 0.04* -0.4 (-2.8, 1.9) 0.73 0.70 0.0 (0.0, 0.1) 0.58 -0.1 (-0.3, 0.1) 0.37 0.30 
Asa 0.8 (-1.5, 3.1) 0.49 2.9 (-0.8, 6.7) 0.13 0.35 0.0 (-0.1, 0.2) 0.63 0.0 (-0.3, 0.3) 0.93 0.86 
Cda 0.6 (-1.7, 2.9) 0.61 -4.7 (-8.5, -0.8) 0.02** 0.02* -0.1 (-0.3, 0.1) 0.18 0.4 (0.1, 0.8) 0.01* 0.003** 
Hg 0.3 (-1.3, 1.8) 0.75 1.2 (-1.0, 3.5) 0.27 0.43 0.1 (-0.1, 0.2) 0.44 0.1 (-0.1, 0.2) 0.56 0.91 
Pb -2.0 (-3.4, -0.7) 0.003** -0.4 (-3, 2.2) 0.77 0.27 0.0 (-0.1, 0.2) 0.47 0.1 (-0.1, 0.4) 0.21 0.43 
     
 
    
 
Metals Preterm birth (overall) Preterm birth (spontaneous) 
 PSS-Perceived Stress (<75th) PSS-Perceived Stress (>=75th )  PSS-Perceived Stress (<75th) PSS-Perceived Stress (>=75th )  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 1.18 (0.88, 1.60) 0.27 1.92 (1.03, 3.58) 0.04* 0.18 1.27 (0.84, 1.91) 0.25 2.75 (1.25, 6.06) 0.01* 0.07* 
Cs 1.15 (0.76, 1.74) 0.52 1.09 (0.54, 2.19) 0.80 0.92 1.13 (0.67, 1.89) 0.64 0.91 (0.36, 2.31) 0.85 0.70 
Cu 1.15 (0.80, 1.66) 0.45 1.83 (0.99, 3.38) 0.06 0.18 1.16 (0.73, 1.84) 0.53 1.49 (0.66, 3.33) 0.33 0.56 
Mn 1.17 (0.80, 1.72) 0.41 2.50 (1.15, 5.44) 0.02* 0.09* 1.32 (0.82, 2.14) 0.25 3.19 (1.16, 8.79) 0.02* 0.12 
Ni 0.96 (0.70, 1.30) 0.78 0.70 (0.39, 1.27) 0.24 0.40 1.04 (0.70, 1.54) 0.84 0.55 (0.26, 1.15) 0.11 0.13 
Zn 2.16 (1.37, 3.42) <0.001** 1.31 (0.67, 2.56) 0.43 0.17 2.06 (1.17, 3.62) 0.01* 0.78 (0.38, 1.62) 0.51 0.04* 
Asa 0.68 (0.36, 1.28) 0.23 0.72 (0.26, 1.98) 0.52 0.93 0.61 (0.28, 1.35) 0.23 0.44 (0.10, 1.91) 0.27 0.69 
Cda 0.70 (0.37, 1.30) 0.26 1.74 (0.57, 5.30) 0.33 0.16 0.78 (0.35, 1.71) 0.53 4.42 (0.52, 37.34) 0.17 0.13 
Hg 1.18 (0.77, 1.82) 0.45 0.90 (0.48, 1.69) 0.74 0.51 1.60 (0.96, 2.67) 0.07 0.75 (0.29, 1.91) 0.55 0.17 
Pb 1.73 (1.14, 2.61) 0.01** 1.28 (0.63, 2.61) 0.50 0.47 1.68 (1.00, 2.83) 0.05* 0.74 (0.28, 1.96) 0.54 0.15 
          
 
Metals SGA LGA 
 PSS-Perceived Stress (<75th) PSS-Perceived Stress (>=75th )  PSS-Perceived Stress (<75th) PSS-Perceived Stress (>=75th )  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 0.85 (0.60, 1.19) 0.34 1.02 (0.60, 1.74) 0.95 0.58 1.15 (0.84, 1.57) 0.38 0.88 (0.51, 1.54) 0.66 0.40 
Cs 0.75 (0.55, 1.01) 0.06 1.31 (0.61, 2.82) 0.49 0.16 1.24 (0.83, 1.85) 0.29 0.76 (0.39, 1.49) 0.42 0.21 
Cu 0.95 (0.82, 1.10) 0.49 1.81 (0.97, 3.36) 0.06 0.05* 1.00 (0.82, 1.22) 1.00 0.99 (0.66, 1.49) 0.97 0.97 
Mn 0.83 (0.58, 1.18) 0.29 0.97 (0.56, 1.69) 0.91 0.64 1.00 (0.69, 1.45) 0.99 1.51 (0.83, 2.72) 0.17 0.26 
Ni 0.57 (0.39, 0.83) 0.003** 0.85 (0.51, 1.40) 0.52 0.19 0.98 (0.70, 1.36) 0.89 1.00 (0.66, 1.52) 1.00 0.94 
Zn 1.00 (0.81, 1.23) 0.99 0.98 (0.58, 1.66) 0.93 0.93 1.16 (0.78, 1.73) 0.47 0.82 (0.50, 1.36) 0.45 0.29 
Asa 0.68 (0.37, 1.25) 0.21 1.09 (0.42, 2.82) 0.85 0.40 0.85 (0.46, 1.57) 0.60 1.20 (0.49, 2.94) 0.68 0.52 
Cda 0.84 (0.46, 1.55) 0.58 0.58 (0.22, 1.51) 0.26 0.52 0.60 (0.32, 1.13) 0.11 1.70 (0.65, 4.44) 0.28 0.07* 
Hg 0.87 (0.58, 1.31) 0.50 0.91 (0.50, 1.69) 0.78 0.91 1.10 (0.73, 1.66) 0.65 1.24 (0.72, 2.12) 0.44 0.69 




Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 
(SGA); large for gestational age (LGA). 
a As, Cd were compared between two categories of above LOD and below LOD  
*p value <0.05 considered significant for effect estimates, **indicate q value <0.1& p value <0.05 












































Table IV.9 Change in birth outcomes associated with geometric mean exposure biomarker concentration within two groups of high and low social support (ESSI). Effect estimates 
presented as changes or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal education, pre-pregnancy BMI, 
and exposure to secondhand smoking 
Metals Gestational age  Birthweight z-score  
 SS-Social Support (>25th) SS-Social Support (<=25th )  SS-Social Support (>25th) SS-Social Support (<=25th )  
 Change in days p value Change in days p value Int p Change in z-score p value Change in z-score p value Int p 
  (95% CI)   (95% CI)   (95% CI) (95% CI) 
 
 
Co -1.4 (-2.6, -0.2) 0.02* -2.3 (-4.3, -0.2) 0.03* 0.52 0.1 (0.0, 0.2) 0.16 0.1 (-0.1, 0.2) 0.45 0.92 
Cs -0.2 (-1.5, 1.2) 0.80 -0.4 (-3, 2.1.0) 0.76 0.87 0.1 (0.0, 0.2) 0.21 0.0 (-0.2, 0.3) 0.73 0.76 
Cu -0.5 (-1.3, 0.3) 0.24 -0.2 (-2.3, 1.9) 0.85 0.84 0.0 (0.0, 0.1) 0.48 -0.1 (-0.3, 0.1) 0.36 0.27 
Mn -0.8 (-2.2, 0.6) 0.27 -3.3 (-5.7, -0.9) 0.01** 0.09* 0.0 (-0.1, 0.2) 0.41 0.1 (-0.1, 0.3) 0.42 0.79 
Ni 0.0 (-1.1, 1.1) 0.98 1.9 (-0.1, 3.9) 0.06 0.11 0.0 (-0.1, 0.1) 0.41 0.1 (-0.1, 0.3) 0.32 0.65 
Zn -0.8 (-1.6, 0.0) 0.05 -0.4 (-2.7, 1.9) 0.72 0.76 0.0 (-0.1, 0.1) 0.91 0.1 (-0.1, 0.3) 0.54 0.59 
Asa 1.2 (-1.0, 3.5) 0.28 1.5 (-2.2, 5.2) 0.42 0.91 0.1 (-0.1, 0.3) 0.40 0.0 (-0.3, 0.3) 0.82 0.52 
Cda -0.5 (-2.8, 1.8) 0.67 -3.4 (-7.2, 0.4) 0.08 0.20 -0.2 (-0.3, 0.0) 0.12 0.5 (0.1, 0.8) 0.01 0.00 
Hg 0.9 (-0.6, 2.3) 0.24 -0.5 (-3, 2.1) 0.71 0.37 0.0 (-0.1, 0.2) 0.46 0.1 (-0.1, 0.3) 0.52 0.83 
Pb -1.8 (-3.0, -0.5) 0.01** -2.2 (-4.9, 0.6) 0.13 0.89 0.1 (0.0, 0.2) 0.17 0.0 (-0.2, 0.2) 0.96 0.56 
     
 
    
 
Metals Preterm birth (overall) Preterm birth (spontaneous) 
 SS-Social Support (>25th) SS-Social Support (<=25th )  SS-Social Support (>25th) SS-Social Support (<=25th )  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 1.26 (0.92, 1.74) 0.15 1.56 (0.89, 2.75) 0.12 0.55 1.36 (0.90, 2.04) 0.14 1.94 (0.96, 3.92) 0.07 0.46 
Cs 1.04 (0.71, 1.52) 0.83 1.74 (0.79, 3.86) 0.17 0.25 0.93 (0.60, 1.45) 0.76 2.61 (0.98, 6.96) 0.06 0.06* 
Cu 1.35 (0.94, 1.93) 0.10 1.05 (0.54, 2.03) 0.89 0.54 1.27 (0.79, 2.06) 0.33 1.03 (0.50, 2.12) 0.94 0.67 
Mn 1.11 (0.75, 1.63) 0.60 3.73 (1.54, 9.06) 0.003** 0.01** 1.17 (0.72, 1.89) 0.52 5.2 (1.62, 16.68) 0.01* 0.03* 
Ni 1.10 (0.82, 1.46) 0.52 0.33 (0.16, 0.67) 0.002** 0.002** 1.14 (0.79, 1.64) 0.50 0.37 (0.16, 0.82) 0.01* 0.01* 
Zn 1.93 (1.25, 2.99) 0.003** 1.30 (0.61, 2.77) 0.50 0.36 1.54 (0.89, 2.68) 0.12 1.23 (0.54, 2.79) 0.63 0.67 
Asa 0.77 (0.42, 1.43) 0.41 0.47 (0.15, 1.52) 0.21 0.46 0.61 (0.27, 1.38) 0.23 0.55 (0.14, 2.15) 0.39 0.90 
Cda 0.81 (0.44, 1.50) 0.50 2.00 (0.52, 7.76) 0.32 0.23 0.72 (0.32, 1.61) 0.42 0.66 (0.23, 1.87) 0.98 0.98 
Hg 1.06 (0.71, 1.57) 0.78 1.25 (0.56, 2.79) 0.59 0.71 1.43 (0.84, 2.45) 0.19 1.04 (0.44, 2.46) 0.93 0.60 
Pb 1.53 (1.03, 2.27) 0.03* 2.33 (0.99, 5.49) 0.05 0.43 1.27 (0.74, 2.18) 0.38 2.50 (0.88, 7.06) 0.08 0.27 
          
 
Metals SGA LGA 
 SS-Social Support (>25th) SS-Social Support (<=25th )  SS-Social Support (>25th) SS-Social Support (<=25th )  
 OR (95% CI) p value OR (95% CI) p value Int p OR (95% CI) p value OR (95% CI) p value Int p 
Co 0.89 (0.63, 1.25) 0.49 0.91 (0.48, 1.72) 0.78 0.93 1.08 (0.76, 1.55) 0.66 1.09 (0.73, 1.62) 0.67 0.90 
Cs 0.78 (0.58, 1.03) 0.08 1.11 (0.49, 2.54) 0.80 0.37 1.02 (0.70, 1.50) 0.91 1.27 (0.69, 2.35) 0.44 0.54 
Cu 0.96 (0.83, 1.11) 0.61 2.16 (1.01, 4.63) 0.05* 0.04* 1.03 (0.81, 1.31) 0.81 0.84 (0.52, 1.34) 0.46 0.44 
Mn 0.79 (0.55, 1.12) 0.19 1.13 (0.60, 2.13) 0.70 0.36 0.90 (0.63, 1.30) 0.58 2.16 (1.07, 4.34) 0.03* 0.03* 
Ni 0.67 (0.48, 0.93) 0.02* 0.65 (0.32, 1.32) 0.23 0.89 0.94 (0.69, 1.28) 0.69 1.18 (0.69, 2.00) 0.55 0.47 
Zn 1.00 (0.83, 1.20) 0.96 0.98 (0.49, 1.98) 0.96 0.97 1.00 (0.82, 1.23) 0.97 1.32 (0.69, 2.53) 0.40 0.43 
Asa 0.93 (0.52, 1.66) 0.80 0.41 (0.13, 1.30) 0.13 0.22 1.19 (0.65, 2.18) 0.58 0.70 (0.27, 1.81) 0.46 0.36 
Cda 0.91 (0.51, 1.64) 0.76 0.41 (0.13, 1.28) 0.13 0.22 0.65 (0.36, 1.20) 0.17 1.67 (0.56, 4.96) 0.36 0.14 
Hg 0.90 (0.61, 1.33) 0.60 0.85 (0.39, 1.85) 0.67 0.86 1.11 (0.77, 1.61) 0.58 1.32 (0.66, 2.62) 0.43 0.67 




Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 
(SGA); large for gestational age (LGA). 
a As, Cd were compared between two categories of above LOD and below LOD  
*p value <0.05 considered significant for effect estimates, **indicate q value <0.1& p value <0.05 











































Table IV.10 Change in birth outcomes associated with geometric mean exposure biomarker concentration within three groups of overall negative, neutral, and positive life events 
(LES). Effect estimates presented as changes or odds ratio (OR) for IQR increase in exposure biomarker concentrationa. Models were adjusted for maternal age, maternal 
education, pre-pregnancy BMI, and exposure to secondhand smoking 
 
 Gestational age  
Metals LES-Life Events (negative) LES-Life Events (neutral) LES-Life Events (positive) 
 Change in days p value int pa Change in days p value Int pb Change in days p value Int pc 
  (95% CI)    (95% CI) 
 
  (95% CI) 
 
 
Co 0.2 (-1.8, 2.3) 0.83 0.51 -2.0 (-3.7, -0.3) 0.02* 0.12 -0.8 (-2.9, 1.3) 0.47 0.38 
Cs 0.9 (-1.8, 3.7) 0.51 0.16 0.5 (-1.8, 2.8) 0.67 0.79 -1.4 (-3.3, 0.4) 0.13 0.18 
Cu -0.3 (-2.5, 1.8) 0.77 0.96 -0.9 (-2.7, 1.0) 0.35 0.78 -0.5 (-1.4, 0.5) 0.35 0.71 
Mn -1.0 (-3.4, 1.4) 0.42 0.97 -0.9 (-3.1, 1.4) 0.46 0.89 -0.9 (-3.0, 1.1) 0.38 0.86 
Ni 1.3 (-1.0, 3.6) 0.27 0.30 1.6 (-0.1, 3.3) 0.06 0.73 -0.2 (-2.0, 1.5) 0.79 0.13 
Zn -0.6 (-2.8, 1.6) 0.60 0.98 -1.6 (-3.9, 0.7) 0.17 0.63 -0.6 (-1.5, 0.3) 0.20 0.48 
Asd 3.6 (-0.4, 7.6) 0.08 0.46 0.7 (-2.6, 3.9) 0.69 0.27 1.5 (-2.1, 5.1) 0.41 0.73 
Cdd -2.1 (-6.2, 1.9) 0.30 0.70 0.1 (-3.2, 3.4) 0.95 0.40 -1.1 (-4.8, 2.7) 0.58 0.64 
Hg 0.5 (-2.4, 3.3) 0.76 0.90 1.0 (-1.0, 3.0) 0.31 0.72 0.2 (-2.3, 2.7) 0.86 0.60 
Pb -2.2 (-4.9, 0.4) 0.10 0.38 -2.5 (-4.7, -0.3) 0.03* 0.75 -0.7 (-2.7, 1.3) 0.47 0.21 
  
 Birthweight z-score  
 LES-Life Events (negative) LES-Life Events (neutral) LES-Life Events (positive) 
 Change in z-score p value int pa Change in z-score p value Int pb Change in z-score p value Int pc 
 (95% CI)  (95% CI) 
 
 (95% CI) 
 
 
Co 0.0 (-0.2, 0.2) 0.94 0.70 0.1 (0.0, 0.2) 0.09 0.28 0.0 (-0.1, 0.2) 0.63 0.50 
Cs 0.1 (-0.2, 0.3) 0.60 0.84 0.1 (-0.1, 0.3) 0.22 0.73 0.0 (-0.1, 0.2) 0.68 0.52 
Cu 0.0 (-0.2, 0.2) 0.97 0.99 0.1 (-0.1, 0.2) 0.44 0.64 0.0 (-0.1, 0.1) 0.95 0.48 
Mn 0.1 (-0.1, 0.2) 0.59 0.47 0.1 (-0.1, 0.3) 0.20 0.67 0.0 (-0.2, 0.1) 0.63 0.22 
Ni -0.1 (-0.3, 0.1) 0.47 0.12 0.1 (-0.1, 0.2) 0.29 0.22 0.1 (0.0, 0.2) 0.12 0.72 
Zn 0.0 (-0.2, 0.1) 0.81 0.82 0.0 (-0.1, 0.2) 0.60 0.61 0.0 (-0.1, 0.1) 0.98 0.64 
Asd -0.1 (-0.4, 0.2) 0.42 0.15 0.0 (-0.2, 0.3) 0.82 0.44 0.2 (-0.1, 0.5) 0.20 0.43 
Cdd 0.1 (-0.2, 0.5) 0.36 0.76 -0.1 (-0.4, 0.1) 0.40 0.21 0.1 (-0.2, 0.4) 0.59 0.33 
Hg -0.1 (-0.3, 0.2) 0.63 0.07* 0.0 (-0.1, 0.2) 0.95 0.67 0.2 (0.0, 0.4) 0.03* 0.11 















Table IV.10 Continued 
 
 Preterm birth (overall) 
Metals LES-Life Events (negative) LES-Life Events (neutral) LES-Life Events (positive) 
 OR (95% CI) p value int pa OR (95% CI) p value Int pb OR (95% CI) p value Int pc 
Co 1.44 (0.92, 2.24) 0.11 0.14 1.26 (0.86, 1.83) 0.24 0.59 0.87 (0.52, 1.46) 0.60 0.26 
Cs 1.21 (0.63, 2.35) 0.57 0.76 1.08 (0.61, 1.90) 0.79 0.77 1.39 (0.77, 2.49) 0.27 0.51 
Cu 1.13 (0.68, 1.87) 0.64 0.44 1.40 (0.88, 2.23) 0.15 0.65 1.60 (0.92, 2.77) 0.09 0.68 
Mn 1.59 (0.95, 2.64) 0.08 0.54 1.10 (0.64, 1.90) 0.73 0.30 1.20 (0.70, 2.06) 0.51 0.77 
Ni 0.86 (0.48, 1.55) 0.62 0.37 0.56 (0.36, 0.88) 0.01* 0.20 1.19 (0.80, 1.75) 0.39 0.01* 
Zn 1.40 (0.81, 2.42) 0.22 0.22 1.90 (1.03, 3.49) 0.04* 0.64 2.46 (1.28, 4.72) 0.01* 0.38 
Asd 0.92 (0.35, 2.42) 0.86 0.35 0.89 (0.41, 1.93) 0.76 0.95 0.49 (0.20, 1.21) 0.12 0.33 
Cdd 1.52 (0.55, 4.23) 0.42 0.15 1.11 (0.50, 2.45) 0.79 0.63 0.56 (0.23, 1.36) 0.20 0.26 
Hg 1.45 (0.74, 2.83) 0.28 0.46 0.96 (0.59, 1.57) 0.88 0.35 1.04 (0.56, 1.91) 0.91 0.85 
Pb 1.79 (0.98, 3.27) 0.06 0.31 2.02 (1.18, 3.44) 0.01* 0.62 1.15 (0.65, 2.06) 0.63 0.13 
  
 Preterm birth (spontaneous) 
 LES-Life Events (negative) LES-Life Events (neutral) LES-Life Events (positive) 
 OR (95% CI) p value int p
a OR (95% CI) p value Int pb OR (95% CI) p value Int pc 
Co 1.67 (1.04, 2.69) 0.03* 0.26 1.15 (0.67, 1.96) 0.61 0.29 1.11 (0.53, 2.30) 0.78 0.90 
Cs 1.38 (0.63, 3.04) 0.42 0.89 0.80 (0.37, 1.74) 0.57 0.32 1.25 (0.64, 2.43) 0.52 0.38 
Cu 1.35 (0.69, 2.64) 0.37 0.93 1.25 (0.68, 2.32) 0.48 0.81 1.31 (0.66, 2.60) 0.44 0.89 
Mn 1.94 (1.07, 3.50) 0.03* 0.29 1.08 (0.56, 2.10) 0.81 0.24 1.12 (0.50, 2.50) 0.79 0.97 
Ni 0.74 (0.42, 1.31) 0.30 0.07 0.34 (0.17, 0.70) 0.003** 0.15 1.45 (0.94, 2.25) 0.09 <0.001** 
Zn 1.05 (0.57, 1.92) 0.88 0.13 1.59 (0.75, 3.38) 0.22 0.43 2.60 (1.04, 6.51) 0.04* 0.44 
Asd 0.57 (0.19, 1.77) 0.33 0.94 0.78 (0.26, 2.33) 0.66 0.70 0.54 (0.17, 1.72) 0.30 0.65 
Cdd 1.66 (0.49, 5.57) 0.41 0.31 1.54 (0.49, 4.83) 0.45 0.93 0.70 (0.22, 2.18) 0.54 0.33 
Hg 1.47 (0.70, 3.10) 0.31 0.84 0.92 (0.46, 1.84) 0.82 0.36 1.64 (0.79, 3.42) 0.19 0.26 



















Table IV.10 Continued 
 
 SGA 
Metals LES-Life Events (negative) LES-Life Events (neutral) LES-Life Events (positive) 
 OR (95% CI) p value int pa OR (95% CI) p value Int pb OR (95% CI) p value Int pc 
Co 1.27 (0.84, 1.91) 0.91 0.67 1.27 (0.84, 1.91) 0.15 0.42 1.27 (0.84, 1.91) 0.63 0.21 
Cs 1.13 (0.67, 1.89) 0.98 0.48 1.13 (0.67, 1.89) 0.37 0.56 1.13 (0.67, 1.89) 0.16 0.93 
Cu 1.16 (0.73, 1.84) 0.40 0.29 1.16 (0.73, 1.84) 0.49 0.74 1.16 (0.73, 1.84) 0.54 0.36 
Mn 1.32 (0.82, 2.14) 0.13 0.01* 1.32 (0.82, 2.14) 0.06 0.90 1.32 (0.82, 2.14) 0.04* 0.01* 
Ni 1.04 (0.70, 1.54) 0.76 0.08 1.04 (0.70, 1.54) 0.05* 0.03* 1.04 (0.70, 1.54) 0.04* 0.83 
Zn 2.06 (1.17, 3.62) 0.94 0.87 2.06 (1.17, 3.62) 0.43 0.59 2.06 (1.17, 3.62) 0.73 0.43 
Asd 0.61 (0.28, 1.35) 0.72 0.25 0.61 (0.28, 1.35) 0.52 0.50 0.61 (0.28, 1.35) 0.21 0.56 
Cdd 0.78 (0.35, 1.71) 0.77 0.64 0.78 (0.35, 1.71) 0.55 0.88 0.78 (0.35, 1.71) 0.34 0.71 
Hg 1.60 (0.96, 2.67) 0.76 0.77 1.60 (0.96, 2.67) 0.78 0.93 1.60 (0.96, 2.67) 0.44 0.67 
Pb 1.68 (1.00, 2.83) 0.07 0.07 1.68 (1.00, 2.83) 0.47 0.37 1.68 (1.00, 2.83) 0.44 0.29 
  
 LGA 
 LES-Life Events (negative) LES-Life Events (neutral) LES-Life Events (positive) 
 OR (95% CI) p value int p
a OR (95% CI) p value Int pb OR (95% CI) p value Int pc 
Co 1.18 (0.88, 1.60) 0.69 0.24 1.18 (0.88, 1.60) 0.81 0.64 1.18 (0.88, 1.60) 0.23 0.39 
Cs 1.15 (0.76, 1.74) 0.38 0.48 1.15 (0.76, 1.74) 0.67 0.67 1.15 (0.76, 1.74) 0.99 0.75 
Cu 1.15 (0.80, 1.66) 0.19 0.22 1.15 (0.80, 1.66) 0.72 0.20 1.15 (0.80, 1.66) 0.95 0.79 
Mn 1.17 (0.80, 1.72) 0.86 0.37 1.17 (0.80, 1.72) 0.74 0.72 1.17 (0.80, 1.72) 0.32 0.53 
Ni 0.96 (0.70, 1.30) 0.57 0.82 0.96 (0.70, 1.30) 0.13 0.14 0.96 (0.70, 1.30) 0.33 0.08* 
Zn 2.16 (1.37, 3.42) 0.75 0.81 2.16 (1.37, 3.42) 0.91 0.87 2.16 (1.37, 3.42) 0.92 0.96 
Asd 0.68 (0.36, 1.28) 0.93 1.00 0.68 (0.36, 1.28) 0.92 0.90 0.68 (0.36, 1.28) 0.93 0.89 
Cdd 0.70 (0.37, 1.30) 0.32 0.20 0.70 (0.37, 1.30) 0.28 0.15 0.70 (0.37, 1.30) 0.41 0.98 
Hg 1.18 (0.77, 1.82) 0.47 0.27 1.18 (0.77, 1.82) 0.17 0.16 1.18 (0.77, 1.82) 0.40 0.86 
Pb 1.73 (1.14, 2.61) 0.97 0.52 1.73 (1.14, 2.61) 0.06 0.16 1.73 (1.14, 2.61) 0.39 0.06* 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 
(SGA); large for gestational age (LGA). 
a interaction between negative and positive categories 
b interaction between neutral and negative categories 
c interaction between positive and neutral categories 
d As, Cd were compared between two categories of above LOD and below LOD  
*p value <0.05 considered significant for effect estimates, **indicate q value <0.1& p value <0.05 






Chapter V  
Performance of Urine, Blood, and Integrated Metal Biomarkers in Relation to 
Birth Outcomes in a Mixture Setting 
 
Abstract 
Background: Studies on the health effects of metal mixtures typically utilize biomarkers measured 
in a single biological medium, such as blood or urine. However, the ability to evaluate mixture 
effects are limited by the uncertainty whether a unified medium can fully capture exposure for 
each metal. Therefore, it is important to compare and assess metal mixtures measured in different 
media in epidemiology studies. Objective: The aim of this study was to examine the mixture 
predictive performance of urine and blood metal biomarkers and integrated multi-media 
biomarkers in association with preterm birth. Methods: In our analysis of 847 women from the 
Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) study, we measured 10 
essential and non-essential metals in repeated and paired samples of urine and blood during 
pregnancy. For each metal, we integrated exposure estimates from paired urine and blood 
biomarkers into multi-media biomarkers (MMBs), using intraclass-correlation coefficient (ICC) 
and weighted quantile sum (WQS) approaches. Using Ridge regressions, four separate 
Environmental risk scores (ERSs) for metals in urine, blood, MMBICC, and MMBWQS were 
computed as a weighted sum of the 10 metal concentrations. We then examined associations 
between urine, blood, and multi-media biomarker ERSs and preterm birth using logistic 
regressions, adjusting for maternal age, maternal education, pre-pregnancy body mass index 
(BMI), and second-hand smoke exposure. The performance of each ERS was evaluated with 
continuous and tertile estimates and 95% confidence intervals of the odds ratio of preterm birth 
using area under the curve (AUC). Results: Pb was the most important contributor of blood ERS 
as well as the two integrated multi-media biomarker ERSs. Individuals with high ERS (3rd tertile) 
showed increased odds of preterm birth compared to individuals with low ERS (1st tertile), with 
2.8-fold (95% CI, 1.49 to 5.40) for urine (specific gravity corrected); 3.2- fold (95% CI, 1.68 to 
6.25) for blood; 3.9-fold (95% CI, 1.72 to 8.66) for the multi-media biomarkers composed using 
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ICC; and 5.2-fold (95% CI, 2.34 to 11.42) for multi-media biomarkers composed using WQS. The 
four ERSs had comparable predictive performances (AUC ranging from 0.64 to 0.68) when urine 
is examined with specific gravity corrected concentrations; the performances were also 
significantly better than the performance of urine ERS without accounting for specific gravity.  
Conclusions: Within a practical metal panel, measuring metals in either urine or blood may be an 
equally good approach to evaluate the metals as a mixture, but only when the urine measurements 
are corrected for urinary dilution. Applications in practical study design require validation of these 
methods with other cohorts, larger panels of metals and also within the context of other adverse 




Exposure biomonitoring, which estimates human exposure by measuring chemical or other agents 
of interest or their metabolic products in different biologic media, such as blood and urine [1], has 
become a fundamental approach used in exposure assessment and environmental epidemiology 
[2]. With growing interest in the realistic scenario of studying the collective effects of 
environmental chemicals on humans, including metals [3-11], biomonitoring has become 
indispensable in studies of mixtures. Due to limiting factors such as financial cost and 
methodologic challenges, mixture studies based on biomarkers typically use a unified human 
specimen (i.e. blood, urine, etc.) to determine exposure to various chemicals [12-17]. While this 
approach may capture overall exposure to a class of chemicals with similar structure and 
pharmacokinetic properties, such as urinary phthalates and blood perfluorinated compounds 
(PFCs), it is more challenging to evaluate chemical classes such as metals.  Because each metal 
possesses different pharmacokinetic properties, utilizing one medium for measuring metal 
mixtures may not represent exposure for each metal or accurately reflect overall human exposure.  
Moreover, for different metals, each medium may also represent a different window of exposure 
that provides important information in relation to the health outcome of interest. 
 
A set of biomarkers reflecting integrated metal mixture information from multiple media not only 
reduces the error in the exposure estimation, but also captures different exposure sources and 
pathways. Thus, it may be appropriate to combine exposure from different media to assess human 
exposure to both single metal and metal mixtures. Previous studies have proposed different 
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techniques to integrate biomarkers of exposure to single chemicals, including confirmatory factor 
analysis [18, 19], structural equation models [19-21], and the derivation of multi-media biomarkers 
(MMBs) through mixture methods: non-negative matrix factorization (NMF), independent 
component analysis (ICA) and weighted quantile sum (WQS) regression [22]. A few studies have 
modeled metal mixtures measured in multiple matrices simultaneously and demonstrated that a 
combination of different metal biomarker factors may improve the prediction of health outcomes 
[23, 24]. Those studies have validated techniques to select the most important biomarker for each 
exposure individually, which has provided useful information for recommending a more suitable 
biomarker for a single metal. However, to our knowledge, no epidemiological study has evaluated 
the overall performance of metal mixtures measured in different media in association with health 
outcomes. Therefore, our goals were to assess whether data on metal mixture exposures measured 
using different media can be integrated and compare the performances of different matrices when 
measuring metal mixtures.  
 
To achieve this goal, we conducted the following study. First, we proposed ways to integrate multi-
media exposure information from biomarkers measured in different media. Second, we assessed 
the performance of metal mixtures measured in different media and the combined multi-media 
exposure as related to health outcomes. We chose adverse birth outcomes as our outcome of 
interest because exposure to metals impacts various biological pathways that contribute to adverse 
birth outcomes, including preterm delivery and low birthweight [4, 12, 25-37]. Limited mixture 
studies on this topic have mostly focused on metals measured in either urine or blood [4-8]. In the 
Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) study, we measured a wide 
range of metals in paired urine and blood samples, which enabled us to compare the associations 
between adverse birth outcomes and urinary or blood metal mixtures, as well as integrated metal 
mixtures utilizing both matrices. We hypothesized that the use of urine, blood, and the integrated 
metal mixtures would demonstrate differing performance when modeling adverse birth outcomes, 
informing more efficient study designs for exposure assessment. 
 
2. Methods 
2.1 Study population  
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This study used data collected from 847 pregnant women participating in the PROTECT study, an 
ongoing, prospective birth cohort [38-41]. The PROTECT study was launched in 2010 with 
funding from the National Institute of Environmental Health Sciences (NIEHS) Superfund 
Research Program to investigate Puerto Rico’s high preterm birth rate and the extent of hazardous 
waste contamination on the island. PROTECT aims to explore environmental exposures and other 
factors contributing to preterm birth risk and other adverse birth outcomes in Puerto Rico.  
 
Study participants were recruited at approximately 14 ± 2 weeks of gestation at seven prenatal 
clinics and hospitals throughout Northern Puerto Rico and followed until delivery. [38, 39]. 
Pregnant women included in the study were aged between 18 to 40 years, resided inside of the 
Northern Karst aquifer region, and were planning to deliver in the participating hospitals. 
Exclusion criteria have been described elsewhere [42]. Each woman participated in a total of up 
to three study visits during 18 ± 2 weeks, 22 ± 2 weeks, and 26 ± 2 weeks of gestation. At the 
initial visit, detailed information on medical and pregnancy history was collected. Nurse-
administered questionnaires were used to gather information on housing characteristics, 
employment status, and family situation at an in-home visit (22 ± 2 weeks). Spot urine samples 
were collected from women at up to three visits and blood samples were collected during the first 
and third visits. A total of 847 women who delivered a live singleton birth had available data on 
10 paired urine and blood metal biomarkers (collected at the same time point) as well as 
information on covariates (Figure V.1).  
 
The research protocol was approved by the Ethics and Research Committees of the University of 
Puerto Rico and participating clinics, the University of Michigan, Northeastern University, and the 
University of Georgia. The study was described in detail to all participants, and informed consent 
was obtained prior to study enrollment. 
 
2.2 Measurement of metals 
Spot urine was collected in sterile polypropylene cups and aliquoted within one hour after 
collection, while blood samples were collected in metal-free whole blood tubes. All samples were 
frozen and stored at -80°C and shipped on dry ice. Analysis was performed at NSF International 
(Ann Arbor, MI, USA), where concentrations of 16 metals and metalloids were measured in both 
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urine and blood: arsenic (As), barium (Ba), beryllium (Be), cadmium (Cd), cobalt (Co), chromium 
(Cr), cesium (Cs), copper (Cu), mercury (Hg), manganese (Mn), nickel (Ni), lead (Pb), titanium 
(Ti), uranium (U), vanadium (V), and zinc (Zn); an additional 5 metals and metalloids were 
measured in urine only: molybdenum (Mo), platinum (Pt), antimony (Sb), tin (Sn), and tungsten 
(W). Metal(loid) concentrations were measured using inductively coupled plasma mass 
spectrometry (ICPMS) as described previously [4]. The laboratory selected the appropriate 
isotopes for the requested elements to best avoid interferences from high levels of carbon and 
chloride in the biological sample matrix. The ICPMS was calibrated with a blank and a minimum 
of 4 standards for each element of interest. An R2 value of >0.995 was the minimum criterion for 
an acceptable calibration curve. The calibration curves were verified by initial checks at three 
calibration points within the curve. Continuing calibration checks and blanks after every 10 
samples were also utilized throughout the analytical run to ensure the ICPMS system was 
maintaining acceptable performance. Urinary specific gravity (SG) was measured at the University 
of Puerto Rico Medical Sciences Campus using a hand-held digital refractometer (Atago Co., Ltd., 
Tokyo, Japan) as an indicator of urine dilution.  
 
2.3 Preterm birth and auxiliary birth outcomes   
All birth outcome data were extracted from medical records. We used the American Congress of 
Gynecologists (ACOG) recommendations to calculate gestational age at birth [43], as previously 
described in detail [44, 45]. In this study, preterm birth was defined as delivery < 37 completed 
weeks of gestation, as per common practice. Preterm birth can be classed into two groups, based 
on the clinical presentation of preterm delivery: medically indicated preterm birth (preterm births 
with preeclampsia, or with both artificial membrane rupture and induced labor) and spontaneous 
preterm birth (presentation of premature rupture of the membranes, spontaneous preterm labor, or 
both). In our analysis, the outcome of interest was overall and spontaneous preterm birth. 
 
Other birth outcomes, including gestational age, and fetal growth outcomes [birthweight z-score, 
small for gestational age (SGA), and large for gestational age (LGA)], were also included in our 
analysis as auxiliary outcomes. INTERGROWTH-21st standard gestational age- and sex-specific 
birthweight z-scores were constructed and used in the analysis [46]. SGA and LGA births were 
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defined as below the 10th percentile and above the 90th percentile of birthweight z-scores, 
respectively.  
 
2.4 Data pre-processing for statistical analyses 
To account for urinary dilution, metal(loid) concentrations in urine were corrected for SG using 
the equation: Pc = P[(SGp – 1)/(SGi – 1)]; where Pc is the SG corrected biomarker concentration 
(ng/mL), P is the measured biomarker concentration, SGp is the median urinary specific gravity in 
this population (1.019), and SGi is the individual's urinary specific gravity. Metal concentrations 
below the limit of detection (LOD) were replaced by LOD/√2. Metals that were measured in paired 
media (urine and blood) and had at least 50% of samples with concentrations above the LOD in 
both matrices were included in statistical analysis.  
 
Descriptive statistics were calculated for all exposures and outcome variables. We applied natural 
logarithmic transformation to all urinary and blood metals because the distributions were right-
skewed prior to transformation. The geometric averages of participant concentrations across the 
visits were calculated for each urinary and blood metal. Spearman's rank correlations (rs) were 
used for the analysis of the relationships between paired urinary and blood metal concentrations. 
Data were analyzed using R version 3.6.2. A schematic representation of the data accumulation 
and analytic procedure is also presented in Figure 1.  
 
2.5 MMB composition 
2.5.1 Integrating multi-media biomarker (MMB) using intraclass correlation coefficient (ICC) 
Characterizing the within- and between-individual variation of measurements with parameters 
such as intraclass correlation coefficient (ICC) gives information on the reliability of the different 
media biomarkers. ICC is defined as the proportion of the total variance that is attributed to 







In epidemiological studies with repeated measurements, the ICC metric, ranging from 0 to 1, 
indicates reliability among multiple measurements of a quantity; when close to 0, ICC reflects 
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large variations between repeated measures, a.k.a. poor ability to distinguish between individuals 
with high and low exposure levels; when close to 1, the repeated measures are close to each other 
which reflects a good ability to discriminate between individuals with high and low exposure 
levels. In this unsupervised machine learning approach, we utilized the ICCs calculated from 
repeated measurements of urinary and blood metals [17] as weighting parameters to construct an 





   ; 
 
[3] MMB𝐼𝐶𝐶=𝑤𝑢𝑟𝑖𝑛𝑒[𝐼𝐶𝐶]C𝑢𝑟𝑖𝑛𝑒 + (1 − 𝑤𝑢𝑟𝑖𝑛𝑒[𝐼𝐶𝐶])C𝑏𝑙𝑜𝑜𝑑 , 
 
where 𝓌 is the weight of a medium and C is the metal concentration.  
 
2.5.2 Integrating multi-media biomarker (MMB) using weighted quantile sum regression (WQS) 
In addition to the unsupervised learning method, the amount of exposure information each 
biomarker carries can be quantified simultaneously based on the relationship of the exposure 
measured in a certain medium and health effect--a supervised approach. Therefore, the second 
approach for integrating urinary and blood biomarkers was weighted quantile sum regression 
(WQS), which models the body burden of quantiles of exposure. WQS estimates a set of weights, 
such that the linear combinations of the weights * quantile biomarkers have the highest association 
with the outcome [47] (equation [4]). Details of the WQS equation and annotations are previously 
described [48]. In our analysis, 𝑤𝑖  is the unknown weight for the ith medium (1=urine, 2=blood, 
c=2), z represents a vector of adjusted covariates, and ϕ is a vector of regression coefficients for 
those covariates. By placing the constraints of the weight (𝑤𝑖) estimates to be non-negative and 
sum to 1, the comparative values of urine and blood metals to multi-media biomarkers and the 
joint effect can be determined. The weights can then be used to quantify the contribution of each 
medium to the multi-media biomarker. In this supervised learning approach, we used WQS (100 
bootstraps) to determine the association between each birth outcome and urinary and blood 
biomarkers of each metal, separately. Then we combined the weights to generate multi-media 
biomarkers using equation [5]. 
[4] g(μ)=β0+β1(∑ 𝑤𝑖𝑞𝑖
𝑐





[5] MMB𝑊𝑄𝑆=𝑤𝑢𝑟𝑖𝑛𝑒[𝑊𝑄𝑆]  C𝑢𝑟𝑖𝑛𝑒 + 𝑤𝑏𝑙𝑜𝑜𝑑[𝑊𝑄𝑆]C𝑏𝑙𝑜𝑜𝑑 . 
 
2.6 Single-pollutant Analysis 
Generalized linear models (GLM) were used to examine the associations between four types of 
metal biomarkers measured and composed (urinary, blood, MMBICC, and MMBWQS) and birth 
outcomes. Separate models were used for each metal biomarker and outcome. The full models 
included the tertiles of metal biomarker concentrations and a final set of covariates that were 
selected based on a priori knowledge and whether their inclusion appreciably changed the effect 
estimates of metal exposure [49]. These covariates were maternal age, maternal education level, 
pre-pregnancy BMI, and exposure to second-hand smoking. Effect estimates and 95% confidence 
intervals were calculated for the highest versus the lowest tertiles of exposure to measure the risk 
stratification properties of individual metals and compare them to the collective effects of metal 
mixtures as described below.  
 
2.7 Mixture Analysis 
2.7.1 Construction of Environmental Risk Scores (ERSs) using Ridge regression 
We constructed Environmental Risk Scores (ERSs) as weighted summary measures of the effects 
of metals where the weights were regression coefficients derived from models of the association 
between metal mixtures and the outcome of interest. We utilized Ridge regression to guide the 
weight of each metal in relation to preterm birth. Ridge regression is a regularized regression 
technique and it is one of the commonly used supervised machine learning solutions. Ridge is used 
to constrain the size of the estimated coefficients, and the objective function for a continuous 
outcome can be expressed as: 
 
[6]  ?̂?𝑅𝑖𝑑𝑔𝑒 = arg min
(𝛽0 ,𝛽)∈ℝ𝑝+1
∑ (𝑦𝑖 − 𝛽0 − 𝑥𝑖
𝑇𝛽)2 + 𝜆‖𝛽‖2
2𝑛
𝑖=1  , 
 
where 𝑖 = 1, … , 𝑛 indexes the subjects, 𝑥𝑖
𝑇 ∈ ℝ𝑝 is the vector of 𝑝 covariates for the 𝑖th subject, 
and 𝑦𝑖 is the continuous health outcome for the 𝑖th subject. Ridge regression utilizes the 
regularization penalty parameter 𝜆 (𝜆 ∈ [0, ∞)) to solve the multicollinearity problem and control 
 165 
the shrinkage of the L2 penalty. Ridge regression decreases the complexity of the models and 
enforces the β coefficients to be lower without forcing them to be zero. This was ideal as our 
analytic purpose was to evaluate the same full set of metals as mixtures across different media and 
integrated biomarkers. Using Ridge regression with an underlying model including biomarkers of 
10 metals and covariates, we performed 10-fold cross-validation and selected the value that 
minimized the cross-validated sum of squared residuals. Four separate ERSs for metals in urine, 





𝑖=1 𝐶𝑖   . 
2.7.2 ERS models and evaluations 
We further categorized ERSs by tertiles and refit the regression models with both continuous and 
categorical ERSs to examine its associations with preterm birth as well as the auxiliary birth 
outcomes. We conceptualized the ERSs as a weighted sum of metal exposure measured in urine, 
blood, and multi-media biomarkers composed by WQS and ICC methods, namely, ERSurine, 
ERSblood, ERSMMB-WQS, and ERSMMB-ICC. ROC (Receiver Operating Characteristics) curves were 
used to evaluate the preterm, spontaneous preterm birth, SGA, and LGA classification model 
performances of four ERSs. Specifically, the area under curve (AUC) of ROC were computed for 
quantifying and visualizing the biomarkers’ classification accuracy for the above-mentioned 
binary outcomes. We used a bootstrap resampling (2000 iterations) to compute 95% confidence 
intervals of AUCs for different models [50] and to test the difference between AUCs (the ci.auc() 
and roc.test() functions in the pROC package in R [51]). For binary outcome models with ERS 
tertiles, we also computed the odds ratio (OR) for the highest tertile versus the lowest tertile to 
measure the risk stratification properties of ERS. 
 
3. Results 
3.1 Descriptive statistics 
Demographic characteristics of the 847 women in this analysis are summarized in Table V.1 and 
were described previously [41, 52]. Briefly, the cohort included women in their late 20s (median 
=27 years) and half of them had a BMI less than 25 kg/m2 prior to pregnancy. The majority of 
women (57%) had private medical insurance, were non-smokers (86%) and very few (6%) 
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reported alcohol consumption within the last few months. More than half reported an annual 
household income of less than $30,000, while 44% had reported graduating from college or higher. 
Table V.2 displays descriptive statistics, including geometric mean, geometric standard deviation, 
and selected percentiles, of 10 metal concentrations measured in the paired urine and blood 
samples, as well as Spearman correlation coefficients between two media for each metal. Most of 
the paired metal concentrations in the two matrices had a low but significant correlation, with 
Spearman correlation coefficient ranging from 0.07 to 0.43, while Mn, Ni, and Zn concentrations 
measured in urine and blood were not correlated. All the following results on urinary metals are 
presented for SG-corrected concentrations unless described otherwise.  
 
3.2 MMB composition 
The weights of urinary and blood metals in the composition of MMBs from ICC and WQS 
approaches are depicted in Figure V.2. As the ICC approach is based on an unsupervised learning 
method, the metal biomarker weights are the same across the birth outcomes. In contrast, the WQS 
approach is a supervised learning method, therefore, the weights constructed for each of the metal 
biomarkers were different for the respective birth outcomes. The corresponding urinary and blood 
weights (WQS) for each birth outcome are presented in Table V.3, while Figure V.2 focuses on 
weights constructed from WQS models regressing preterm birth. For the majority of metals, blood 
was the main contributor to the MMBs from both ICC and WQS approaches. The blood weights 
for those metals were higher from the WQS approach than the ICC approach, except for Mn and 
Pb where the blood weights were higher from the ICC approach (60% and 88%) than the WQS 
approach (56% and 72%). In contrast, MMB for As was mostly attributed to urine from the WQS 
approach (95%).  
 
3.2 ERSs 
ERS weights derived from Ridge models regressing preterm and spontaneous preterm birth on 
metal mixtures are shown in Figure V.3. The values of the weights for all the outcomes are 
provided in Table V.4. The largest contributors to preterm birth ERS from urine mixture were Cd 
(-0.01), Ni (-0.008), and As (-0.006). For preterm birth ERSs constructed from the blood, MMBICC, 
and MMBWQS mixtures, Pb and Mn were the largest positive weight contributors for all three. A 
similar weight distribution was observed for spontaneous preterm birth. The preterm birth ERSs 
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from each biomarker mixture were normally distributed and ranged from −0.06 to 0.04 for urine; 
−0.13 to 0.88 for blood; −0.001 to 0.11 for MMBICC; and 0.08 to 0.48 for MMBWQS. For preterm 
birth ERSs, pairwise correlations among urine ERS and other ERSs were weak (r<0.2), whereas 
blood ERS had relatively higher correlations with the ERSs for MMBICC (r=0.88) and MMBWQS 
(r=0.53). The weight distribution for spontaneous preterm birth ERSs were similar to overall 
preterm birth ERS weights.  
 
3.3 Continuous ERSs and birth outcomes 
The result from our primary analyses of continuous ERSs and preterm birth are presented in Figure 
V.4. To illustrate the difference in the urine biomarker performance between disregarding versus 
accounting for urine dilution, we reported the odds ratio associated with both uncorrected and SG-
corrected urine ERSs. Therefore, the performance was compared between metal mixtures 
measured in uncorrected urine, SG-corrected urine, blood, MMBICC, and MMBWQS. As shown in 
Figure V.4, all the ERSs were significantly associated with increased odds of preterm birth except 
for uncorrected urine metal ERS. Although not significant, the odds of preterm birth was 1.3 times 
higher for a subject in the 75th percentile of exposure, as determined via ERS for uncorrected urine 
metals, compared with a subject in the 25th percentile of exposure (95% CI: 0.94 to 1.86). The 
odds ratios for other ERS associations were greater than the odds ratio of uncorrected urine metal 
ERS, ranging from 1.81 (95% CI: 1.27 to 2.59) to 2.00 (95% CI: 1.45 to 2.75). Changes in auxiliary 
birth outcomes associated with ERSs are shown in Table V.5. When spontaneous preterm birth is 
regressed on the four ERSs, odds ratios were generally higher compared to the overall preterm 
birth models, ranging from 2.34 (95% CI: 1.53, 3.56) to 2.56 (95% CI: 1.58, 4.14). For fetal growth 
outcomes, all ERSs were significantly associated with lower birthweight z-scores; the associations 
between ERSs and SGA were stronger (OR: 1.54 to 1.99) than the associations between ERSs and 
LGA (OR: 1.32 to 1.51) (Table V.5). 
 
The p values in Figure V.4 represent the significance of the test results for comparing the 
predictive performances (preterm birth) of different ERSs using AUC. While the consistent 
performance of SG-corrected urine, blood, and MMB biomarkers were observed, the uncorrected 
urine ERS showed lower prediction performance than SG-corrected urine (p=0.04), blood ERS 
(p=0.02), MMBICC ERS (p=0.003), and MMBWQS ERS (p=0.07). This is visualized by the AUC 
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plots depicting the performance of different ERSs and preterm birth models (Figure V.5). Figure 
V.5 (a) shows that the area under the uncorrected urine ERS curve (AUC = 0.61; 95%CI = 0.54–
0.68) is smaller than the blood ERS (AUC = 0.68; 95%CI = 0.62–0.74), MMBICC ERS (AUC = 
0.67; 95%CI = 0.61–0.73), and MMBWQS (AUC = 0.68; 95%CI = 0.62–0.74). Figure V.5 (b) 
shows that there are no obvious differences in the AUC between SG-corrected urine, blood, and 
two MMB ERSs. Predictive performances of ERS on other binary outcomes followed similar 
patterns; performances of SG-corrected urine, blood, and MMB biomarkers were comparable, with 
AUC ranging from 0.66 to 0.69 for spontaneous preterm birth, from 0.60 to 0.65 for SGA, and 
from 0.60 to 0.62 for LGA; uncorrected urine ERS showed substantially lower prediction 
performance for spontaneous preterm birth, but not SGA and LGA. 
 
Because Pb was the most important contributor of preterm birth blood ERS as well as the two 
MMB ERSs, we conducted additional analyses excluding Pb from Ridge models while 
constructing and evaluating the performance of the ERSs. The effect estimates from this analysis 
for all four (urine, blood, MMBICC, MMBWQS) ERS were attenuated compared to the primary 
analyses (Table V.6). Continuous blood ERS was no longer significantly associated with preterm 
birth (OR/IQR=1.03, 95% CI 0.77 to 1.37, p=0.83). The effect estimates for urine ERS was 1.73 
(95% CI 1.22 to 2.43, p=0.002), MMBICC was 1.83 (95% CI 1.23 to 2.54, p<0.001), and MMBWQS 
was 1.76 (95% CI 1.29 to 2.41, p<0.001). The AUCs for these ERSs without Pb are shown in 
Figure 5(c). Although the performance of SG corrected urine (blue line) and blood ERSs (red line) 
are comparable, the area is significantly smaller for the blood ERS model compared to the MMBICC 
(p=0.01) and MMBWQS models (p=0.02). 
  
3.4 Tertile metals, ERSs, and birth outcomes 
ORs of preterm birth comparing the highest versus the lowest tertiles of individual metal 
biomarkers and ERSs are shown in Figure V.6. After adjusting for covariates, individual 
associations for Mn (MMBs), Ni (urine), Zn (blood, MMBs), Cd (urine), Pb (blood, MMBs), and 
odds of preterm were significant. Ni and Cd biomarkers were associated with lower odds of 
preterm birth while Mn, Zn, and Pb were associated with higher odds of preterm birth. For 
example, a subject in Ni tertile 3 had 0.76 times lower odds of preterm birth (95% CI, 0.57 to 1) 
compared with a subject in Ni tertile 1. In contrast, a subject in Pb tertile 3 had 1.53 times higher 
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odds of preterm birth (95% CI 1.14 to 2.06) compared with a subject in Pb tertile 1. As for ERS 
models, ORs of preterm birth ranged from 2.83 (95% CI, 1.49 to 5.40) for urine; 3.24 (95% CI, 
1.68 to 6.25) for blood; 3.86 (95% CI, 1.72 to 8.66) for MMBICC; and 5.17 (95% CI, 2.34 to 11.42) 
for MMBWQS, after controlling for the same set of covariates. These ORs from the mixture analysis 
were considerably stronger than those for individual metals. Both individual and mixture analysis 
results for spontaneous preterm birth and auxiliary outcomes can be found in Tables V.5 and V.7. 
  
4. Discussion 
Epidemiologic studies aiming to determine the effects of environmental chemical mixtures on 
human health are growing rapidly. Due to limiting factors such as the financial cost and 
methodologic challenges, mixture studies based on biomarkers typically use a unified human 
specimen, such as blood or urine to determine exposure to various chemicals [12-17]. Although 
this approach applies well to chemicals with similar structure and pharmacokinetics, it is 
challenging to accurately describe metal mixtures using one unified medium. Each metal exhibits 
unique physiochemical properties and toxicokinetics, such as half-life, storage, or elimination rate 
from the body. As such, the preference for either blood or urine concentration as a better indicator 
is different across metals, often determined by the half-life of each metal and cost of measurement. 
For example, urinary concentration of As has often been used as an indicator of recent exposure 
because urine is the main route of excretion of most arsenic species [53, 54]. In contrast, blood is 
the preferred specimen for Pb, as blood Pb has a longer half-life and subsequently lower variability 
in the body compared to urine [55]. As for other metals such as Mn, Cu, and Cr, there is a lack of 
consensus in the literature as to which biomarker is the most consistent and valid. Previous mixture 
studies on prenatal metal exposures and birth outcomes measured metals in different media 
including urine [4, 56-58], whole blood [7, 59], cord blood [60], toenails [5], and teeth [61]. As 
mentioned above, each medium depicts biomarker levels in a particular body compartment that 
may have differential biological relevance and may not fully represent the best measure of internal 
dose for all the metals. Therefore, it is imperative that we understand how the choice of different 
media can impact the performance of analyzing chemical mixtures in relation to a specific health 
outcome. In this paper, we evaluated metals measured in urine and blood, as well as two integrated 
multi-media biomarker indices, in relation to birth outcomes among pregnant women.  
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We first applied supervised and unsupervised approaches to combine exposure information from 
multi-media (urine and blood) metal biomarkers. For each individual metal, the weights for urine 
and blood from both approaches were generally similar with a few exceptions, most notably with 
As. When applying the supervised approach with WQS where the relationship of urine and blood 
biomarkers with the health outcome (preterm birth) is considered, approximately 95% of the As 
association was driven by urinary As. This result indicates that urinary As is the more important 
predictor than the blood As in modeling preterm birth. However, the weight for urinary As from 
the ICC approach was much lower (42%). This difference is mainly due to a lower ICC (0.21) for 
the repeated measurements of urinary As in this study [17]. To our knowledge, only one previous 
study on pregnant women reported an ICC (0.16) for urinary As during pregnancy, which is similar 
to the ICC calculated in the present study [62]. These ICCs indicate weak reliability of urinary As 
during pregnancy, while reports on the general population demonstrated fair reliability of urinary 
As (ICC ranging from 0.45 to 0.49) over a longer period of time (1-2 years) [63, 64]. The 
discrepancy was possibly due to the physiological changes related to the pregnancy (i.e. metabolic 
changes, plasma volume expansion) [65-68], and unique environmental and behavioral factors 
such as dietary habits unique to this population. 
 
Once we constructed MMBs, we used Ridge models to guide the weights of each metal biomarker 
in constructing the ERSs. Examining uncorrected metal mixture concentrations resulted in a 
significantly lower performance in urine ERS compared to the other ERSs (SG-corrected urine, 
blood, and the integrated MMBs) that had comparable level of performances amongst themselves. 
These results indicate that consideration of measuring metal mixtures in either urine or blood may 
be an equally good approach when correcting urinary metals for SG. Although the optimal urine 
concentration adjustment approach for metals remains uncertain [69-71], our findings underline 
the importance of considering urinary dilution when evaluating the health effects of a metal 
mixture measured in urine. This conclusion is supported by previous literature validating the 
improved robustness and reliability of physiological measures for correcting variation in urinary 
output [72-76].  
 
In Ridge models using blood, MMBICC, and MMBWQS, Pb was most strongly associated with 
preterm birth. This is consistent with our previous finding within this population where 
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concentrations of blood Pb among pregnant women in Puerto Rico (average=0.33 μg/dL) were 
well below the level of concern set by CDC, a blood level of 5 μg/dL for pregnant women [77]. 
Yet Pb was the most significant predictor of preterm birth [49]. Therefore, when we conducted the 
same analysis for all the biomarker mixtures excluding Pb, the association between blood ERS and 
preterm birth were no longer significant. The performance of blood ERS was also significantly 
lower than the MMBICC (p=0.01) and MMBWQS (p=0.02) models. However, the performance of 
urine and blood ERSs was still comparable in that the addition of urine biomarker information 
significantly improved the performance of blood biomarkers but not vice versa. These findings 
shed light on the importance of studying Pb in metal mixtures, especially blood biomarkers, as the 
performance of blood ERS was mainly driven by the strong effect of Pb. The findings also warrant 
further studies of different metal panels in regard to mixture performance. 
 
After analyzing individual and ERS tertiles with preterm birth, we observed a few significant but 
overall smaller effects corresponding to individual metals and stronger effects corresponding to 
the four combined ERSs, indicating the cumulative impact of the individual metals (Figure 6). 
This is consistent with previous literature where stronger cumulative effects of metals and 
environmental chemicals were reported when analyzed as mixtures [6, 78, 79]. After adjusting for 
covariates, the odds ratio of preterm birth comparing a subject in the higher end of overall metals 
exposure (ERS tertile 3) with a subject in the lower end (ERS tertile 1) were 2.8 for urine (95% 
CI, 1.49 to 5.40), 3.2 for blood (95% CI, 1.68 to 6.25), 3.9 for MMBICC (95% CI, 1.72 to 8.66), 
and 5.2 for MMBWQS (95% CI, 2.34 to 11.42). Assuming these odds ratios quantify the potential 
for risk stratification of preterm birth, the integrated multi-media biomarker models resulted in a 
higher risk of preterm birth associated with overall metal exposure. From a risk stratification 
perspective, integration of urine and blood biomarkers that were derived from both ICC and WQS 
approaches improved the model performance in the mixture models compared to the sole urine or 
blood biomarker models. Although the confidence intervals for these odds ratio estimates were 
wider, the MMB integration, especially using the WQS approach, resulted in substantially higher 
effect estimate. This finding supports that while multiple measurements of the exposure mixture 
may measure metal body burden differentially, there may still be room for improvement for 




Specific strengths of our study include its longitudinal design in which repeated urinary and blood 
biomarkers provided more accurate exposure information during pregnancy. This allowed us to 
quantify the temporal reliability of the two media measurements (ICCs), which were further used 
as weights to integrate the multi-media measure of exposure. Secondly, this study utilized data-
driven machine learning approaches to 1) inform the composition of multi-media metal biomarkers 
measured in different media and 2) guide the construction of environmental risk scores for each 
medium reflecting the overall exposure to the metal mixture. Finally, this study evaluated the 
health effects of multiple metals simultaneously and compared the performance of different media 
biomarkers and integrated biomarkers in relation to adverse birth outcomes in the context of a 
mixture. The results lay the groundwork for future epidemiological studies on biomarker selection 
when examining the mixture effects of metals. 
  
However, our study has several limitations. The relatively small sample size did not allow cross-
validation within this population on ERS, which may have caused overfitting of ERS. Future 
studies with a larger sample size should implement training and test datasets to cross-validate 
ERSs. Studies with larger sample sizes are also needed to address potential improvement of models 
by including non-linear terms and interactions between metals and covariates that were not 
accounted for in the current analysis. Depending on the pharmacokinetics of each chemical within 
a family, mixture studies, in general, are challenged by the complications of combining chemical 
biomarkers where each may be representing a unique window of exposure. While our ERS 
estimates also suffered from this limitation, by combining multi-media exposure using both urine 
and blood biomarkers, we were able to reduce the measurement error in the mixture analysis to an 
extent. In addition, while we evaluated a mixture of 10 essential and non-essential metals, it is 
possible that other metals that were not assessed in our study affect the performance of urine or 
blood biomarkers. Future work is needed to expand the mixture evaluation to include more metals 
and other biospecimens including hair and saliva, as well as other adverse health outcomes because 
our results may not be generalizable to other outcomes of interest. Finally, while the mixture of 
metals in this study is representative of exposures experienced by Puerto Rican populations, it may 




Our study used innovative methodology to provide new detailed insights into the individual and 
integrated associations of urinary and blood mixture biomarkers of metal exposure with birth 
outcomes. Our investigation demonstrates, within practical metal analytical panels, that measuring 
metals in either urine or blood may be an equally good approach to evaluate the metals as a 
mixture, but only when the urine measurements are corrected for urinary dilution. The results of 
our study elucidate the importance of considering the overall mixture performance of a certain 
medium. Future studies are needed to expand to evaluate the performance with different metal 
panels, media, health outcomes of interest, and methods to integrate exposure information, to 
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Figure V.1 Schematic plot of study design, sample size, and statistical methods for constructing and evaluating multi-media 
biomarker (MMB) and Environmental Risk Score (ERS) 
 
Abbreviations: intraclass correlation coefficient (ICC); weighted quantile sum regression (WQS); area under the curve (AUC); 













Table V.1 Demographic characteristics of study participants from the Puerto Rico Testsite for Exploring Contamination Threats 
(PROTECT) cohort (n=847) 
Variable Mean (SD) 
Maternal age at enrollment (years) 26.9 (5.6) 
gravidity (# pregnancies) 2 (1) 
  
Insurance type N (%) 
Private 480 (57%) 
Public (Mi Salud) 281 (33%) 
Missing 86 (10%) 
Maternal education (years)  
High school/GED 185 (22%) 
Some College or technical school 293 (35%) 
College degree 268 (32%) 
Masters degree or higher 101 (12%) 
Missing 0 (0%) 
Income status (US $)  
<$10,000 260 (31%) 
≥$10,000 to <$30,000 212 (25%) 
≥$30,000 to <$50,000 176 (21%) 
≥$50,000 104 (12%) 
Missing 95 (11%) 
Marital status  
Single 163 (19%) 
Married or living together 680 (80%) 
Missing 4 (0%) 
Gravidity (# pregnancies)  
0 361 (43%) 
1 304 (36%) 
>1 181 (21%) 
Missing 1 (0%) 
Pre-pregnancy BMI (kg/m2)  
≤25 447 (53%) 
>25 to ≤30 230 (27%) 
>30 170 (20%) 
Missing 0 (0%) 
Smoking Status  
Never 726 (86%) 
Ever  109 (13%) 
Current 12 (1%) 
Missing 0 (0%) 
Exposure to second hand smoking   
None 772 (91%) 
Up to 1 hour/day 30 (4%) 
More than 1 hour/day 45 (5%) 
Missing 0 (0%) 
Alcohol consumption  
None 438 (52%) 
Before pregnancy 354 (42%) 
Within the last few months 50 (6%) 
Missing 5 (1%) 
Infant Sex  
Female 406 (48%) 
Male 437 (52%) 
Missing 4 (0%) 
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Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); 
mercury (Hg); lead (Pb); limit of detection (LOD); geometric mean (GM); geometric standard deviation (GSD). 
a Includes SG-corrected urinary metal concentrations for up to 3 repeated samples per woman (n = 1601 samples) 
b Includes blood metal concentrations for up to 2 repeated samples per woman (n = 1217 samples) 
c Blood Pb concentration unit is µg/dL 

















Specimen N %>LOD GM GSD 25% 50% 75% 95% Max rd 
Co Urinea 632 100 1.1 1.6 0.80 1.1 1.5 2.8 16.4 
0.30** 
  Bloodb 948 98.2 0.35 1.4 0.29 0.34 0.41 0.57 1.6 
Cs Urinea 632 100 5.5 1.4 4.4 5.6 6.9 9.8 18.4 
0.43** 
  Bloodb 948 99.9 1.1 1.4 0.9 1.2 1.4 1.9 2.9 
Cu Urinea 632 99.3 15.2 1.5 11.5 14.8 19.3 32.1 109 
0.23** 
  Bloodb 948 99.9 1568 1.3 1408 1583 1756 2103 3798 
Mn Urinea 632 100 1.0 2.4 0.83 1.2 1.6 2.6 6.7 
-0.01 
  Bloodb 948 99.9 11.2 1.4 9.0 11.3 13.9 19.1 90.7 
Ni Urinea 632 98.9 5.4 1.8 3.8 5.4 7.9 13.4 127 
-0.06 
  Bloodb 948 96.4 1.0 1.6 0.79 1.0 1.3 2.3 22.8 
Zn Urinea 632 100 309 2.1 204 330 521 878 2136 
0.07* 
  Bloodb 948 99.9 4720 1.3 4288 4793 5322 6102 8043 
As Urinea 632 100 11.3 2.2 6.6 11.0 18.3 41.4 281 
0.26** 
  Bloodb 948 48.9 0.33 1.8 <LOD <LOD 0.47 1.0 7.9 
Cd Urinea 632 74.5 0.13 2.0 0.08 0.12 0.20 0.48 1.8 
0.18** 
  Bloodb 947 60.9 0.12 1.6 <LOD 0.11 0.16 0.27 1.3 
Hg Urinea 628 98.6 0.72 2.7 0.37 0.73 1.3 3.5 64.9 
0.36** 
  Bloodb 948 99.9 1.2 1.7 0.85 1.2 1.7 3.0 10.6 
Pbc Urinea 632 72.1 0.25 2.4 <LOD 0.26 0.44 1.1 4.6 
0.28** 
  Bloodb 948 99.9 3.3 1.6 2.5 3.3 4.3 6.4 21.8 
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Figure V.2 Bar graph of estimated urinary and blood biomarker weights for the MMBs using ICC approach and the WQS models 
of overall preterm birth. Larger weights indicate greater contributions of the original biomarkers to the MMBs 
 
 
Abbreviations: multi-media biomarkers (MMBs); intraclass correlation coefficient (ICC); weighted quantile sum regression 
(WQS); cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury 






















Table V.3 Estimated biomarker weights for the MMBs using WQS approach regressing birth outcomes on urinary and blood 
biomarkers 
 Gestational age Preterm birth Spontaneous preterm birth 
Metals urine blood urine blood urine blood 
Co 0.15 0.85 0.03 0.97 0.32 0.68 
Cs 0.13 0.87 0.14 0.86 0.89 0.11 
Cu 0.16 0.84 0.21 0.79 0.76 0.24 
Mn 0.36 0.64 0.44 0.56 0.00 1.00 
Ni 0.21 0.79 0.08 0.92 0.29 0.71 
Zn 0.08 0.92 0.25 0.75 0.72 0.28 
As 0.94 0.06 0.95 0.05 0.05 0.95 
Cd 0.90 0.10 0.14 0.86 0.64 0.36 
Hg 0.18 0.82 0.01 0.99 1.00 0.00 
Pb 0.36 0.64 0.28 0.72 0.01 0.99 
 Birthweight z-score SGA LGA 
Metals urine blood urine blood urine blood 
Co 0.13 0.87 0.00 1.00 0.97 0.03 
Cs 0.83 0.17 0.54 0.46 0.10 0.90 
Cu 0.78 0.22 0.70 0.30 0.16 0.84 
Mn 0.34 0.66 0.55 0.45 0.30 0.70 
Ni 0.51 0.49 0.29 0.71 0.60 0.40 
Zn 0.92 0.08 0.94 0.06 0.08 0.92 
As 0.98 0.02 0.69 0.31 0.58 0.42 
Cd 0.33 0.67 0.92 0.08 0.99 0.01 
Hg 0.53 0.47 0.42 0.58 0.77 0.23 
Pb 0.29 0.71 0.21 0.79 0.21 0.79 
Abbreviations: multi-media biomarkers (MMBs); weighted quantile sum regression (WQS); cobalt (Co); cesium (Cs); copper 
(Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 
























Figure V.3 Heat map of weights for each individual metal biomarker extracted by the Ridge regression models regressing birth 
outcomes on urinary, blood, and two integrated multi-media biomarkers (MMB)  
 
Abbreviations: multi-media biomarkers (MMBs); cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); 
arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); intraclass correlation coefficient (ICC); weighted quantile sum regression 
(WQS). 
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Table V.4 Estimated environmental risk score (ERS) weights (regression coefficient) for metals from each birth outcome Ridge models. Models were adjusted for maternal age, 




































Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); mercury (Hg); lead (Pb); small for gestational age 




Gestational age Preterm birth Spontaneous preterm birth 
Metals urine blood MMBICC MMBWQS urine blood MMBICC MMBWQS urine blood MMBICC MMBWQS 
Co 0.40 -0.12 0.062 -0.266 -0.006 0.009 0.000 0.006 -0.001 0.000 -0.002 -0.001 
Cs 0.17 0.04 0.117 0.143 -0.002 0.005 0.000 0.003 -0.006 0.000 -0.003 -0.001 
Cu -0.64 -0.03 -0.134 -0.081 0.002 0.004 0.001 0.003 0.003 0.000 0.002 0.002 
Mn -0.31 -0.18 -0.528 -0.646 0.004 0.012 0.003 0.012 0.006 0.001 0.013 0.013 
Ni 0.40 0.09 0.329 0.338 -0.008 0.002 -0.001 0.000 -0.009 0.000 -0.009 -0.003 
Zn -0.06 -0.09 -0.167 -0.201 -0.003 0.012 0.002 0.009 -0.003 0.001 0.003 0.004 
As -0.74 0.31 -0.103 -0.636 0.005 -0.013 0.000 0.006 0.007 -0.002 -0.003 0.007 
Cd 1.12 0.04 0.457 0.525 -0.010 -0.015 -0.003 -0.013 -0.013 -0.001 -0.011 -0.007 
Hg 0.76 0.10 0.465 0.405 -0.001 0.003 0.000 0.002 -0.006 0.001 0.000 0.006 
Pb -0.59 -0.37 -0.596 -0.827 0.003 0.023 0.003 0.017 -0.002 0.002 0.010 0.010 
 Birthweight z-score SGA LGA 
Metals urine blood MMBICC MMBWQS urine blood MMBICC MMBWQS urine blood MMBICC MMBWQS 
Co 0.004 0.030 0.027 0.029 -0.175 0.001 -0.018 -0.001 -0.003 0.006 0.002 0.006 
Cs 0.002 0.023 0.017 0.013 -0.112 -0.005 -0.022 -0.009 0.001 0.003 0.003 0.002 
Cu 0.000 0.001 0.002 0.002 0.074 0.001 0.007 0.003 0.000 0.001 0.001 0.001 
Mn 0.001 -0.010 -0.001 -0.003 -0.067 0.003 -0.001 0.000 0.001 0.003 0.003 0.004 
Ni 0.003 0.012 0.019 0.026 -0.053 -0.002 -0.019 -0.009 0.002 0.001 0.003 0.004 
Zn -0.002 -0.002 -0.003 -0.013 0.035 0.001 0.005 0.001 -0.007 0.001 0.000 -0.009 
As -0.002 0.028 0.007 -0.008 0.063 -0.001 0.004 0.003 0.001 0.008 0.006 0.001 
Cd 0.001 0.022 0.017 0.021 0.102 -0.007 -0.012 -0.004 0.003 0.002 0.004 0.005 
Hg -0.003 -0.014 -0.016 -0.020 0.022 0.000 0.004 0.002 -0.002 0.004 0.000 0.000 
Pb 0.001 -0.006 -0.004 -0.003 -0.093 0.003 0.007 0.002 0.000 -0.005 -0.004 -0.005 
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Figure V.4 Odds ratio (OR) of preterm birth associated with Environmental Risk Scores (ERSs) constructed for uncorrected urine, 
SG-corrected urine, blood, and two integrated multi-media biomarkers (MMB) as well as including both SG-corrected urine and 
blood ERS. Effect estimates presented as OR for IQR increase in average exposure biomarker concentration. Models were adjusted 
for maternal age, maternal education, pre-pregnancy BMI, and exposure to secondhand smoking. P values are from tests comparing 








































Table V.5 Change in birth outcomes associated with Environmental Risk Score (ERS) constructed for uncorrected urine, SG-
corrected urine, blood, and two integrated multi-media biomarkers (MMBs). Effect estimates presented as changes or odds ratio 
(OR) for IQR increase in exposure biomarker concentration. Models were adjusted for maternal age, maternal education, pre-
pregnancy BMI, and exposure to secondhand smoking 
 
Abbreviations: specific gravity (SG); intraclass correlation coefficient (ICC); weighted quantile sum regression (WQS); small for 



























 Gestational age Preterm birth Spontaneous preterm birth 
ERSs Change in days (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
Urineuncorrected -3.0 (-4.2, -1.8) <0.001*** 1.32 (0.94, 1.86) 0.11 1.64 (1.04, 2.57) 0.03** 
UrineSG -3.1 (-4.4, -1.9) <0.001*** 1.83 (1.29, 2.61) <0.001*** 2.53 (1.58, 4.03) <0.001*** 
Blood -1.8 (-2.9, -0.8) <0.001*** 1.89 (1.40, 2.54) <0.001*** 2.34 (1.53, 3.56) <0.001*** 
MMBICC -2.2 (-3.3, -1.2) <0.001*** 2.00 (1.45, 2.75) <0.001*** 2.44 (1.55, 3.85) <0.001*** 
MMBWQS -3.2 (-4.4, -2.0) <0.001*** 1.92 (1.36, 2.70) <0.001*** 2.56 (1.58, 4.14) <0.001*** 
 Birthweight z-score SGA LGA 
ERSs Change in z-score (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
Urineuncorrected -0.12 (-0.21, -0.02) 0.02** 1.84 (1.32, 2.57) <0.001*** 1.50 (1.10, 2.05) 0.01** 
UrineSG -0.13 (-0.22, -0.03) 0.01** 1.99 (1.41, 2.81) <0.001*** 1.51 (1.11, 2.03) 0.01** 
Blood -0.15 (-0.24, -0.06) 0.001*** 1.54 (1.10, 2.15) 0.01** 1.40 (1.05, 1.87) 0.02** 
MMBICC -0.16 (-0.26, -0.07) <0.001*** 1.64 (1.16, 2.30) 0.005*** 1.32 (0.98, 1.79) 0.07* 
MMBWQS -0.14 (-0.24, -0.05) 0.004*** 1.70 (1.23, 2.36) <0.001*** 1.53 (1.11, 2.10) 0.01** 
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Figure V.5 Area under the curves (AUCs) for preterm birth according to environmental risk score (ERS) constructed for urinary, 
blood, and two integrated multi-media biomarkers (MMB) 
 
 












































Table V.6 Change in birth outcomes associated with Environmental Risk Score (ERS) constructed for SG-corrected urine, blood, 
and two integrated multi-media biomarkers (MMBs), excluding Pb in Ridge models. Effect estimates presented as changes or odds 
ratio (OR) for IQR increase in exposure biomarker concentration. Models were adjusted for maternal age, maternal education, pre-
pregnancy BMI, and exposure to secondhand smoking 
 
Abbreviations: specific gravity (SG); intraclass correlation coefficient (ICC); weighted quantile sum regression (WQS); small for 




























 Gestational age Preterm birth Spontaneous preterm birth 
ERSs 
Change in days (95% 
CI) 
p value OR (95% CI) p value OR (95% CI) p value 
UrineSG -3.0 (-4.3, -1.7) <0.001*** 1.73 (1.22, 2.43) 0.002*** 2.65 (1.64, 4.28) <0.001*** 
Blood -1.4 (-2.4, -0.4) 0.01** 1.03 (0.77, 1.37) 0.83 2.19 (1.40, 3.42) <0.001*** 
MMBICC -1.9 (-3.0, -0.8) <0.001*** 1.83 (1.32, 2.54) <0.001*** 2.13 (1.35, 3.35) 0.001*** 
MMBWQS -2.2 (-3.4, -1.0) <0.001*** 1.76 (1.29, 2.41) <0.001*** 1.93 (1.25, 2.97) 0.002*** 
 Birthweight z-score SGA LGA 
ERSs 
Change in z-score 
(95% CI) 
p value OR (95% CI) p value OR (95% CI) p value 
UrineSG -0.13 (-0.22, -0.03) 0.01** 1.94 (1.36, 2.77) <0.001*** 1.52 (1.13, 2.06) 0.01** 
Blood -0.11 (-0.20, -0.02) 0.02** 1.52 (1.09, 2.12) 0.01** 0.97 (0.72, 1.31) 0.86 
MMBICC -0.16 (-0.26, -0.07) <0.001*** 1.58 (1.13, 2.21) 0.01** 1.23 (0.90, 1.69) 0.20 
MMBWQS -0.16 (-0.25, -0.07) <0.001*** 1.59 (1.12, 2.25) 0.01** 1.45 (1.06, 1.97) 0.02** 
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Figure V.6 Odds ratio (OR) comparing the highest versus the lowest tertiles of individual metals and environmental risk scores 
(ERSs) constructed for urine, blood, and two integrated multi-media biomarkers (MMB) mixtures. Models were adjusted for 
maternal age, maternal education, pre-pregnancy BMI, and exposure to secondhand smoking 
 
 
Abbreviations: intraclass correlation coefficient (ICC); weighted quantile sum regression (WQS); cobalt (Co); cesium (Cs); 









Table V.7 Odds ratio (OR) comparing the highest vs. the lowest tertiles of individual metals and environmental risk scores (ERSs) 
constructed for urine, blood, and two integrated multi-media biomarkers (MMB) mixtures. Models were adjusted for maternal age, 
maternal education, pre-pregnancy BMI, and exposure to secondhand smoking 
 
  Gestational age Preterm birth Spontaneous preterm birth 
Metals Biomarkers 
Change in days 
(95% CI) 
p value OR (95% CI) p value OR (95% CI) p value 
Co 
UrineSG 0.6 (-0.6, 1.8) 0.30 0.82 (0.60, 1.11) 0.20 0.95 (0.63, 1.43) 0.81 
Blood -0.6 (-1.6, 0.5) 0.31 1.18 (0.90, 1.54) 0.24 0.95 (0.65, 1.37) 0.77 
MMBICC 0.0 (-1.2, 1.3) 0.97 0.99 (0.72, 1.35) 0.93 0.93 (0.61, 1.42) 0.74 
MMBWQS -0.5 (-1.6, 0.6) 0.34 1.17 (0.89, 1.53) 0.26 0.94 (0.65, 1.38) 0.76 
Cs 
UrineSG 0.3 (-0.9, 1.4) 0.67 0.93 (0.69, 1.26) 0.66 0.77 (0.52, 1.15) 0.20 
Blood 0.0 (-1.2, 1.2) 0.95 1.11 (0.80, 1.55) 0.52 1.00 (0.66, 1.52) 0.99 
MMBICC 0.2 (-1.1, 1.4) 0.80 1.06 (0.76, 1.47) 0.72 0.90 (0.59, 1.37) 0.62 
MMBWQS 0.1 (-1.1, 1.3) 0.86 1.09 (0.78, 1.52) 0.60 0.96 (0.63, 1.45) 0.83 
Cu 
UrineSG -0.7 (-1.7, 0.4) 0.20 1.05 (0.81, 1.35) 0.73 1.10 (0.79, 1.53) 0.56 
Blood -0.3 (-1.0, 0.5) 0.48 1.16 (0.86, 1.55) 0.34 1.10 (0.76, 1.60) 0.62 
MMBICC -0.5 (-1.4, 0.4) 0.27 1.17 (0.85, 1.60) 0.34 1.15 (0.76, 1.75) 0.51 
MMBWQS -0.4 (-1.3, 0.4) 0.34 1.17 (0.85, 1.60) 0.33 1.14 (0.75, 1.72) 0.54 
Mn 
UrineSG -0.6 (-1.6, 0.3) 0.17 1.15 (0.88, 1.49) 0.30 1.30 (0.90, 1.87) 0.16 
Blood -1.0 (-2.1, 0.2) 0.11 1.24 (0.93, 1.67) 0.15 1.35 (0.93, 1.98) 0.12 
MMBICC -1.2 (-2.3, -0.1) 0.04** 1.31 (0.98, 1.76) 0.07* 1.52 (1.04, 2.24) 0.03** 
MMBWQS -1.1 (-2.2, -0.1) 0.04** 1.30 (0.97, 1.74) 0.07* 1.52 (1.04, 2.23) 0.03** 
Ni 
UrineSG 0.4 (-0.7, 1.5) 0.46 0.76 (0.57, 1.00) 0.05* 0.70 (0.48, 1.01) 0.06* 
Blood 0.3 (-0.7, 1.2) 0.59 1.04 (0.81, 1.32) 0.77 0.92 (0.66, 1.29) 0.64 
MMBICC 0.5 (-0.6, 1.6) 0.36 0.89 (0.66, 1.18) 0.41 0.74 (0.50, 1.10) 0.14 
MMBWQS 0.3 (-0.6, 1.3) 0.53 1.02 (0.80, 1.30) 0.89 0.90 (0.64, 1.26) 0.53 
Zn 
UrineSG -0.1 (-1.4, 1.2) 0.88 0.91 (0.66, 1.24) 0.54 0.89 (0.58, 1.35) 0.57 
Blood -0.5 (-1.3, 0.2) 0.17 1.66 (1.19, 2.30) 0.003*** 1.35 (0.88, 2.08) 0.16 
MMBICC -0.5 (-1.4, 0.3) 0.21 1.45 (1.05, 2.00) 0.02** 1.22 (0.80, 1.86) 0.36 
MMBWQS -0.5 (-1.3, 0.3) 0.20 1.55 (1.12, 2.15) 0.01** 1.28 (0.84, 1.97) 0.25 
As 
UrineSG -1.2 (-2.3, -0.1) 0.03** 1.17 (0.89, 1.53) 0.27 1.30 (0.92, 1.85) 0.14 
Blood 1.1 (-0.4, 2.5) 0.16 0.78 (0.51, 1.19) 0.24 0.49 (0.26, 0.93) 0.03** 
MMBICC 0.7 (-0.6, 2.1) 0.75 1.00 (0.74, 1.33) 0.98 0.92 (0.62, 1.36) 0.67 
MMBWQS 0.4 (-1.1, 1.9) 0.04** 1.16 (0.88, 1.53) 0.29 1.28 (0.90, 1.84) 0.17 
Cd 
UrineSG 1.5 (0.2, 2.7) 0.02** 0.71 (0.51, 1.00) 0.05 0.54 (0.34, 0.88) 0.01** 
Blood 0.1 (-1.5, 1.8) 0.87 0.77 (0.49, 1.20) 0.25 0.86 (0.48, 1.55) 0.62 
MMBICC 0.0 (-1.2, 1.3) 0.30 0.71 (0.49, 1.03) 0.07* 0.69 (0.42, 1.14) 0.15 
MMBWQS -0.5 (-1.6, 0.6) 0.59 0.74 (0.49, 1.10) 0.14 0.77 (0.45, 1.31) 0.34 
Hg 
UrineSG 1.1 (-0.1, 2.2) 0.07* 0.97 (0.73, 1.29) 0.84 0.80 (0.54, 1.18) 0.27 
Blood 0.4 (-0.8, 1.6) 0.48 1.05 (0.77, 1.43) 0.76 1.32 (0.87, 2.01) 0.20 
MMBICC 0.9 (-0.3, 2.1) 0.13 1.01 (0.74, 1.36) 0.97 1.00 (0.67, 1.51) 0.99 
MMBWQS 0.4 (-0.8, 1.6) 0.53 1.05 (0.77, 1.43) 0.76 1.31 (0.87, 1.99) 0.20 
Pb 
UrineSG -0.4 (-1.7, 0.8) 0.50 1.09 (0.80, 1.48) 0.59 0.92 (0.60, 1.39) 0.68 
Blood -1.6 (-2.8, -0.5) 0.01** 1.53 (1.14, 2.06) 0.01** 1.57 (1.07, 2.29) 0.02** 
MMBICC -1.5 (-2.6, -0.4) 0.01** 1.50 (1.12, 1.99) 0.01** 1.51 (1.04, 2.19) 0.03** 
MMBWQS -1.5 (-2.6, -0.4) 0.01** 1.46 (1.10, 1.95) 0.01** 1.43 (0.98, 2.10) 0.06* 
ERS 
UrineSG -3 (-4.3, -1.7) <0.001*** 1.73 (1.22, 2.43) 0.002*** 2.65 (1.64, 4.28) <0.001*** 
Blood -1.4 (-2.4, -0.4) 0.01** 1.03 (0.77, 1.37) 0.83 2.19 (1.4, 3.42) <0.001*** 
MMBICC -1.9 (-3, -0.8) <0.001*** 1.83 (1.32, 2.54) <0.001*** 2.13 (1.35, 3.35) 0.001*** 












Table V.7 Continued 
 
  Birthweight z-score SGA LGA 
Metals Biomarkers 
Change in z-score 
(95% CI) 
p value OR (95% CI) p value OR (95% CI) p value 
Co 
UrineSG 0.07 (-0.02, 0.17) 0.13 0.66 (0.47, 0.93) 0.02 0.89 (0.65, 1.20) 0.44 
Blood 0.10 (0.02, 0.19) 0.02 1.02 (0.77, 1.36) 0.87 1.23 (0.94, 1.60) 0.13 
MMBICC 0.12 (0.02, 0.22) 0.02 0.80 (0.57, 1.10) 0.17 0.98 (0.74, 1.29) 0.87 
MMBWQS 0.11 (0.02, 0.20) 0.01 0.98 (0.73, 1.30) 0.88 1.19 (0.92, 1.55) 0.18 
Cs 
UrineSG 0.04 (-0.05, 0.14) 0.39 0.77 (0.56, 1.05) 0.10 1.03 (0.77, 1.38) 0.83 
Blood 0.08 (-0.02, 0.17) 0.12 0.83 (0.63, 1.09) 0.17 1.10 (0.81, 1.50) 0.55 
MMBICC 0.08 (-0.02, 0.18) 0.11 0.77 (0.57, 1.04) 0.08 1.17 (0.87, 1.56) 0.30 
MMBWQS 0.05 (-0.04, 0.15) 0.28 0.75 (0.54, 1.03) 0.07 1.05 (0.78, 1.41) 0.76 
Cu 
UrineSG 0.01 (-0.08, 0.09) 0.88 1.07 (0.83, 1.40) 0.60 1.01 (0.79, 1.29) 0.93 
Blood 0.01 (-0.05, 0.07) 0.68 1.09 (0.83, 1.44) 0.54 1.04 (0.83, 1.29) 0.75 
MMBICC 0.02 (-0.06, 0.09) 0.67 1.13 (0.82, 1.54) 0.46 1.05 (0.83, 1.33) 0.68 
MMBWQS 0.01 (-0.08, 0.10) 0.78 1.11 (0.83, 1.48) 0.49 1.02 (0.79, 1.33) 0.86 
Mn 
UrineSG 0.02 (-0.06, 0.09) 0.68 0.89 (0.72, 1.10) 0.30 1.03 (0.82, 1.30) 0.78 
Blood -0.01 (-0.11, 0.08) 0.79 1.13 (0.84, 1.52) 0.43 1.09 (0.81, 1.46) 0.59 
MMBICC 0.00 (-0.09, 0.09) 0.94 0.99 (0.74, 1.31) 0.93 1.00 (0.78, 1.28) 0.98 
MMBWQS 0.00 (-0.09, 0.09) 0.99 1.01 (0.75, 1.36) 0.94 1.09 (0.82, 1.46) 0.54 
Ni 
UrineSG 0.05 (-0.04, 0.13) 0.28 0.82 (0.62, 1.09) 0.17 1.08 (0.82, 1.42) 0.58 
Blood 0.05 (-0.03, 0.13) 0.19 0.92 (0.72, 1.18) 0.50 1.04 (0.82, 1.31) 0.76 
MMBICC 0.08 (-0.01, 0.17) 0.08 0.81 (0.60, 1.09) 0.17 1.11 (0.86, 1.43) 0.44 
MMBWQS 0.09 (-0.01, 0.18) 0.08 0.78 (0.56, 1.08) 0.13 1.10 (0.82, 1.49) 0.52 
Zn 
UrineSG -0.04 (-0.14, 0.06) 0.45 1.02 (0.73, 1.43) 0.89 0.77 (0.58, 1.04) 0.09 
Blood 0.00 (-0.06, 0.07) 0.90 1.07 (0.81, 1.40) 0.64 1.07 (0.82, 1.38) 0.63 
MMBICC 0.00 (-0.07, 0.06) 0.90 1.07 (0.81, 1.41) 0.64 1.00 (0.83, 1.21) 0.99 
MMBWQS -0.04 (-0.14, 0.06) 0.46 1.03 (0.74, 1.45) 0.84 0.78 (0.58, 1.05) 0.11 
As 
UrineSG -0.03 (-0.12, 0.06) 0.48 1.09 (0.82, 1.45) 0.57 1.04 (0.79, 1.36) 0.79 
Blood 0.10 (-0.02, 0.22) 0.11 0.97 (0.66, 1.43) 0.87 1.25 (0.88, 1.79) 0.21 
MMBICC 0.03 (-0.07, 0.12) 0.56 1.04 (0.77, 1.40) 0.81 1.11 (0.86, 1.43) 0.43 
MMBWQS -0.03 (-0.12, 0.06) 0.50 1.09 (0.81, 1.47) 0.57 1.04 (0.79, 1.37) 0.77 
Cd 
UrineSG 0.02 (-0.08, 0.12) 0.69 1.18 (0.85, 1.63) 0.33 1.14 (0.84, 1.54) 0.40 
Blood 0.09 (-0.04, 0.23) 0.18 0.73 (0.45, 1.17) 0.19 1.06 (0.70, 1.61) 0.79 
MMBICC 0.07 (-0.04, 0.18) 0.20 0.88 (0.60, 1.27) 0.49 1.04 (0.76, 1.42) 0.80 
MMBWQS 0.07 (-0.04, 0.18) 0.22 0.91 (0.63, 1.31) 0.61 1.11 (0.80, 1.55) 0.52 
Hg 
UrineSG -0.06 (-0.15, 0.03) 0.20 1.06 (0.79, 1.42) 0.71 0.92 (0.69, 1.22) 0.54 
Blood -0.05 (-0.15, 0.05) 0.34 1.02 (0.75, 1.40) 0.90 1.13 (0.84, 1.52) 0.42 
MMBICC -0.07 (-0.16, 0.03) 0.17 1.05 (0.77, 1.44) 0.76 1.10 (0.83, 1.45) 0.52 
MMBWQS -0.07 (-0.16, 0.03) 0.17 1.05 (0.77, 1.43) 0.75 1.01 (0.75, 1.36) 0.96 
Pb 
UrineSG 0.02 (-0.08, 0.12) 0.69 0.83 (0.59, 1.15) 0.26 1.02 (0.75, 1.37) 0.92 
Blood -0.01 (-0.1, 0.08) 0.82 1.13 (0.83, 1.54) 0.44 0.88 (0.67, 1.14) 0.33 
MMBICC -0.01 (-0.1, 0.08) 0.87 1.10 (0.81, 1.48) 0.54 0.87 (0.68, 1.10) 0.25 
MMBWQS 0 (-0.09, 0.09) 0.96 1.05 (0.78, 1.41) 0.76 0.89 (0.68, 1.17) 0.40 
ERS 
UrineSG -0.13 (-0.22, -0.03) 0.01** 1.94 (1.36, 2.77) <0.001*** 1.52 (1.13, 2.06) 0.01** 
Blood -0.11 (-0.2, -0.02) 0.02** 1.52 (1.09, 2.12) 0.01** 0.97 (0.72, 1.31) 0.86 
MMBICC -0.16 (-0.26, -0.07) <0.001*** 1.58 (1.13, 2.21) 0.01** 1.23 (0.90, 1.69) 0.20 
MMBWQS -0.16 (-0.25, -0.07) <0.001*** 1.59 (1.12, 2.25) 0.01** 1.45 (1.06, 1.97) 0.02** 
Abbreviations: cobalt (Co); cesium (Cs); copper (Cu); manganese (Mn); nickel (Ni); zinc (Zn); arsenic (As); cadmium (Cd); 
mercury (Hg); lead (Pb); intraclass correlation coefficient (ICC); weighted quantile sum regression (WQS); small for gestational 









Chapter VI  
Conclusions 
 
Summary of findings 
This dissertation presents findings from four studies investigating the relationships between metal 
exposures and adverse birth outcomes. Figure VI.1 illustrates the main findings and significance 
of this dissertation. Using novel study designs, I evaluated the predictors of metal profiles 
measured in different media and their association with adverse birth outcomes, as well as the 
interactions between metals and maternal psychosocial status. The results provide strong evidence 
for the relationship between environmental metal exposure during pregnancy and increased risk of 
adverse pregnancy and fetal growth outcomes, and also suggest a possible role of psychosocial 
status in modifying these relationships. While additional epidemiological investigations are 
required, the present dissertation work has potential implications for public health policies and 
infrastructure design changes aimed at reducing the rates of adverse birth outcomes and their social 
and economic burdens.  
 
Predictors of maternal metal exposure. The investigation in Aim 1 characterized the metal(loid) 
biomarker variation over time and between matrices and explored important exposure sources and 
predictors among 1040 study participants from the PROTECT cohort. Distributions, trends, 
correlations, predictors of urinary and blood metal(loid) concentrations were assessed. Levels of 
blood Pb in pregnant Puerto Rican women were particularly low (GM=0.33 μg/dL) when 
comparing across other studies of pregnant women and all blood samples in our study had Pb 
concentration lower than the level of concern set by CDC for pregnant women (5 μg/dL) [1, 2]. 
Correlations for urine:blood metal pairs were weak to moderate. This is consistent with our 
knowledge that the circulating level and excreted level may not be correlated and often are 
representing different windows of exposure. Urinary concentrations of metal(loid)s were 
significantly different between the three visits for Co, Cs, Cu, Mo, and Zn. Reported use of shaving 





and Zn concentrations while fish and rice consumption were associated with an increase in urinary 
As and blood Hg concentrations. Iron and folic supplement intake was associated with elevated 
urinary Cs, Mo, and Sb concentrations. 
 
Maternal blood metal exposure and adverse pregnancy outcomes. Aim 2 assessed the individual 
and collective effects of maternal blood metal(loid)s on adverse birth outcomes in 812 pregnant 
women in the PROTECT cohort. The analysis revealed that maternal blood Pb, even at very low 
levels, was most strongly associated with increased risk of preterm birth and shorter gestational 
age. When analyzed as a mixture, odds ratios were greater in magnitude and more precise 
compared to the odds ratio estimates from the single pollutant models. Mixture analysis also 
provided evidence that Pb, Zn, and Mn are likely key exposures during pregnancy contributing to 
adverse birth outcomes. The stratified analysis by study visits of sample collection revealed 
potential windows of susceptibility for adverse birth outcomes, especially for overall and 
spontaneous preterm birth. In samples collected at median 22 weeks of gestation, increases in 
blood Pb and Zn were associated with a twofold increase in the odds of overall and spontaneous 
preterm birth, while an association with similar magnitude was observed between Hg and the odds 
of spontaneous birth at median 26 weeks of gestation. Additionally, an infant sex-specific 
interaction was noted for Zn and gestational age, which could be indicative of vulnerability for 
women carrying a female fetus. We did not detect any significant associations for birthweight or 
large for gestational age. 
 
Interaction between psychosocial status and metal exposure. Aim 3 examined the extent to which 
overall psychosocial status, characterized by depression, perceived stress, social support, and life 
events, modified the association between metal exposure and adverse pregnancy outcome in 682 
women from the PROTECT study.  The examination of two clusters of women being in “good” 
and “poor” psychosocial status reported significant and strengthened associations in the presence 
of “poor” psychosocial status. Specifically, women with “poor” psychosocial status had stronger 
associations between blood Mn concentration and gestational age and preterm birth. The 
association between Cu and small for gestational age was also statistically significant only among 






Evaluating the performance of urine, blood, multimedia metal mixtures. For Aim 4, we focused 
on a subset of 847 PROTECT participants with paired urine and blood measurements of 10 metals. 
First, integrated exposure estimates, multi-media biomarkers (MMBs), were composed from 
paired urine and blood biomarkers. Then, the mixture predictive performance of urine and blood 
metal biomarkers, and integrated multi-media biomarkers, were evaluated using associations 
between environmental risk scores (ERSs) and preterm birth. The ERSs constructed for urine 
biomarkers correcting for urinary dilution, blood biomarkers, and multi-media biomarkers had 
comparable predictive performances, and they all substantially outperformed urine ERS when 
using uncorrected urine metal concentrations, which do not account for urinary dilution.  
 
Integration of findings 
Together, the results from the four aims of this dissertation research showed significant evidence 
of associations between metal exposure and adverse birth outcomes, some of which are modified 
by maternal psychosocial stress. Some of the essential and non-essential metals presented 
consistent associations that were supported by results from limited previous studies, while some 
associations were less understood in the previous literature. Nonetheless, several overarching 
themes emerged from this dissertation: 
 
Pb exposure is crucial in metal mixtures, even at low levels. Findings from all four aims 
strongly suggest that Pb was the most important metal for the determination of true impact 
of metal mixtures on pregnancy. All of the women in the PROTECT cohort had blood Pb 
levels well below the level of concern set by CDC, a blood level of 5 µg/dL for pregnant 
women [1, 2]. Moreover, the average blood Pb concentration among Puerto Rican women 
(3.3 µg/dL) was particularly low compared to the levels reported in other existing literature 
on pregnant women. And yet, mixtures analyses (Aim 2 and Aim 4) revealed that blood Pb 
level was the most important predictor of increased risk of preterm birth, when accounting 
for the effect of other metals. Excluding Pb from metal mixtures in the analysis 
significantly lowered the impact of mixture on preterm birth, suggesting that the mixture 
effect was driven mainly by the strong effect of Pb. Aim 3 shed light on another notable 
finding on Pb. Even though the effect of Pb on birth outcomes did not differ by overall 





among women within the “poor” psychosocial status group compared to the “good” 
psychosocial status group. It is possible that this is due to unmeasured common cause(s) of 
high Pb exposure and “poor” psychosocial status and/or the potential of Pb exposure 
impacting psychosocial health. Together, these findings suggest that not only Pb exposure 
has its own dominant contribution to the effect of metal mixtures, but it may also influence 
the association of other metals. Therefore, in the case of Pb, this dissertation highlights the 
importance of considering Pb and the framework of metal dyshomeostasis in metal mixture 
studies. Furthermore, this dissertation provide evidence for the need to reduce Pb exposure 
as much as possible for all pregnant women.  
 
Considering both predictors and modifiers of metal exposure for mitigation strategies. Aim 
1 and Aim 3 results suggest that interventions through predictors and modifiers of metal 
exposure should be put in place to alleviate the effects of metals on pregnant women. Aim 
1 identified that diet, water sources, and smoking were predictors and sources of metal 
exposures, which suggests that reduction of exposure may be achieved by modifying 
consumer behaviors and the household environment. Identified sources of exposure can 
also inform techniques and tools for reducing the actual exposure, including infrastructure 
designs.  In Aim 3, the strengthened effects of metals on adverse birth outcomes among 
women with poor overall psychosocial health give insights to modifiable psychosocial 
assets that may help mitigate risk. Knowledge on psychosocial modifiers can help us 
integrate useful mental health resources to provide for expecting mothers. From a chemical 
and psychosocial stress interaction perspective, by identifying pregnant women who are at 
higher risk (who are at “poor” psychosocial status) at early visits, care providers can 
provide mental health resources for them. This identification can also help target groups to 
focus more attention on reducing actual chemical exposure through primary sources of 
different metal exposure. These suggestions are especially relevant today as the island is 
still recovering from the catastrophic damages caused by Hurricane Maria, a Category 5 
Hurricane, hitting Puerto Rico in late 2017. While the hurricane spared no one, leaving 
residents homeless and short of electricity, water, and food supply, the unique 
vulnerabilities of particular groups, including pregnant women, were exposed. 





of buildings, combined with the elevated levels of stress as a result of Hurricane Maria 
created an especially vulnerable state for pregnant women. Psychosocial scale data used in 
this dissertation were collected prior to Hurricane Maria and therefore do not reflect the 
difference between pre- and post-hurricane. Nonetheless, findings from this dissertation 
suggest that interventions should be initiated to alleviate the effects of chemical and 
psychosocial stressors on pregnant women, in addition to the continuing recovery efforts 
on the island.  
 
Importance of considering windows of vulnerability and effect modification by fetal sex. 
Limited studies have measured and/or compared metal(loid) concentrations at different 
times during pregnancy and explored window specific or sex-specific association among 
existing cohorts assessing the impact of environmental chemicals and adverse birth 
outcomes among pregnant women [3-7]. The PROTECT study design enables the 
assessment of the differences in associations by study visit and fetal sex. In this 
dissertation, we provided evidence that the association between study visits and fetal sex, 
manifested differential associations between metals and birth outcomes. Firstly, in Aim 1, 
we studied the variability of metal(loid)s across pregnancy and reported that the 
concentrations of some metals varied across three visits, which may due to various factors 
including a metal’s unique physiochemical properties and toxicokinetics, the changes in 
fetal and maternal nutrient supply [8], and the metabolic changes such as variation in 
glomerular filtration rate [9, 10] and plasma volume expansion [11]. In Aim 2 and Aim 3, 
we explored whether the associations of metals with birth outcomes differed between study 
visits. Aim 2 revealed positive and robust associations between the metals such as Pb and 
Zn that are mainly driven by associations in an earlier visit. In contrast, Aim 3 showed that 
the interaction of metals and psychosocial status on birth outcomes did not statistically vary 
by visits. The inconsistent findings from Aim 2 and Aim 3 were likely due to the small 
sample size in the “poor” psychosocial status cluster in Aim 3, limiting the assessment 
power of effects estimates. Therefore, we suggest that elevated levels at particular 
gestational ages may play a critical role in the association between metal(loid)s and adverse 
birth outcomes. In Aim 2, we also provided evidence for a heightened vulnerability to metal 





preterm birth, Zn, showed a significant association with increased odds of preterm birth 
among women carrying female fetuses, while the association were null among women 
carrying male fetuses. In order to fully test the hypothesis of window specific vulnerability 
and effect modification of fetal sex, larger longitudinal cohorts with repeated 
measurements are needed. 
Urine and blood biomarkers highlight different prediction performances. In the PROTECT 
study, repeated measures of metal(loid) concentrations in both blood and urine samples 
enabled us to characterize the reliability and predictive performance of metal exposures 
measured in different biological matrices. Results from Aim 1 and Aim 4 provide useful 
information on metal biomarker selection to future epidemiology studies of birth outcomes. 
More specifically, Aim 1 concluded that blood measurements of metals such as Cu, Zn, 
Mn, Hg, and Pb presents higher reliability and abundance compared to urine 
measurements. This conclusion can inform single-pollutant studies on recommending a 
more suitable biomarker for a single metal. Aim 4 examined the predictive performance of 
metal exposures measured in different biological matrices in a mixture setting because 
there is growing interest in the realistic scenario of studying the collective effects of 
environmental chemicals on humans, including metals [4, 12-19]. Our investigation in Aim 
4 demonstrates, within practical metal analytical panels, that measuring metals in either 
urine or blood may be an equally good approach to evaluate the metals as a mixture, but 
only when the urine measurements are corrected for urinary dilution. These findings 
provide evidence that exposure assessment in urine and blood may inform us of different 
biological relationships under single metal and metal mixture scenarios. However, future 
expanded studies are needed to evaluate the performance with different metal panels, 
media, health outcomes of interest, and methods to integrate exposure information, to 
further address how to most effectively study the health impacts of exposure to metals. 
Future research questions 
Employing an innovative study design and novel statistical methodologies, this dissertation adds 
to the growing evidence on the risk of metals exposure on adverse birth outcomes. However, future 






Mechanisms of action and mediation analysis. As this study suggests that metal exposures 
may be a contributor to adverse birth outcomes, additional research is necessary to explore 
the mechanisms and pathways through which metals are impacting pregnancy. Exposure 
to metals impacts various biological pathways associated with adverse birth outcomes: (1) 
one of the leading proposed mechanisms for metal toxicity is oxidative stress, defined as 
the homeostatic imbalance between cellular oxidants and availability of antioxidants to 
favor oxidation [20, 21]. Oxidative stress plays an important role in the development of 
many adverse birth outcomes, including preeclampsia, preterm birth, and intrauterine 
growth restriction [22-26]. The levels of oxidative stress biomarkers, such as 8-iso-
prostaglandin F2α (8-iso-PGF2α), increase during pregnancy and peak at delivery [27], 
suggesting that this mechanism plays an important role in normal childbirth. Previous 
human studies have shown positive associations between higher levels of oxidative stress 
biomarkers (8-iso-PGF2α) and preterm birth [28-32]. A recent analysis in the PROTECT 
study also suggested that elevated levels of 8-iso-PGF2α and its metabolite are associated 
with higher odds of overall preterm birth, and particularly spontaneous preterm birth [33]. 
Several in vivo and in vitro studies have linked metal exposure with increased formation 
of reactive oxygen species (ROS) [34, 35]. The excessive ROS can induce oxidative stress 
and cause damage to cells, leading to the release of lipid peroxidation products into 
circulation [20]. Elevated biomarkers of oxidative stress in association with exposure to 
heavy metals, including lead (Pb), arsenic (As), and cadmium (Cd), have been reported 
[36-40]. (2) Reproductive hormones also play an important role in maintaining pregnancy; 
in turn, disruption of the complex interplay between hormones may lead to adverse effects 
during gestation. A number of metals, including Cd, Hg, As, and Pb, are reproductive 
toxicants and suspected endocrine disruptors [41-44]. Evidence suggests that metals can 
influence reproductive hormone levels through several pathways, including hormone 
synthesis, regulation, transport and metabolism, and/or interference with receptors [45-52]. 
These results suggest that the mechanism of action for metals affecting pregnancy may also 
be through disrupting reproductive hormones. (3) Epigenetic changes could also play a role 






Longitudinal studies such as PROTECT with data on molecular markers of these potential 
mediators provide an opportunity to explore the biological mechanisms and pathways through 
which prenatal exposure metals are influencing the length of gestation and fetal growth. The 
role of these potential underlying mechanisms should be investigated more closely as 
mediation analysis will provide an additional step towards establishing a causal pathway. 
 
Comprehensive evaluation of metal and psychological stressor interactions. Our research 
findings also provide motivation for future work investigating other adverse health effects 
resulting from the interaction between metal and psychosocial stressors. While this 
dissertation demonstrates that the effects of metals on adverse birth outcomes vary by 
maternal psychosocial status, the interaction between metal and psychosocial status may 
also contribute to other known outcomes associated with metals, including reproduction, 
neurodevelopmental outcomes, and sexual development. Future research is required to 
elucidate more comprehensive interactive relationships between metals and psychosocial 
factors on reproductive and child health. 
  
Expanding mixture analysis. Considering the prevalence and daily exposure of 
environmental contaminants in the island, an important next step is to assess the collective 
effect of different chemical mixtures in relation to adverse birth outcomes. The mixture 
approaches and models established in the present work using metal biomarkers may serve 
as a useful tool for a larger mixture analysis including additional chemical families, such 
as phenols, phthalates, metals, and particulate matter altogether.   
 
Public health impact and innovation 
The rate of preterm births in the U.S. has been increasing over the last few decades and is 
associated with many chronic health conditions and developmental disabilities. Over the decades, 
Puerto Rico has been experiencing an unusually high rate of preterm birth, as well as 
environmental and financial burdens. PROTECT, a large prospective longitudinal cohort study in 
Puerto Rico, is exploring how environmental exposures during pregnancy are potentially 
associated with preterm birth. With repeated longitudinal data on chemical panels, PROTECT 





and preterm birth in this at-risk population, and to test more realistic exposure profiles’ impact on 
preterm birth. 
 
This work produced important insights into the levels of prenatal exposure of Puerto Rican 
pregnant women to metals, as well as helping to fill knowledge gaps about the individual and 
collective effects of prenatal metals exposure on adverse birth outcomes and the interaction 
between chemical and psychosocial stressors. Evaluation of chemical mixtures measured in 
different media will inform more efficient study designs for exposure assessment. Improved 
understanding of environmental and other factors that contribute to preterm birth, together with 
developing sustainable technologies to remove contamination, will have a direct impact in Puerto 
Rico. The metal exposures targeted for this analysis are ubiquitous in the U.S. and elsewhere 




The present dissertation utilized innovative approaches to provide important evidence on the 
impact of a class of chemicals, metals, on adverse birth outcomes. The dissertation includes the 
first study to characterize the profile, trends, and predictors of metal exposure among pregnant 
women in Puerto Rico. Incorporating the full richness and structure of the repeated data across 
pregnancy, important predictors and sources of a large panel of metals were identified which can 
provide potential guidelines for food choice and behavioral changes during pregnancy and also 
inform engineering designs that may help reduce metal exposure. In this dissertation, more realistic 
exposure profiles were analyzed both individually and collectively as a mixture which provided 
evidence that selected metals including Pb, Zn, Mn are associated with adverse birth outcomes. A 
novel example of dimension reduction on the effect of modifier space with clustering revealed that 
the presence of “poor” psychosocial status is strengthening the negative effect of some metals, 
especially manganese, on gestational length. This finding complements current research regarding 
how environmental and psychosocial stressors interact in their contribution to birth outcomes. 
Together with knowledge on the predictor and sources of metal exposures, the findings also help 
identify the appropriate mitigation strategies and interventions necessary to reduce the burden of 





learning approaches were also utilized to integrate exposure to metals measured in different media 
and evaluate the performance of different metal mixture biomarkers; the findings demonstrate, 
within practical metal analytical panels, that measuring metals in either urine or blood may be an 
equally good approach to evaluate the metals as a mixture, but only when the urine measurements 
are corrected for urinary dilution. Future expanded studies are needed to evaluate the performance 
with different metal panels, media, health outcomes of interest, and methods to integrate exposure 
information, to further address how to most effectively study the health impacts of exposure to 
metals. A significant overall finding from all the aims in this dissertation is that even though Pb 
level among this population is particularly low Pb exposure measured in blood was the most 
important predictor of preterm birth among all the metals we examined. Our study supports the 
recent suggestion from the scientific community on lowering guideline levels for Pb to protect 
pregnant women and their children. Altogether, this dissertation advances our understanding of 
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Ø Supplement-Cs, Mo, and Sb
Ø Pb at low levels / below 
current guidelines may be 
associated with preterm 
birth.
Ø Some essential metals such 
as Mn and Zn may be 
harmful at higher levels.
Ø Women were clustered to 
two groups of having “good” 
vs “poor” psychosocial status
Ø Adverse associations between 
Mn and preterm birth and Cu 
and SGA were stronger in 
the presence of poor 
psychosocial status
Ø Measuring metals in either urine 
or blood may be an equally good 
approach to evaluate the metals 
as a mixture, but only when the 
urine measurements are 
corrected for urinary dilution
Overview of Research Aims and Main Findings Impact and Significance
Ø Fills a critical gap in literature by 
reporting evidence of metal mixture 
influencing birth outcomes.
Ø Findings suggest that reduction of 
exposure may be achieved by 
modifying consumer behaviors, 
household environment.
Ø Modifiable psychosocial assets that 
may help mitigate risk 
Ø Data-driven machine learning 
approaches to inform the selection 
of biomarker sets in the context of 
a mixture 
Predictor/
Sources
Metals Birth 
Outcomes
Psychosocial
Stress
Metals
Aim 2
Aim 3
Aim 4
Aim 1
